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N o law of nature, 
however general, has been established 
all at once; its recognition has always been preceded 
by many presentiments. The establishment of a law, 
moreover, does not take place when the first 
thought of it takes form, or even when its significance is 
recognized, but only when it has been confirmed by 
the results of the experiment. The man of science 
must consider these results as the only proof of the 
   correctness of   his conjectures 
   and opinions.  
         D mitri Ivanovich M endeleev 
              (1834 – 1907)
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Summary
Defined interactions between thymocytes and thymic antigen presenting cells ensure 
that each T cell found in an individual is both self-restricted and self-tolerant. By inter-
acting with pMHC ligands, T cell receptors (TCRs) expressed on developing T cells initiate 
intracellular signaling cascades which lead either to survival and differentiation, referred to 
as positive selection, or to apoptotic cell death, referred to as negative selection. 
This thesis is aimed to a better understanding of how thymocytes distinguish between 
pMHC ligands inducing positive selection from those inducing negative selection. Transgenic 
mice and hybridomas expressing TCRs of defined specificity, referred to as T1-TCRs, were 
produced to study the role of TCR-ligand affinity in thymic selection of developing T cells. 
Ligand binding studies were performed with the photoaffinity labeling system developed by 
Immanuel Lüscher (Ludwig Institute; Epalinges, Switzerland). 
By defining the selection properties of various T1-TCR ligands and comparing their poten-
cy in inducing positive and negative selection with their TCR affinity it is shown, that TCR 
affinity is a key parameter for thymocyte selection. High affinity ligands induced negative 
selection, while low affinity ligands induced positive selection. A ligand with a moderate 
affinity was shown to induce either positive or negative selection, depending on the dose 
of the peptide. It was further shown, that the reduced sensitivity observed for mature T 
cells compared to thymocytes is not mediated by developmental changes in the affinity 
of TCR-ligand interactions. All ligands tested bound the TCR expressed on naive, mature 
T cells with the same affinity as the TCR expressed on thymocytes. Therefore, the results 
presented in the first part of this thesis suggest, that positive and negative selection of T 
cells depends on TCR-ligand affinity and that this affinity is preserved through all stages of 
T cell development. 
In the second part of this thesis studies are presented analyzing the role of the evolu-
tionarily conserved α-chain connecting peptide motif (α-CPM) in TCR-ligand binding and 
thymocyte development. Experiments performed with hybridomas and transgenic mice 
showed  that α-CPM deficient TCRs are not properly cooperating with the coreceptor mol-
ecule, CD8 to elicit responses to low affinity ligands. Interestingly responses to high affinity 
ligands were less affected. Thymocytes of α-CPM mutant mice were specifically defective in 
undergoing positive selection but were still able to undergo negative selection. By compar-
ing the TCR-ligand affinities on cells expressing either wildtype or α-CPM mutant T1-TCRs it 
was shown, that the absence of the α-CPM leads to a slight decrease in CD8 cooperativity 
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for ligand binding. The data therefore suggest, that the α-CPM plays an important role for 
successful cooperation of TCR and coreceptor in generating signals to low affinity, positive 
selecting ligands. 
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13
Abbreviations
ABA    Azidobenzoic acid
APC    Allophycocyanine
APS    Ammonium persulfate
ATCC    American Type Culture Collection
β2m    Beta-2 microglobulin
BSA     Bovine serum albumine
BSP    BirA specific peptide
CPM    Counts per minute
CD    Cluster of differentiation antigen
CDR    Complementarity Determining Region
CTL    Cytotoxic T lymphocyte
kD    Kilo Dalton    
DOC    Deoxycholic acid
DMEM    Dulbecco’s modified eagle medium
DMSO     Dimethylsulfoxid
DTT    Dithiothreitol
ECL    Enhanced chemoluminescence
ER    Endoplasmic Reticulum
FCS    Fetal calf serum
FACS    Fluorescence activated cell sorting
FPLC    Fast performance liquid chromatography
FITC    Fluorescein isothiocyanate
HEPES    N-2-hydroxyethylpoperazine-
    N-2-ethansulfonic acid 
HPLC    High pressure liquid chromatography
HRP    Horse radish peroxidase
IASA    4-iodo azidosalicylic acid
Ig    Immunoglobulin
IP    Immunoprecipitation
IPTG    Isopropyl β-D-1-thiogalactopyranoside
ITAM    Immunoreceptor tyrosine activation motif
LB    Luria-Bertani
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MFI    Mean fluorescence intensity
MW    Molecular weight
MES    2-[N-Morpholino]ethansulfonic acid
n.d    Not determined
mAb    Monoclonal antibody
OD    Optical density
PAGE    Polyacrylamid gel electrophoresis
PbCS    Plasmodium circumsporozoite
PCR    Polymerase chain reaction
PE    Phycoerythrin
pMHC    Peptide-majorhistocompatibility complex
PMSF    Phenylmethylsulfonylfluoride
PNA    Peanut agglutinine
PerCP    Peridinine chlorophyll protein
RT    Room temperature
SA    Streptavidin
SDS    Sodium dodecyl sulfate
Si    Sievert (conductivity unit)
TCR    T cell receptor
Temed   N,N,N,N’ tetramethyl ethylenediamine
tg    Transgenic
Tris    tris(hydroxymethyl)aminomethane
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1. Introduction
The two major functions of the vertebrate immune system are to protect individuals 
from parasites like bacteria, viruses, fungi, protozoa and worms on one hand and to kill 
potentially malignant tumor cells on the other hand. Many bacteria, virus and fungus 
strains expose conserved structural features (i.e. proteins, lipids or carbohydrates) on 
their cell surface which are recognized by the innate immune system including white 
blood cells (leucocytes) and soluble factors of the complement system. Organisms which 
are properly recognized by the innate immune system are either killed or kept under 
tight control and are therefore non-pathogenic. In contrast, pathogens have developed 
strategies to escape the survey of the innate immune system by constantly changing the 
appearance of their cell surface. 
To be able to recognize and eliminate such pathogenic organisms, the adaptive im-
mune system has evolved. Cells of the adaptive immune system, including B and T cells, 
clonotypically express cell surface receptors which are produced by somatic gene recom-
bination. By the stochastic process of VDJ gene-segment recombination, an enormous 
diversity of B cells and T cells is produced whereby each cell expresses a different B cell 
receptor (BCR) in the case of B cells or T cell receptor (TCR) in the case of T cells. Be-
cause the recombination process produces BCRs and TCRs of random specificities, poten-
tially useless or self-reactive receptors and hence cells are produced during this process. 
Therefore B and T cells are subjected to selection processes which lead to the withdrawal 
of those cells which express BCRs or TCRs with unfavorable specificities. These selection 
processes are of particular importance for T cells, which can not only directly kill tumor 
cells or virus infected cells of the body, but also control the activation of other immune 
effector cells like macrophages and B cells. 
The thymus has developed as a specialized organ in which the T cell selection pro-
cesses take place. As soon as the developing T cells in the thymus, referred to as thy-
mocytes, express somatically rearranged TCRs on their cell surface they interact with 
majorhistocompatibility molecules (MHCs) expressed on thymic stromal cells. If this in-
teraction is too weak, the thymocytes die by ‘neglect’. If this interaction is too strong, 
the thymocytes die by apoptosis, removing potentially ‘self-reactive’ cells from the T cell 
repertoire. Only thymocytes which express TCRs that can moderately interact with the 
MHC ligand molecules receive a survival signal and continue their development leading 
to mature T cells, which leave the thymus, enter the blood stream and migrate to the 
peripheral lymphatic organs to protect the individual against infections and tumors. Thus, 
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TCR ligand binding is a pivotal feature of T cell development, determining the fate of 
all the thymocytes which have started to express randomly rearranged TCRs. The results 
shown in this thesis present further insights in the control of T cell development mediated 
by TCR ligand interactions. 
1.1 Molecules Involved in TCR Ligand Binding
1.1.1 The T Cell Receptor (TCR)
Each T cell receptor molecule is a disulfide linked heterodimer composed of polymorphic, 
membrane-bound polypeptide chains. Two different forms of TCR heterodimers have been 
identified: TCRα/β and TCRγ/δ. Receptor genes encoding TCRα and δ chains are assembled 
from separate V, J and C gene segments, while complete TCRβ and γ genes are assembled 
from separate V, D, J and C gene segments by genetic recombination similar to the biosyn-
thesis of antibody genes (Reviewed in Jung et al., 2004). In the case of TCRα/β receptors, 
three loops forming complementary determining regions (CDRs) from TCRα pair with three 
CDRs from TCRβ creating a binding site which interacts with pMHC ligand. While CDR1 and 
CDR2 are formed by the interaction of germ line encoded in the Vα and Vβ regions, the 
CDR3 regions are much more diverse, as they are formed by juxtaposition of polymorphic 
VJ or V(D)J gene segments by an imprecise joining of the coding regions. Regarding the high 
numbers of Vα gene segments (~70) and the 20 Vβ gene segments found in mice combined 
with several D (2) and J (12) segments, several thousand different TCRs could be produced. 
In fact, due to imprecise end-joining the number of successfully, inframe recombined TCRs 
is estimated to be in the billions (Reviewed in Nikolich-Zugich et al., 2004). Despite this 
large diversity of the TCR variable regions, all α/βTCRs of a single species express the same 
constant regions Cα and Cβ. Their extracellular regions consist of an Immunoglobulin (Ig) 
like domain and a connecting peptide (CP). In the case of Cα, the CP region contains the 
evolutionarily highly conserved α-chain connecting peptide motif (α-CPM). The transmem-
brane (TM) regions of Cα and Cβ link the extracellular domains to the very short cytosolic 
(cyto) regions (See Fig. 1.1A). Importantly, neither of the cytoplasmic tails of the TCRα/β 
chains contain known signaling domains; therefore, to transduce signals the TCRα/β het-
erodimer has to be associated with the CD3 complex. 
1.1.2 The TCR-CD3 Complex
The CD3 complex consists of four different chains which form two non-covalently linked 
heterodimers, CD3δ/ε and CD3γ/ε and a disulfide linked ζ homodimer. Proper assembly of 
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the CD3 complex in the endoplasmic reticulum (ER) together with the TCRα/β heterodimer 
is essential for TCR expression at the plasma membrane (Fig. 1.1B) (Letourneur et al., 1992; 
Kearse et al., 1994). The extracellular domains of CD3γ, δ and ε share little homology with 
Ig domains and the extracellular part of ζ is only 8 amino acids long (Sun et al., 2001). Each 
intracellular region of CD3γ, δ and ε contains one immunoreceptor tyrosine-based activation 
motif (ITAM) whereas ζ contains three ITAMs (Reviewed in Garcia et al., 1999). The ITAMs of 
the CD3 complex couple the TCR to intracellular Src tyrosine kinases Lck and Fyn (Reviewed 
by Germain, 1999).  
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class I class II
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ε δ γ ε
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α β
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Figure 1.1: Molecules involved in TCR ligand binding. (A) TCRα/β are heterodimeric, disulfide linked 
transmembrane molecules consisting of variable (V) and constant (C) regions containing a Ig-like domain 
each. The location of the connecting peptide (CP) the transmembrane region (TM) and the cytosolic (cyto) 
regions are indicated. The α-CPM is indicated in red. (B) The TCRα/β forms a non-covalent complex with 4 
different CD3 chains (γ/δ/ε and ζ). CD3γ, δ and ε contain each one ITAM (filled circles) while the homodimeric 
ζ molecule contains 3 ITAMs for each chain. TCR-ligand binding is coupled to the intracellular signaling 
cascades via the ITAMs found in the CD3 complex. (C) MHC class I and MHC class II molecules. The various Ig-
like domains are indicated (α1,α2,α3 for class I MHC and α1,α2,β1,β2 for class II MHC). Class I MHC forms a 
non-covalent complex with β2m. (D) CD4 coreceptors are comprised of four Ig-like domains (D1-D4) a short 
stalk region and a transmembrane region followed by a cytosolic regions which can interact with the Src 
kinase Lck. CD8 coreceptors are either comprised of disulfide linked α/α homodimers or α/β heterodimers. 
Both CD8α and CD8β contain one Ig-like domain, a long and extended stalk region, transmembrane regions 
and a cytosolic tail. While CD8α can interact with Lck, CD8β can not, but can instead be palmitoylated (not 
shown).
1.1.3 pMHC Complexes
TCRs are not able to recognize antigens in their native conformation. Instead, antigens 
have to be cleaved into relatively short peptides and presented by specialized proteins 
encoded in the major histocompatibility gene complex (MHC) on mouse chromosome 17. 
Two major classes of MHC molecules were identified, which are able to present peptides to 
TCRα/β. MHC class I molecules present peptides which are derived from proteins found in 
the cytosol. Cytosolic proteins are degraded by the proteasome complex and transported 
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into the ER via the TAP1/2 proteins. In the ER, the peptides are delivered into the peptide 
binding groove of the freshly synthesized MHC class I and β-2 microglobulin (β2m) mol-
ecules. In contrast, MHC class II molecules present peptides derived from extracellular pro-
teins, which are endocytosed by specialized antigen presenting cells (APCs) and degraded 
in the early endosomes. The resulting peptides are transported to the Trans-Golgi compart-
ment where they encounter newly synthesized MHC class II molecules bound to an invariant 
chain. Enzymatic digestion of this invariant chain leads to its release and the extracellu-
larly derived peptides can be placed in the binding groove of the MHC class II molecules. 
Peptide loaded MHC class I and MHC class II are transported to the plasma membrane and 
are stably expressed on the surface of APCs (Reviewed by Gascoigne et al., 2001). Despite 
their different subunit structures, MHC class I and MHC class II molecules show similar three 
dimensional structures (Fig. 1.1C). The membrane-distal face of the peptide-MHC complex 
that interacts with the TCR consists of a flat surface made up of two α-helices of the MHC 
surrounding a central peptide. MHC class I molecules present peptides of 8 to 10 amino ac-
ids, while MHC class II molecules are able to bind peptides consisting of 13 to 20 amino ac-
ids. In both cases the peptides make tight contacts with polymorphic amino acids lining the 
peptide binding groove of MHCs via amino acid anchor residues (Reviewed in Rammensee et 
al., 1995). Besides the TCR interaction site, MHC molecules are able to bind to the CD4 or 
CD8 coreceptors, which are expressed by T cells. MHC class I molecules interact with their 
α3 domain with CD8 while MHC class II molecules interact with their α2 domain with CD4.
 
1.1.4 CD4 and CD8 Coreceptor Molecules
CD4 and CD8 are referred to as coreceptors, because they are able to cooperate with 
TCR in antigen recognition. Upon induction of the genes encoding CD4 and CD8 during T 
cell development, both coreceptors are expressed on the cell surface of developing TCRα/β 
thymocytes. Depending on the type of MHC molecule recognized by the TCR, thymocytes 
develop into either MHC class II restricted CD4+ T cells or MHC class I restricted CD8+ T cells 
(Reviewed by Germain,  2002). CD4 is a single chain molecule consisting of four Ig-like do-
mains (D1, D2, D3, D4) a transmembrane region and a cytosolic tail which interacts with the 
Src kinase Lck. CD8 can either exist as a disulfide linked CD8α/α homodimer or a CD8α/β 
heterodimer (Fig. 1.1D). Both CD8α and CD8β are glycosylated transmembrane proteins con-
taining a N-terminal Ig domain each, extended hinge and stalk regions and transmembrane 
as well as cytoplasmic portions. On the other hand CD8β has only about 30% homology to 
CD8α and has a 13 amino acid longer extracellular domain (Reviewed by Gao et al., 2000). 
While the cytosolic tail of CD8α interacts with Lck, CD8β does not directly interact with the 
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kinase but can be palmitoylated and in this way controls the activity of the Lck (Irie et al., 
1995; Arcaro et al., 2000). CD8α/α homodimers are found on NK cells and intestinal T cells, 
while the expression of CD8α/β is necessary for the development of conventional  CD8 T 
cells (Wheeler et al., 1992; Nakayama et al., 1994; Crooks et al., 1994). 
1.1.5 Structural Aspects of TCR Ligand Binding
As described in Section 1.1.3 the TCR is not able to bind antigens in their native confor-
mation. Instead peptide fragments of antigens are presented by MHC class I or MHC class II 
molecules to the TCR. TCR-pMHC interactions are established between the CDR1, CDR2 and 
CDR3 loops of the TCR and the antigenic peptide bound between two α-helices of the MHC. 
Several crystal structures of TCR-pMHC interactions have been analyzed, including pMHC 
Figure 1.2: Crystal structure of TCR-pMHC class I interactions. (A) Extracellular fragments of TCR interacting 
with MHC class I ligand. The peptide is bound between the two α-helices of the α1 and α2 domains of class 
I MHC (blue) and presented to the TCR. The TCR interacts with the CDR2 domains (indicated with gray 
circles) of TCRα (green) and TCRβ (orange) with the α1 and α2 domains of the MHC molecule, while the 
CDR3 loops in the center of the binding interface contact the peptide (dark green). A two side views of the 
same interaction are shown. (B) TCR binds pMHC in a topologically constrained manner with TCRα placed 
over the N-terminus of the peptide and the α2 domains of MHC and TCRβ placed over the C-terminus of the 
peptide and the α1 domain of MHC. (Modified Figure from Garboczi et al., 1996).
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class I and pMHC class II complexes (Garboczi et al., 1996; Garcia et al., 1996; Garcia et al., 
1998; Gao et al., 1997; Hennecke et al., 2000). Detailed analysis of such complexes revealed 
certain common features of the TCR-pMHC interactions observed with all crystal structures 
described so far (Fig. 1.2A). TCR binds pMHC in a topologically constrained, diagonal man-
ner with the Vα domain of the TCR positioned over the N-terminal half of the MHC bound 
peptide and with the TCR Vβ domain over the C-terminal half of the peptide (Fig. 1.2B). 
In this orientation the CDR1 and CDR2 loops of the TCR are placed over the two α-helices 
of the peptide binding groove mediating most of the contacts between the TCR and MHC. 
The CDR3 loop instead is placed directly over the peptide. In this respect it is interesting 
to consider that the greatest diversity between TCR molecules is observed in the CDR3 
loops (due to non-homologous end joining of V (D) and J regions) interacting with the pep-
tide, while the CDR1 and CDR2 loops are less diverse (germline encoded in Vα and Vβ) and 
generally interact with the MHC. The affinities of a variety of TCR-pMHC interactions have 
been determined using surface plasmon resonance (SPR; BIACore; see Introduction 1.3.2.2). 
These measurements revealed very broad affinity range for bimolecular TCR-pMHC interac-
tions  from 1µM to 1mM (Reviewed in Davis et al., 1998 and Gascoigne et al., 2001). The fact 
that all crystallized CDR3 loops showed considerable conformational flexibility suggested 
that the interaction betweens CDR3s and the peptide utilize an ‘induced fit’ mechanism, in 
which proper binding is achieved by small conformational changes at the binding face. Sup-
port for this view came from surface plasmon experiments in which the curves gained from 
association and dissociation kinetics were best fit using induced-fit models (Wu et al., 2002; 
Gakamsky et al., 2004). This implied that depending on the structure of the CDR3 loop and 
the peptide, the kinetics of TCR-pMHC interactions can differ considerably due to the vary-
ing energy requirements needed to ‘induce’ an optimal ‘fit’. A different binding mechanism 
is proposed for the interaction of the coreceptors with MHC. Due to the low flexibility at 
the binding interfaces between CD8 and MHC class I and CD4 and MHC class II, these in-
teractions might resemble the ‘rigid-body association’ as it is described for many antibody 
antigen interactions or NK cell receptor-pMHC interactions (Maenaka et al., 1999). Despite 
this similarity, the interaction between coreceptors and MHCs are much weaker than most 
antibody antigen interactions. For CD8, KD values between 50µM and 150µM were described 
while the interaction between CD4 and MHC class II was described to be even weaker (KD 
>200µM). On the other hand, the simultaneous binding of coreceptors and TCR (Fig. 1.3) 
to the same pMHC complex leads to substantial stabilization of the TCR-pMHC interaction 
(Lüscher et al., 1995; Denkberg et al., 2001; Holler et al., 2003). 
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1.2 TCR Ligand Binding in T Cell Development
1.2.1 The Role of the Thymus in T Cell Development
Bone marrow derived T cell precursors migrate via the blood stream to the thymus at 
a very early stage of development, prior to TCR expression. T cell precursors found in the 
thymus and referred to as thymocytes initiate TCR expression and pass through a tightly 
controlled series of developmental stages, before they enter the blood stream again as 
mature, self-restricted and self-tolerant T cells. Several of these developmental stages are 
non cell-autonomous. Two of these are explained here in more detail. 
1.2.2 Positive and Negative Selection of Thymocytes
When T cell precursors enter the thymus, they express neither CD4 nor CD8 corecep-
tors and are therefore called ‘double negative’ (DN) thymocytes. DN thymocytes migrate 
to the subcapsular region of the thymic cortex, where they start to rearrange their TCR 
genes. Following successful TCRβ gene rearrangement, TCRβ molecules interact with the 
invariant pre-TCR surrogate chain and the CD3 complex and signal the cell to go through 
several  rounds of division and to upregulate the CD4 and CD8α/β coreceptor molecules. 
CD4
CD8
pMHC class II
TCRTCR
pMHC class IAPC
T cell or thymocyte
Figure 1.3: Models of TCR/CD4-pMHC class II and TCR/CD8-pMHC class I interactions. Crystallographic 
models of simultaneous TCR/coreceptor binding to pMHC complexes. The 3-D structures of class I and class 
II MHC molecules (shown in red) are very similar. While TCR (blue) interacts with MHC (red) and peptide 
(yellow) in a topologically constraint manner, the coreceptors can bind to membrane proximal domains 
of the MHC molecules independent of TCR/MHC binding. Coreceptor-MHC interactions do not sterically 
interfere but stabilize the interaction between TCR and pMHC (Modified Figure from van der Merwe et al., 
2003).
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CD4/CD8 ‘double positive’ (DP) cells then rearrange their TCRα gene locus, which leads to 
the production of TCRα chains which replace the pre-TCR surrogate chain and form α/βTCR 
heterodimers. Importantly, due to the processes of allelic exclusion (reviewed by Bassing, 
2000), each thymocyte generally expresses TCRs of only one specificity, i.e. TCRs are clo-
notypically expressed. As soon as TCRα/β is expressed on the surface of DP thymocytes it 
interacts with pMHC molecules presented by thymic epithelial cells. From this timepoint 
on, thymocyte survival is critically dependent on TCR signaling. Thymocytes which receive 
no TCR signal die by neglect within 3 to 4 days. Only those DP thymocytes receiving signals 
from TCRs engaging positive selecting pMHC will survive and become self-restricted CD4+ or 
CD8α+/β+ ‘single positive’ (SP) thymocytes found in the medullary region of the thymus (Re-
viewed by Germain, 2002). On the other hand if DP or SP thymocytes receive signals from 
TCR interacting with negative selecting ligands development ceases and the cells undergo 
apoptosis. Therefore only self-restricted and self-tolerant immature T cells are able to leave 
the thymus and re-enter the blood stream to seed the peripheral lymphatic organs as either 
class II MHC restricted CD4 T cells or class I MHC restricted CD8 T cells.
1.2.2.1 Defining Positive and Negative Selecting Ligands
As described above the decision whether a thymocyte gets neglected, positively se-
lected or negatively selected depends on the TCR-pMHC interaction. That means that in 
the thymus of a wildtype mouse, ~100 million thymocytes, each expressing a TCR of a dif-
ferent specificity undergo the selection processes on a number of different MHC class I and 
MHC class II molecules expressed in a particular individual. Given the fact that the peptides 
are unknown and MHC molecules are the most polymorphic proteins found in nature, it is 
obvious that simplified model systems had to be developed to identify and define positive 
and negative selecting pMHC ligands. The development of inbred mice expressing a unique 
combination (haplotype) of MHC molecules together with the development of recombina-
tion deficient (Rag2-/-) TCR transgenic mice created a system, in which the TCR specificity 
and the MHC haplotype were well defined. Based on this, several different approaches were 
developed to study the role of TCR, peptide and MHC in thymic selection. A widely used 
technique is the so called fetal thymic organ culture (FTOC). In this assay, fetal thymi of 
TCR transgenic, Rag2-/- mice which are deficient in MHC class I cell surface expression due to 
the absence of the MHC class I ‘light chain’, β2m are placed in organ culture. The develop-
mental arrest of MHC class I restricted, DP thymocytes caused by the absence of TCR ligand 
is restored by exogenous administration of the β2m protein in combination with a well de-
fined (synthetic) peptide (Hogquist et al., 1994). Several variations of this system, including 
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TAP1 (see Introduction 1.1.3) deficient mice instead of β2m deficient mice (Van Kaer et al., 
1992), or mutants of MHC class II peptide presentation (Fukuy et al., 1997) led to the iden-
fication of positive and negative selecting peptides in a series of TCR transgenic systems 
and MHC haplotypes. Interestingly, it was shown, that (agonist) peptides which induced a 
response in mature T cells, lead to negative selection of thymocytes expressing the same 
TCR. On the other hand, (antagonistic or weakly agonistic) peptide variants which were un-
able to fully activate mature T cells induced positive selection in the thymus of the same 
mice. Thus agonist peptides activate T cells, but induce negative selection of thymocytes. 
In contrast, antagonist peptides fail to activate mature T cells but induce positive selection 
in thymocytes. This demonstrates that different TCR signals can be elicited from the same 
ligand depending on the developmental stage of the cell. To understand this phenomenon 
in molecular terms, TCR signals involved in thymocyte selection as well as the role of TCR-
ligand binding in positive and negative selection has been studied in detail. 
1.2.2.2 TCR Signaling Involved in Thymocyte Selection
One approach to understand the differences between weak and strong TCR signals is to 
study the intracellular signaling cascades that are initiated upon TCR ligand binding during 
thymic selection. Using knockout animals and various biochemical approaches, profound 
insights were gained in the signaling cascades coupling TCR triggering to gene activation.  
1.2.2.2.1 TCR Signaling Cascades
Figure 1.4A shows a simplified overview of intracellular TCR signaling, emphasizing on 
membrane proximal signaling (Reviewed by Germain et al., 1999). It is proposed that in un-
stimulated T cells, membrane proximal tyrosine kinases (Lck, Fyn and ZAP70), are located 
in specialized membrane compartments (DIGs; detergent insoluble glycolipid complexes), 
which are spatially separate from their ITAM substrates found in the cytosolic tails of the 
TCR/CD3 complex. pMHC induced TCR/coreceptor ligation leads to the phosphorylation of 
the ITAMs from CD3 ζ by Lck or Fyn. Following ITAM phosphorylation ZAP-70 is recruited 
and phosphorylation of ζ-associated ZAP-70 (by Lck) causes its activation leading to the 
phosphorylation of the linker of activation of T cells (LAT). LAT is a transmembrane adaptor 
molecule containing 9 tyrosine residues, which connects events on the plasma membrane 
to distal signaling cascades. Dependent on which of LAT’s tyrosine residues are phosphory-
lated, distinct sets of cytosolic adaptor proteins (Reviewed by Rudd, 1999) are recruited, 
contributing to the activation of small GTP-binding proteins (Ras, Rac) or the recruitment 
of PLCγ1. Small GTP-binding proteins are activators of the Erk, Jnk and MAP kinases, which 
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control the function of transcription factors (NF-κB, Jun, Fos). On the other hand binding of 
PLCγ1 to LAT initiates calcium and PKC dependent signaling pathways which can modulate 
the MAP kinase pathways and NFAT activation (Fig.1.4A).
1.2.2.2.2 Signaling Cascades Involved in Positive and Negative Selection
It is intriguing that TCRs are able to generate signals which result in such opposing cel-
lular responses as differentiation or death. It was proposed that these different MAP kinase 
pathways account for positive (Erk) and negative (Jnk, p38) selection. A modification of 
this idea suggests that both positive and negative selection signals use all three MAP kinase 
pathways but with distinct kinetics (Reviewed in Werlen et al., 2003). According to this 
model, TCR triggering by negative selection ligands induces a LAT phosphorylation pattern 
which recruits Grb-2, Gads, SLP-76 and PLCγ, leading to a transient calcium burst and Erk 
activation which are down-regulated before the Jnk and p38 pathways. This pattern of MAP 
kinase activation induces negative selection. In contrast, positive selection ligands induce a 
LAT phosphorylation pattern which recruits only Gads and SLP-76 leading to weak but sus-
tained Erk activation which extends after the down-regulation of Jnk and p38. This configu-
ration induces positive selection. How these different LAT phosphorylation patterns are ac-
complished is not known. Interestingly, TCRs lacking the α-CPM are completely defective in 
Erk activation in response to positive selecting ligands while the same α-CPM mutant TCRs 
Figure 1.4: Signaling cascades discriminating negative selection from positive selection. (A) Schematic 
representation of key molecules involved in TCR signaling. Blue arrows schematically represent proposed 
cascades involved in signals elicited by positive selecting ligands, red arrows represent proposed cascades 
involved in signaling elicited by negative selecting ligands. Dashed arrows represent phosphorylation of 
molecules similarly involved in positive and negative selection. (B) Proposed mechanisms underlying signal 
differentiation between positive and negative selection. Positive selecting ligands lead to slow and sustained 
phosphorylation of Erk while negative selection ligands lead to fast and transient phosphorylation of Erk.
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are fully competent to activate Erk rapidly and transiently and induce apoptosis in response 
to negative selecting ligands (Werlen et al., 2000). The fact that α-CPM mutant TCRs show 
defective CD3δ association (Backstrom et al., 1998) leading to defective TCR/coreceptor 
cooperativity (Naeher et al., 2002; Doucey et al., 2002) could explain the altered corecep-
tor/Lck recruitment to the TCR/CD3 complex leading to abrogation of positive selection. 
Along the same line it was shown that CD3δ deficient and CD8β deficient mice show specific 
defects in positive selection but normal negative selection supporting a model in which the 
α-CPM links ligand binding to intracellular signaling. In this thesis it has been addressed to 
what extent the α-CPM plays a role in TCR-ligand binding (See Results 3.2).  
1.2.2.3 The α-Chain Connecting Peptide Motif (α-CPM)
The α-chain connecting peptide motif (α-CPM) consists of seven highly conserved amino 
acids (FETDxNLN) which are found in the membrane proximal connecting peptide (CP) do-
main of the α-chain from TCRα/β (Fig. 1.1A and Results 3.2.4: Naeher et al., 2002: Fig.1) of 
all vertebrates. Deletions or point mutations in the α-CPM lead to abrogation of TCR surface 
expression. Therefore, analysis of the role of the α-CPM in TCR signaling and T cell develop-
ment was performed using chimeric TCRα chains containing the CP, TM and cytosolic regions 
from homologous TCRδ regions paired with TCR β chains containing the TM and cytosolic 
regions from TCRγ which allowed for surface expression of α-CPM mutant TCRs. Such α-CPM 
mutant TCRs showed defective signaling upon TCR stimulation due to the replacement of 
the α-CPM (Backstrom et al., 1996).
 Thymocytes of transgenic mice either expressing an α-CPM mutant form of the MHC 
class II restricted 3BBM74 TCR (Backstrom et al., 1998) or an α-CPM mutant form of the MHC 
class I restricted OT-1 TCR (Werlen et al., 2000) showed a severe block in thymocyte devel-
opment at the DP stage. Analysis of the TCR/CD3 complex in these mice showed strongly 
reduced association of the CD3δ chain to the complex and it was shown that the develop-
mental block at the DP stage was caused by a specific signaling defect in response to posi-
tive selecting ligands, while signals involved in negative selection were unaffected by the 
replacement of the α-CPM. Biochemical analysis of the signaling cascades in α-CPM mutant 
mice revealed defective activation of the MAP kinase, Erk in response to positive selecting 
ligands, while Erk activation proceeded normally in response to negative selecting ligands. 
The absence of Erk phosphorylation in α-CPM mutant mice in response to positive selecting 
ligands was explained by the absence of phosphorylated CD3ζ, Lck and LAT from DIGs (i.e. 
membrane rafts) upon stimulation with positive selecting ligand. This indicated a defect in 
the initialization of TCR proximal signaling specifically in response to weak pMHC ligands. 
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1.3 TCR Ligand Affinity
1.3.1 TCR Ligand Binding in Positive and Negative Selection
It is generally accepted that ‘weak’ pMHC ligands promote positive selection, while ‘strong’ 
pMHC ligands induce negative selection. Nevertheless how a cell ‘reads’ the ‘strength’ of 
pMHC ligands is unresolved. Several models have been proposed on how ligand binding trig-
gers TCR signaling in developing thymocytes. The conformational change model proposes 
that ligand binding induces qualitatively different responses by inducing different levels of 
conformational changes which are transduced from the TCR variable regions to the cyto-
solic regions of the CD3 complex (Janeway et al., 1989; Yoon et al., 1994; Gil et al., 2002). 
In contrast, the affinity/avidity model (Sprent et al., 1997) proposes, that quantitatively dif-
ferent signals resulting from either differing affinities or avidities of TCR-ligand interactions 
dictate positive or negative selection. This was supported by the finding, that when the 
affinity of the bimolecular TCR-pMHC interactions were measured by SPR (see below), the 
dissociation constants (KD) correlated in the majority of the cases directly with the biologi-
cal potency determined on peripheral T cells, i.e. high affinity TCR-pMHC interactions were 
observed with fully activating ligands (agonists) while low affinity interactions were mea-
sured for weak agonists or ligands that did not elicit a response (antagonists) (Garcia et al,. 
1997; Alam et al., 1996; Davis et al., 1998; Kersh et al., 1998; Alam et al,, 1998; Ding et al., 
1999; Baker et al., 2000; Degano et al., 2000;). When this comparison was performed with 
thymocytes instead of peripheral T cells less definite results were obtained. In some cases, 
low affinity ligands were only able to induce positive selection and high affinity ligands were 
only able to induce negative selection (Hogquist et al., 1994; Hogquist et al., 1995; McK-
eithan et al., 1995: Alam et al,, 1996). These studies argued that the key determinant of 
thymic selection is the TCR affinity for a pMHC ligand. However, other reports supported an 
avidity model of thymic selection, in which TCR occupancy (i.e. ligand avidity) is the key de-
terminant that decides whether a thymocyte gets positively or negatively selected (Ashwell 
et al., 1986; Sebzda et al, 1994; Ashton-Rickard et al., 1994; Liu et al., 1998; Smith et al., 
1998). These conflicting results led to the formulation of two distinct mechanistic models of 
TCR-ligand binding. While the serial triggering model proposes that ligand avidity is ‘read’ 
by a cell by counting the number of TCRs that become serially triggered over a given period 
of time (Valitutti et al., 1995), the kinetic proof-reading model (McKeithan, 1995) suggests 
that T cells are able to distinguish the ligand affinities by measuring the time that a single 
pMHC ligand occupies a single TCR. In both models, the TCR-ligand dissociation kinetics 
and hence the affinities are a very important parameter concerning the signals initiated by 
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TCR. TCR affinity measurements have been hampered by the fact, that the TCR as well as 
its pMHC ligands are integrated into cell surfaces and their affinities could therefore not be 
directly measured. Instead, soluble forms of TCR and pMHC molecules have been used to 
study these affinities in various systems. 
 
1.3.2 TCR Ligand Binding Studies: Theoretical and Technical Considerations
1.3.2.1 Affinity and Avidity: Definitions
Considering a ligand (L) binding to a receptor (R) the affinity of the receptor-ligand in-
teraction (RL) is defined as the concentration of free ligand [L] which leads to a condition 
where 50% of all receptor molecules are bound by ligand. This means that the concentration 
of free receptor [R] equals the concentration of bound receptor [RL]. Given the fact that 
these receptor ligand interactions follow the law of mass action,  such ligand concentrations 
represent the reciprocal value of the equilibrium constant and are referred to as dissocia-
tion constant KD (see Fig. 1.5A). 
The avidity of a multivalent ligand (L) binding to multiple receptors (R) represents the 
sum of a single ligand binding to one receptor (RL) and multiple numbers (x) of receptors 
(RxL). Because the transition of single binding (RL) to multiple binding (RxL) can be influ-
enced by parameters, which are independent of the binding forces at the interaction inter-
face (e.g. distance between multiple receptors or ‘oversaturation‘ of ligands such that only 
one binding site per multivalent ligand interacts with a receptor), the avidity represents a 
mixture of affinity (KD) and parameters (Kx) which are not exclusively defined by the physi-
cal forces that act between the ligand and receptor molecules (see Fig. 1.5B).
Figure 1.5: Theoretical and technical aspects 
of TCR-ligand binding. (A) Affinity is defined 
as the free concentration of monomeric ligand 
[L], which leads to half-maximal saturation 
of receptors [R] on a cell, represented by 
the dissociation constant KD. (B) Avidity is a 
mixture of the affinity (KD) of a monomeric 
ligand subunit of a ligand multimer and steric 
factors (KX) influencing the simultaneous 
binding of the remaining ligand subunits to 
receptors. (C) Surface plasmon resonance 
(SPR) measures binding kinetics (kon) and 
dissociation kinetics (koff) of ligands applied 
at different concentrations (C1-C3) expressed 
by changes in the resonance units (RU). (D) 
Schematic representation of the binding 
involved in avidity measurements  performed 
with fluorescently labeled pMHC multimers 
(tetramers are shown) binding to cell bound 
receptors. 
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1.3.2.2  Surface Plasmon Resonance (SPR; BIACore®)
Surface Plasmon Resonance (SPR; BIACore®) (Jonsson et al., 1991) has been widely used 
to study binding affinities between proteins. In this assay, the changes in surface plasmon 
resonance is measured by the application of constant flow of a soluble ligand to a polymer 
coated sensor chip, comprised of gold plated glass, to which soluble receptor molecules 
have been adsorbed (often the receptor is biotinylated and the sensor is coated with strept-
avidin). Association kinetics (‘on-rates’) are measured by injecting ligand at a defined con-
centration and flow rate. When steady state binding is reached, the ligand is withdrawn 
from the injected buffer and the dissociation kinetics (‘off-rates’) can be measured. From 
the ‘on-‘ and ‘off-rates’ the KD values can be calculated (Fig. 1.5C) For the determination 
of TCR-pMHC interactions both molecules have to be recombinantly produced in a soluble 
form, lacking the transmembrane and cytosolic regions and in the case of the TCR, lacking 
the CD3 complex. Using SPR, the affinities as well as the ‘on-‘ and ‘off-rates’ of several TCR-
pMHC and CD4 or CD8 coreceptor-MHC interactions were measured (Reviewed in Gascoigne 
et al., 2001; König, 2002; van der Merwe et al., 2003).
1.3.2.3 TCR Ligand Binding Studies pMHC Monomers and Multimers
Despite the invaluable advance that has been provided by the development of the SPR 
technique in the quantification of TCR-pMHC and coreceptor-MHC interactions, it did not al-
low the study of the cooperative binding of TCR and coreceptor to the same pMHC as it oc-
curs on living T cells. The development of soluble pMHC multimers carrying fluorochromes 
allowed to study TCR-pMHC binding on live cells using flow-cytometry. Fluorochrome la-
beled pMHC dimers, tetramers and octamers have been widely used to study TCR ligand 
binding avidities under various binding conditions on mature T cells and thymocytes and 
shed light on the role of coreceptors in cognate TCR-pMHC as well as non-cognate corecep-
tor-MHC binding (Altman et al., 1996; O’Herrin et al., 1997; Guillaume et al., 2003 ). 
In order to be able to study TCR ligand binding affinities, pMHC monomers have to be 
used (see Introduction 1.3.2.1 and Fig. 1.5). Initial experiments using pMHC monomers were 
hampered by the fast dissociation kinetics of most TCR-pMHC interactions which interfered 
with the detection of TCR bound pMHC monomers by lysis and PAGE analysis or flow cyto-
metry. This drawback was overcome by the development of photo-reactive pMHC mono-
mers (Lüscher et al., 1994), which allowed specific covalent crosslinking of pMHC bound 
to TCR expressed on live T cells. Using this technique, quantitative aspects of TCR ligand 
binding to pMHC monomers on thymocytes and T cells were analyzed in this thesis. 
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1.3.3 Measuring TCR Ligand Affinities on Living T Cells
1.3.3.1 The Principle of the Photoaffinity Labeling System
Ligand binding studies in this thesis were performed using the photoaffinity labeling 
system developed by Immanuel Lüscher. This system is based on the Plasmodium berghei 
Circumsporozoite (PbCS) peptide derivative 252SYIPSAEK(ABA)I260  containing a photo-reac-
tive azido-benzoic acid (ABA) group (Fig.1.6A), which is selectively activated by UV light at 
~312 nm. This photo-reactive peptide derivative is bound by H-2Kd MHC class I molecules 
to form defined pMHC complexes. After binding of such pMHC complexes to specific TCRs, 
photo-activation of the ABA group allows covalent cross-linking of the pMHC ligand to the 
TCR. Several TCRα/βs specific for this peptide were obtained from different CTL clones 
(e.g. S1, S4, S14, S15, S17, S18, T1) (Lüscher et al., 1992) isolated from mice injected with a 
derivative of this peptide containing photo-reactive iodo-4-azidoslicylic acid (IASA) in place 
of PbCS Serine252 (Fig.1.6B). The N-terminal IASA group can be photo-activated selectively 
by UV light at ≥ 350 nm and allows covalent crosslinking of the peptide derivative to H-2Kd 
molecules (Lüscher et al., 1991). In this thesis, TCR ligand binding was studied using the 
T1-TCR which specifically binds soluble, monomeric H-2Kd complexes either loaded with 
252SYIPSAEK(ABA)I260 or (IASA)-253YIPSAEK(ABA)I260 peptide derivatives (Fig.1.6C). Dependent 
on the assay, ligand binding was either detected by autoradiography or fluoresence based 
flow-cytometry. 
Figure 1.6: Peptide derivatives used for photoaffinity labeling. (A) The PbCS252-260 SYIPSAEK(ABA)I peptide 
derivative contains a photo-reactive ABA group (activated by UV light ~312 nm) coupled to lysine259. (B) The 
PbCS253-260 (
125IASA)YIPSAEK(ABA)I peptide derivative contains two photo-reactive groups, 125IASA and ABA. 
The 125IASA group is activated by UV light of >350 nm; the ABA group is activated by UV light of ~ 312 nm. 
(C) The peptides can be bound to soluble H-2Kd complexes to form ligands of the T1-TCR. Detection of TCR 
bound H-2Kd monomers was performed either by autoradiography (125I signal) or fluorescence intensity (Cy5 
fluorochrome signals). 
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1.3.3.2 Photoaffinity Labeling Using Fluorescently Labeled pMHC Ligands 
To detect TCR bound ligand by flow-cytometry, fluorescently labeled pMHC monomers 
were produced. After refolding of soluble H-2Kd molecules in the presence of β2m and 
photo-reactive peptide, monomeric pMHC complexes were purified and coupled to Cy5 
fluorochrome molecules by alkylation via a cystein residue at the C-terminal end of the 
soluble H-2Kd chain. Like this, defined Cy5 labeled pMHC monomers were produced with a 
1:1 ratio of Cy5:pMHC monomer (Fig.1.7A). These monomeric Cy5 labeled pMHC complexes 
were then applied to thymoyctes or lymph node T cells at various concentrations for de-
fined times leading to steady state ligand binding. Subsequent UV irradiation at ~312 nm led 
to covalent crosslinking of bound pMHC ligand to TCR. After washing the amount of bound 
ligand was determined by flow-cytometry (Fig.1.7B). 
Figure 1.7: Direct Photoaffinity Labeling with Cy5 labeled pMHC monomers. (A) Production of soluble, 
Cy5 labeled pMHC monomers. The PbCS252-260 SYIPSAEK(ABA)I peptide derivative is refolded together with 
pMHC class I heavy chain (H-2Kd) and β2m. Purified SYIPSAEK(ABA)I-Kd complexes are specifically linked to 
the Cy5 fluorochrome by alkylation of a free cysteine at the C-terminus of the H-2Kd heavy chain. (B) Photo-
reactive, Cy5 labeled pMHC monomers are applied to cells expressing T1-TCR at defined concentrations 
(C1-C4) and incubated for a defined period of time allowing steady state ligand binding. UV irradiation at 
~312 nm leads to the formation of covalent bonds between peptide and TCR. The amount of bound ligand 
is determined by FACS analysis of the fluorescence signal emitted by Cy5. 
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1.3.3.3 Photoaffinity Labeling Using Radioactive pMHC Ligands
To compare TCR ligand binding to various mutants of the T1-TCR expressed on hybrid-
omas, radioactively labeled pMHC monomers were produced by Immanuel Lüscher. This 
was achieved using iodinated (I125) (IASA)-253YIPSAEK(ABA)I260 peptide derivatives (either 
(IASA)-253YIPSAEK(ABA)I260 referred to as 
125I-Ag11.3 or (IASA)-253YIASAEK(ABA)I260 peptide de-
rivatives referred to as 125I-P255A) (Fig. 1.8A). After refolding of soluble H-2Kd molecules 
in the presence of β2m and radioactive, bi-reactive peptide, monomeric pMHC complexes 
were purified and the peptide was covalently crosslinked to the H2-Kd heavy chain by UV ir-
radiation at 360 nm. These covalent peptide-MHC complexes were applied to T1 hybridoma 
cells to study ligand binding, following their photo cross-linking to the TCR by UV irradiation 
at 312 nm. After washing and lysis, T1-TCR variants were immunoprecipitated and analyzed 
by PAGE. The radioactive signals obtained from covalent TCR-peptide-MHC complexes were 
quantified by autoradiography (Fig.1.8B).
Figure 1.8: Direct Photoaffinity Labeling using 125I labeled pMHC monomers. (A) Production of soluble, 
covalently linked pMHC monomers, labeled with 125Iodine. The bifunctional PbCS253-260 (
125IASA)YIPSAEK(ABA)I 
peptide derivative was refolded together with pMHC class I heavy chain (H-2Kd) and β2m and subsequently 
covalently crosslinked to the H-2Kd heavy chain by UV irradiation >350 nm. 
Purified, monomeric PbCS253-260(
125IASA)YIPSAEK(ABA)I-Kd complexes were referred to as 125I-Ag11.3-Kd. (B) 
Photo-reactive, 125I labeled pMHC monomers were applied to cells expressing T1-TCR at non-saturating 
concentrations (~5x10-10 M) and incubated for a defined period of time allowing steady state ligand binding. 
UV irradiation at ~312 nm led to the formation of covalent bonds between H2-Kd-peptide and bound TCR. 
The amount of bound ligand was determined by immunoprecipitation, SDS-PAGE and autoradiography.  
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2. Materials and Methods 
2.1. Reagents and Solutions
Materials and reagents used for cellular techniques:
alamar blue oxidation red. Alamar
β-mercaptoethanol  Gibco BRL
β-2 microglobulin   Calbiochem
DMEM    Gibco BRL
fetal calf serum (regular)  Gibco BRL
fetal calf serum (FTOC)  Roche
IL-2, mouse, recombinant  Genzyme
non-essential a.a. (100x)  Gibco BRL
polybrene    Sigma
sodium pyruvate (100x)  Gibco BRL
Materials and reagents used for biochemical techniques:
Reagents which are not listed were all purchased from Sigma or Fluka 
Bottle top, 0.45µm 
(cellulose acetate) filters  Corning
Kodak Biomax films  Kodak
protein A sepharose  Pharmacia
L-Arginine HCl   Merck
Ultrafree-CL 2ml
centrifugal filter devices  Millipore
Ultrafiltration membranes
polyethersulfone (10kD)  Millipore
Stirred ultrafiltration cell
350ml    Millipore
Antibiotics used for cellular and biochemical techniques:
ampicillin    Sigma
carbenicillin   Sigma 
gentamycin   Gibco
hygromycin B   Roche 
l-histidinol    Roche
neomycin    Gibco BRL
penicillin-streptomycin  Gibco BRL
puromycin    Sigma
Enzymes:
lysozyme    Sigma
restriction enzymes/ligases New England Biolabs
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Kits used for molecular techniques:
QuickChange mutagenesis   Stratagene
DNA MaxiPrep    Qiagen
QiaEx gel extraction   Qiagen
Solutions and Media:
Solutions used for molecular techniques:
TAE    40mM  Tris-acetate pH 8.0
    1mM  EDTA
TBE    45mM  Tris-borate
    1mM  EDTA
TE    10mM  Tris pH 8.0
    1mM  EDTA
10x universal buffer 1M  K-glutamate
    250mM  Tris-acetate, pH 7.5
    100mM  Mg-acetate
    500µg/ml BSA
    5mM  β-mercaptoethanol
5x ligation buffer  500mM  Tris pH 8.0
    100mM  DTT
    100Mm  MgCl2
    10mM  ATP
Solutions used for biochemical techniques:
Lysis buffer   1%  TritonX-100
    1%  Nonidet P-40
    150mM  NaCl
    0.2mM  EDTA
    50mM  HEPES pH 8.0
    1mM  PMSF
    10µg/ml leupeptin
    10µg/ml aprotinin
    10µg/ml iodoacetamide
IP wash buffer  0.5%  TritonX-100
    150mM  NaCl
    0.2mM  EDTA
    50mM  HEPES pH 8.0
Tris freezing buffer 50mM   Tris pH 8.0 
    25%   sucrose 
    1mM   EDTA 
    1mM   DTT 
    1mM   PMSF 
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DOC detergent buffer 50mM   Tris pH 8.0 
    2%   Triton X-100 
    1%   NaDOC 
    100mM  NaCl (5M) 
    0.1%   NaN3
    1mM  DTT 
Detergent buffer  50mM   Tris pH 8.0 
    1%   Triton X-100 
    100mM  NaCl 
    0.1%   NaN3 
    1mM   DTT 
Inclusionbody wash 100mM  Tris pH 8.0 
buffer   150mM  NaCl 
    1mM   EDTA (0.5M) 
Upscaled urea buffer 10M   Urea        
    62.5mM  MES pH 6.5 
    0.125mM  EDTA 
    0.25mM  DTT 
Urea buffer  8M   Urea 
    50mM   MES pH 6.5 
    0.1mM  EDTA 
    0.1mM  DTT 
Refolding buffer  400mM  L-Arginine-HCl
    100mM  Tris pH 8.0
    2mM  EDTA
    0.4mM  PMSF
    5mM  Glutathione reduced
    0.5mM  Glutathione oxidized
Solutions used for SDS-PAGE and blotting techniques:
Stacking gel solution   H20
    30%  acrylamide solution
    1.0M  Tris pH 6.8
    10%  SDS
    10%  APS
    0.25%  TEMED
Separating gel solution   H20
    30%  acrylamide solution
    1.5M  Tris pH 8.8
    10%  SDS
    10%  APS
    0.25%  TEMED
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SDS running buffer    H20
    25mM  Tris pH 8.3
    250mM  glycine pH 8.3
    0.1%  SDS
SDS gel loading buffer 50mM  Tris pH 6.8
    100mM  DTT
    2%  SDS
    10%  glycerol
    0.1%  bromphenol blue
Coomassie stain. solution 10%  Acetic acid
    45%  MeOH
    0.25%(w/w) Coomassie brillant blue 
Coomassie destain  10%  Acetic acid
    10%  MeOH
Transfer buffer  38mM  glycine
    48mM  Tris pH 8.3
    0.04%  SDS
    20%  methanol
Blocking solution  5%  TopBlock (Juro, Switzerland)
    0.01%  antifoam A
    0.02%  NaN3
Solutions used for cellular techniques:
PBS    137mM  NaCl
    2.7mM  KCl
    8.0mM  Na2HPO4
    1.5mM  KH2PO4
FACS buffer  2%  FCS
    10mM   NaN3 in PBS
LB-media   1%  Peptone
    0.5%  yeast extract
    90mM  NaCl
LB freezing media    LB media
    30%  glycerol
2x HEPES buffer  50mM  HEPES, pH 7.05
    10mM  KCl
    12mM  Dextrose
    280mM  NaCl
    1.5mM  Na2HPO4
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Media used for cell cultures:
Basic media    DMEM (Gibco)
    100U/ml penicillin
    100µg/ml streptomycin
    2mM  L-glutamine
    1mg/ml gentamycin 
    50µM  β-mercaptoethanol
58 Hybridoma media   Basic media
    2%  FCS
      addition of the respective selecting antibiotics
T cell media    Basic media 
    10%  FCS
    1x  non-essential amino acids     
    1mM  sodium pyruvate 
FTOC media    T cell media
    10%  FCS (from Roche)
    5µg/ml β-2-microglobulin
Devices:
ÄKTA FPLC, Amersham Biosciences, Umea, Sweden
Avanti J25, Beckman Coulter, Palo Alto, CA, USA
DNA sequencer, Applied Biosystems Inc.
JLA-10.500, JA-25.15, JA-25.50 rotors, Beckman Coulter, Palo Alto, CA, USA
Biometra Thermocycler T3, Chatel-St.Denis, Switzerland
Coulter ChannalyzerR, Instrumentengesellsschaft, Zürich, Switzerland
CentrifugeStar 5417R, Eppendorf, Germany
FACSCalibur, Becton Dickinson, Mountainview, CA, USA
FACSVantage, Becton Dickinson, Mountainview, CA, USA
JASCO PU 1580 HPLC System, Omnilab, Mettmenstetten, Switzerland
JASCO UV 2075 Spectrometer, Omnilab Mettmenstetten, Switzerland
Multifuge3 S-R, Heraeus, Kendro, Osterode, Germany
BioRad molecular imager FX pro, BioRad Inc., Reinach, Switzerland
SpectraMax 250 plate reader, Molecular Devices, Palo Alto, CA, USA
Stirred Ultrafiltration Cell, Millipore Corporation, Bedford, MA, USA
UV lamp (VL-215 L), Fisher Bioblock Scientific, Illkirch, France
Columns used for FPLC:
Desalting:   Hi Prep 26/10  Amersham Biosciences
Anion Exchange:  Resorce Q (6ml) Amersham Biosciences
Gel Filtration:  Superdex 75   Amersham Biosciences
Columns used for HPLC:
Reverse Phase: C18 (218TP510)  Grace Vidac, Hesperia, CA, USA
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Software:
Program  Application   Provider
CellQuest Pro FACS     Becton Dickinson
Unicorn  FPLC     Amersham Biosciences
SoftMax Pro Spectraphotometry  GraphPad Software Inc.
ImageQuant Phosphorimaging  Molecular Dynamic
Prism  Curve fitting   GraphPad Software Inc.
Adobe Illustrator Graphics   Adobe Inc.
Adobe Indesign Layout    Adobe Inc. 
Microsoft Word Time wasting   Microsoft Inc. 
Microsoft Excel Data storage   Microsoft Inc. 
Antibodies:
Commercial antibodies were titrated and applied at saturating concentrations for FACS staining. 
Antibodies produced in the laboratory had been individually titrated beforehand.
Antigen   Clone    Ref.
α-mouse CD3ε   (142-2C11)   (Leo et al. 1987)
α-mouse CD3δ  (polyclonal)   (Backstrom et al. 1996)
α-mouse TCR-Cβ  (H57-597)   (Kubo et al. 1989)
α-mouse CD8β(Ly-3.2) (H35-17)   (Golstein et al. 1982)
α-mouse H-2Kd(α3) (SF1-1.1)   (Abasto et al. 1993)
α-mouse H-2Kd(α1) (20-8-4S)   (ATTC, Rockville, MD)
Antibodies used for FACS analysis:
Antigen      Clone  Fluorochrome  Provider
α-mouse CD3ε   (142-2C11) PE or APC  PharMingen 
α-mouse CD4 (L3T4)  (RM4-5) FITC or PerCP  PharMingen 
α-mouse CD8α (Ly-2)  (53-6.7) PE or FITC  PharMingen 
α-mouse CD8β (Ly-3.2)  (53-5.8) PE   PharMingen
α-mouse CD69  (H1.2F3) biotinylated  PharMingen
α-mouse TCR-Cβ  (H57-597) FITC or PE  PharMingen
α-mouse TCR Vb8.1/2 (MR5-2) FITC or PE  PharMingen
α-mouse H-2Kb  (AF6-88.5) FITC or PE  PharMingen
α-mouse H-2Kd(α3) (SF1-1.1) FITC or PE  PharMingen
Secondary FACS reagents and fluorescently labeled pMHC complexes:
Streptavidin-PerCP       PharMingen
4P-H-2Kd-tetramers*  PE    provided by I. Lüscher
4P-H-2Kd-tetramers*  Cy5    provided by I. Lüscher
4A-H-2Kd-tetramers**  Cy5    provided by I. Lüscher
4P-H-2Kd-monomers*  Cy5    provided by I. Lüscher
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* 4P represents the PbCS252-260 SYIPSAEK(ABA)I peptide derivative; ** 4A represents the PbCS252-260 
SYIASAEK(ABA)I peptide derivative
Peptides:
The peptide sequence was derived from the Plasmodium berghei circumsporozoite (PbCS)252-
260 SYIPSAEKI peptide to which photochemical crosslinking groups were covalently linked (IASA 
and/or ABA) (Lüscher et al., 1994).
Sequence    Abbreviation  Provided by
(IASA)YIASAEK(ABA)I  I-P255A  I. Lüscher, Lausanne, CH
(IASA)YIPSAEK(ABA)I  I-Ag11.3  I. Lüscher, Lausanne, CH
(IASA)YISSAEK(ABA)I  I-S255A  I. Lüscher, Lausanne, CH
SYIASAEK(ABA)I   4A   I. Lüscher, Lausanne, CH
SYILSAEK(ABA)I   4L   I. Lüscher, Lausanne, CH
SYINSAEK(ABA)I   4N   I. Lüscher, Lausanne, CH
SYIPSAEK(ABA)I   4P   I. Lüscher, Lausanne, CH
SYISSAEK(ABA)I   4S   I. Lüscher, Lausanne, CH
Expression vectors: 
LXSN    Retroviral Vector  Miller, 1989
LXSP    Retroviral Vector  Backstrom, 1996
pET3α    Proc. Expr. Vector  Novagen Inc.
pHSE3’    Transgenic Vector  Pircher,1989
2.2 cDNA Sequences
T1-TCR Sequences:
The T1 TCR is derived from the H-2Kd restricted, PbCS derivative 253-260(IASA)-YIPSAEK(ABA)I 
(Ag11.3)–specific CTL clone, T1 (Lüscher et al., 1992). Sequences were determined using the ABI 
sequencing kit (ABI Prism).
T1-TCRα (wildtype):
5’ATGAACACTTCTCCAGCTTTAGTGACTGTGATGCTGCTGTTCATGCTTGAGAGGACACATGGAAATTCAG
TGACCCAGATGCAAGGTCAAGTGACCCTTTCAGAAGAGGAGTTTCTATTTATAAACTGTACCTATTCAACCA
CAGGGTACCCGACTCTTTTCTGGTATGTCCAATATCCTGGAGAAGGTCCACAGCTCCTTTTGAAAGTCACAA
CAGCCAACAATAAGGGAAGCAGCAGAGGTTTTGAAGCTACATATGATAAAGGGACCACGTCCTTCCACTTG
CAGAAAGCCTCAGTGCAGGAATCAGACTCGGCTGTGTACTACTGTGTTCTGGGTGATCGGGGTAACAATAA
CAGAATCTTCTTTGGTGATGGGACGCAGCTGGTGGTGAAGCCCAACATCCAGAACCCAGAACCCGCGGTG
TACCAGTTAAAAGATCCTAGATCTCAGGACAGCACCCTCTGCCTGTTCACCGACTTTGACTCCCAAATCAAT
GTGCCGAAAACCATGGAATCTGGAACGTTCATCACTGACAAAACTGTGCTGGACATGAAAGCTATGGATTCC
AAGAGCAATGGGGCCATTGCCTGGAGCAACCAGACTAGTTTCACCTGCCAAGATATCTTCAAAGAGACCAAC
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GCCACCTACCCCAGTTCAGACGTTCCCTGTGATGCCACGTTGACTGAGAAAAGCTTCGAAACAGATATGAAC
CTAAACTTTCAAAACCTGTCAGTTATGGGACTCCGAATCCTCCTGCTGAAAGTAGCCGGATTTAACCTGCTCA
TGACGCTGAGGCTGTGGTCCAGTTGA3’
T1-TCR α-δ chimera αIV:
Nucleotides 1-672 identical to T1-TCR-α (wildtype):
5’...673:TATGGCCCAAGAGTCACAGTTCACACTGAGAAGGTAAACATGATGTCCCTCACGGTGCTGGGCCT
ACGACTGCTGTTTGCCAAGACCATTGCCATCAATTTTCTCTTGACTGTTAAGTTATTCTTTTAA3’
T1-TCR α-δ chimera αIV:
Nucleotides 1-726 identical to T1-TCR-α (wildtype):
5’...727:TCCCTCACGGTGCTGGGCCTACGACTGCTGTTTGCCAAGACCATTGCCATCAATTTTCTCTTGAC
TGTTAAGTTATTCTTTTAA3’
T1-TCR-β (wildtype):
5’ATGGGCTCCAGGCTCTTCTTCGTGCTCTCCAGTCTCCTGTGTTCAAAACACATGGAGGCTGCAGTCACC
CAAAGCCCAAGAAACAAGGTGGCAGTAACAGGAGGAAAGGTGACATTGAGCTGTAATCAGACTAATAACCAC
AACAACATGTACTGGTATCGGCAGGACACGGGGCATGGGCTGAGGCTGATCCATTATTCATATGGTGCTGGC
AGCACTGAGAAAGGAGATATCCCTGATGGATACAAGGCCTCCAGACCAAGCCAAGAGAACTTCTCCCTCATT
CTGGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGAGGGACAGTCCTATGAACA
GTACTTCGGTCCCGGCACCAGGCTCACGGTTTTAGAGGATCTGAGAAATGTGACTCCACCCAAGGTCTCCT
TGTTTGAGCCATCAAAAGCAGAGATTGCAAACAAACAAAAGGCTACCCTCGTGTGCTTGGCCAGGGGCTTC
TTCCCTGACCACGTGGAGCTGAGCTGGTGGGTGAATGGCAAGGAGGTCCACAGTGGGGTCAGCACGGACC
CTCAGGCCTACAAGGAGAGCAATTATAGCTACTGCCTGAGCTCTAGACTGAGGGTCTCTGCTACCTTCTGGC
ACAATCCTCGAAACCACTTCCGCTGCCAAGTGCAGTTCCATGGGCTTTCAGAGGAGGACAAGTGGCCAGAG
GGCTCACCCAAACCTGTCACACAGAACATCAGTGCAGAGGCCTGGGGCCGAGCAGACTGTGGGATTACTAG
TGCATCCTATCAACAAGGGGTCTTGTCTGCCACCATCCTCTATGAGATCCTGCTAGGGAAAGCCACCCTGTAT
GCTGTGCTTGTCAGTACACTGGTGGTGATGGCTATGGTCAAAAGAAAAAACTCATGA3’
T1-TCR β-γ chimera βIII:
Nucleotide 1-825 identical to T1-TCR-β (wildtype):
5’...826:CTCCTCCTGCTCCTCAAGAGTGTGATCTACTTGGCCATCATCAGCTTCTCTCTGCTTAGAAGAACA
TCTGTCTGTGGCAATGAGAAGAAGTCCTAA3’
H-2Kd-BSP Sequence:
The cDNA encoding for the BSP (BirA specific peptide) tail is shown in bold:
5’ATGGCACCCTGCACGCTGCTCCTGCTGTTGGCGGCCGCCCTGGCCCCCACTCAGACCCGCGCGGGCCCA
CATTCGCTGAGGTATTTCGTCACCGCCGTGTCCCGGCCCGGCCTCGGGGAGCCCCGGTTCATCGCTGTCGG
CTACGTGGACGACACGCAGTTCGTGCGCTTCGACAGCGACGCGGATAATCCGAGATTTGAGCCGCGGGCGC
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CGTGGATGGAGCAGGAGGGGCCGGAGTATTGGGAGGAGCAGACACAGAGAGCCAAGAGCGATGAGCAGT
GGTTCCGAGTGAGCCTGAGGACCGCACAGAGATACTACAACCAGAGCAAGGGCGGCTCTCACACGTTCCAG
CGGATGTTCGGCTGTGACGTGGGGTCGGACTGGCGCCTCCTCCGCGGGTACCAGCAGTTCGCCTACGACG
GCCGCGATTACATCGCCCTGAACGAAGACCTGAAAACGTGGACGGCGGCGGACACGGCGGCGCTGATCAC
CAGACGCAAGTGGGAGCAGGCTGGTGATGCAGAGTATTACAGGGCCTACCTAGAGGGCGAGTGCGTGGAG
TGGCTCCGCAGATACCTGGAGCTCGGGAATGAGACGCTGCTGCGCACAGATTCCCCAAAGGCCCATGTGAC
CTATCACCCCAGATCTCAAGTTGATGTCACCCTGAGGTGCTGGGCCCTGGGCTTCTACCCTGCTGATATCAC
CCTGACCTGGCAGTTGAATGGGGAGGACCTGACCCAGGACATGGAGCTTGTAGAGACCAGGCCTGCAGGG
GATGGAACCTTCCAGAAGTGGGCAGCTGTGGTGGTGCCTCTTGGGAAGGAGCAGAATTACACATGCCATGT
GCACCATAAGGGGCTGCCTGAGCCTCTCACCGGATCCCTGCATCATATTCTGGATGCACAGAAAATGGTGT
GGAATCATCGTTAAAAGCTT3’
2.3 DNA Constructs
The cDNA encoding the TCR-α chain was cloned into the G418 resistant retroviral vector, LXSN. 
Similarly, the T1 TCR-β chain was cloned into the puromycin resistant retroviral vector, LXSP. The 
cDNAs encoding the T1 TCR α-δ chimeras were constructed using the previously described αII and 
αIV chimeric cDNAs (Backstrom et al., 1996) specific for the 3BBM74 TCR (Di Giusto et al., 1994) 
by replacing the VJC containing, EcoRI–SpeI fragment byT1 TCR VJCα chain sequences. Similarly 
theT1 TCRβ-γ chimera βIII was constructed by replacing the VDJC containing EcoRI-XbaI fragment 
of the 3BBM74 chimeric β chains by T1 TCR VDJCβ chain containing sequences.  
For the production of T1-TCR transgenic mice the cDNAs either encoding the T1-TCRα chains or the 
αII and αIV T1-TCRα-δ chimerias or the T1-TCRβ chains or the T1 TCRβ-γ chimera βIII were excised 
with EcoRI and BamHI and individually cloned into the SalI and BamHI sites of the expression vector 
pHSE3’. The pHSE3’ vectors encoding the various T1-TCR cDNAs were enzymatically cleaved with 
the XhoI endonuclease and purifed using agarose gel electrophoresis and the QiaEx gel extraction 
kit (Qiagen) before injection into zygotes. 
The pET3a Vectors containing either the cDNA encoding the H-2Kd–BSP protein or containing 
the cDNA encoding human β2m used for the production of inclusion bodies were provided by 
Immanuel Lüscher (Guillaume et al., 2003). The H-2Kd
∆223/227
 constructs were produced by site 
directed mutagenesis of H-2Kd-BSP cDNA. The cDNA encoding the H-2Kd-BSP protein cloned in the 
pET3α vector was used as a template to perform site directed mutagenesis by PCR amplification 
using the QuickChange mutagenesis kit (Stratagene). For PCR amplification the following primers 
were used:
-5’-TTGAATGGGGAGAAGCTGACCCAGGACATG-3’ (forward primer)
-5’-CATGTCCTGGGTCAGCTTCTCCCCATTCAA-3’ (reverse primer) 
-5’-AGCTGACCCAGAAGATGGAGCTTGTAG-3’ (forward primer)
-5’-CTACAAGCTCCATCTTCTGGGTCAGCT-3’ (reverse primer)
2.4 Cell Lines
BOSC  fibroblast cell line   Pear, 1993
HT-2  T cell line    Watson, 1970
RMA-SKd  H-2Kd tranfected RMA-S  provided by T. Potter
T2Kd  H-2Kd transfected T2 cell line Cerundolo, 1990
58   thymoma    Letourneur, 1989
58CD8αβ  CD8α/β tranfected 58 cell line Stotz, 1999
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2.5 Inbred Mouse Strains
Zygotes used for injection of the pHSE3’ vectors containing the cDNA encoding the vari-
ous T1-TCR chains were obtained from BDF1xBDF1 mice. T1-TCR transgenic mice were back-
crossed either on Balb/c;Rag-/- or B10.D2;Rag-/-;β2m-/-mice. T1-TCR transgenic mice, OT-1-
TCR;Rag-/- and TCRβ+ ;Rag-/- tg mice were bred in the mouse facilities of the Basel Institute 
for Immunology or the mouse facilities of the Department Research of the Universitätsspital 
Basel. 
2.6 Molecular Techniques
Transformation of Competent Bacteria
Plasmid DNA or ligation mix was added to 50µl of XL-1blue competent bacteria (Strata-
gene) and incubated on ice for 20 to 30 min., followed by 90 sec. incubation at 42°C. Sub-
sequently, the bacteria were plated on LB agar plates containing 50µg/ml ampicillin and 
incubated overnight at 37°C. 
Plasmid Preparation
150ml of LB broth containing 50µg/ml ampicillin were inoculated with transformed bac-
teria and incubated over night at 37°C while shaking (250 rpm). The bacteria were har-
vested by centrifugation (3500xg, 15min. at 4°C). Subsequently the plasmids were isolated 
using Qiagen (500) columns following the manufacturers protocol. Purified plasmids were 
dissolved in H20 to a final concentration of 0.5mg/ml.
Restriction Enzyme Digestion of Plasmid DNA
Enzymatic digestion of plasmid DNA was performed in 50µl using the appropriate restric-
tion enzyme and the recommended concentration of 10x universal buffer for 1 hour at 37°C. 
Digested plasmids were loaded onto 2% agarose gels and the appropriate DNA fragments 
were isolated using the QiaEx gel extracting kit following the manufacturers protocol. 
DNA Ligation
DNA ligation was carried out in a 20µl volume using 100ng vector DNA and 50ng insert 
DNA mixed with appropriately diluted 10x ligation buffer and 1 unit of T4 DNA ligase for 30 
min. at RT. 5µl of the DNA ligation mixture were used to transform XL-1 Blue competent 
bacteria. 
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DNA Sequencing
DNA sequencing was performed using the ABI prism sequencing reaction kit and follow-
ing the manufacturers protocol. For each reaction 300ng of template DNA and 3.2pmol final 
concentration of each primer was used. 30 cycles of PCR reactions were performed using 
the following cycle steps: I: 96°C, 30 sec.; II: 50°C, 30 sec., III: 60°C, 4 min. Subsequently, 
amplified DNA fragments were precipitated, washed in 70% ethanol and dried before resus-
pending in 4µl ABI prism loading buffer and heating for 2 min. at 90°C. Samples were loaded 
on a 8.5% polyacrylamide gel containing 15M urea and analyzed on a ABI prism sequencer. 
2.7 Cellular Techniques 
Production of Retroviral Supernatant
The retroviral packaging cell line BOSC was used to transfect 58 and 58CD8αβ hybrid-
omas. BOSC cells were plated in 6-well plates at subconfluent density to allow cell growth 
up to 48 hrs. post transfection to obtain high titer viral supernatant. The cells were tran-
fected using the Calciumphosphate precipitation method. 10µg vector DNA in 450µl H2O 
were sterile filtered using 0.2µm Acrodisc syringe filters prior to mixing with 125µl 2M CaCl2. 
The mixture was added dropwise to 0.5ml cold 2X HEPES buffer and subsequently added 
to subconfluently plated BOSC cells. After 12 hrs. incubation at 37°C the supernatant was 
exchanged with fresh basic DMEM containing 5% FCS. 24 hrs. post-transfection, medium was 
exchanged again and replaced by 3ml fresh medium. 36 hrs. post-transfection the virus 
containing supernatant was harvested and instantly used for infection of 58 or 58CD8αβ 
hybridomas. 
Infection of 58 and 58CD8α/β Hybridomas
The supernatant containing retroviral particles was used to infect the 58 and the 58CD8αβ 
hybridomas. 5x105 58 or 58CD8αβ hybridomas were resuspended in 500µl DMEM containing 
4µg/ml Polybrene. After 24 hrs., 5ml of fresh basic DMEM medium containing 5% FCS and 
the appropriate selective drugs were added (1mg/ml G418, 3µg/ml puromycin, 2mM histidi-
nol or 0.5mg/ml hygromycin B). Surviving cells were analyzed after 4 days and sorted for 
high TCR surface expression by FACS®. Transfected cells were continuously maintained in 
medium containing selective drugs. 
Stimulation of T1-TCR Transfected Hybridomas
80µl 58 hybridoma medium containing 6x104 T2-Kd cells were plated in flat bottomed 96-
44
well plates and incubated with various amounts of peptide for 2 hrs. at 37°C. T hybridoma 
cells (6 x 104 in 100µl medium) were subsequently added. After a further 24 hrs. of incuba-
tion at 37°C, the supernatant was transferred into 96-well round bottom plates and frozen 
at -20°C for storage and to kill any transferred cells.
IL-2 Assays
The IL-2 content of supernatants obtained from stimulation of T1-TCR transfected 58 and 
58CD8αβ hybridomas was determined by incubating 2x103 HT-2 cells per well in round-bot-
tom 96-well plates with serial dilutions of culture supernatant for 24 hrs. Alamar Blue sub-
strate was then added over night and IL-2 titers were spectraphotometrically determined by 
comparison to a standard curve generated using recombinant murine IL-2 and the SOFTMax 
Pro version 3.1 software. 
Kd-Stabilization on RMA-S-Kd Cells
The affinity of the SYIPSAEK(ABA)I peptides for the H-2Kd molecules was indirectly mea-
sured by peptide induced stabilization of Kd molecules on the cell surface of RMA-S-Kd cells. 
At RT due to a defective TAP-2 transporter gene only ‘empty’ MHC molecules are expressed 
on the cell surface of these cells. Therefore, the RMA-S-Kd cells were kept for 36 hrs. at 
RT to allow the expression of ‘empty’ MHC molecules on the cell surface. Subsequently, 
graded concentrations of peptides were added. Afer 30 min. the samples were transferred 
to 37°C to allow the degradation of MHC molecules which had not been successfully loaded 
and stabilized by peptide binding. After 3 hrs. incubation at 37°C, cells were washed and 
stained with the PE labeled Kd-specific antibody SF1-1.1 (20µg/ml) in FACS buffer for 1 hour 
on ice. Mean channel fluorescence was determined using a FACSCalibur flow-cytometer and 
CellQuest 3.0 software. 
CD69 Upregulation Assays
150µl T cell medium containing 7.5x105 T2-Kd cells were plated in flat bottomed 96-well 
plates and incubated with various concentrations of peptide for 2 hrs. at 37°C. Thymocytes 
or lymphocytes (5x105 cells in 100µl CD69 assay medium) from T1 transgenic mice were 
subsequently added. After a further 18 hrs. of incubation at 37°C, cells were transferred 
to 96-well round bottom plates, washed and transfered to FACS buffer containing a mix 
of fluorescently labeled mAbs specific for TCR-Cβ, CD4, CD8 and CD69. Subsequently cells 
were analyzed by FACS. 
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Neuraminidase Treatment of Cells
2x106 cells were incubated in 0.016 units of neuraminidase from Vibrio cholerae for 60 
min. at 37°C in DMEM (without additives). Cells were subsequently washed three times in 
DMEM and incubated in 0.1µg/ml PNA for 30 min. on ice. Cells were transferred to 96-well 
round bottom plates, washed and transferred to FACS buffer containing a mix of fluores-
cently labeled mAbs specific for TCR-Cβ, CD4 and CD8. Subsequently cells were analyzed 
by FACS. 
Fetal Thymic Organ Culture (FTOC)
FTOCs were performed using thymi of E15 feti from Rag-/-;β2m-/-; T1-TCR transgenic mice. 
Thymic lobes were placed on 13mm diameter, 0.8µm polycarbonate filter discs in 24-well 
tissue culture plates on top of 1ml of DMEM supplemented with 10% FCS (tested for FTOC 
suitability), 5µg/ml human β2m and various concentrations of peptide. 24-well plates were 
incubated for 7 days in a cell culture incubator with 7.5% CO2 at 37°C and supplemented 
DMEM with peptide was exchanged once after 3 days of culture. After 7 days thymocytes 
were harvested from the lobes, stained and analyzed by FACS for TCR, CD4 and CD8α/β 
expression. 
FACS Analysis
FACS analysis was performed on a FACSCalibur flow-cytometer using the CellQuest Pro 
software. Cells were stained with fluorescently labeled mAbs or pMHC tetramers for 1 hour 
on ice in 96-well round bottom plates and FACS buffer and subsequently washed twice with 
200µl FACS buffer before analysis. In the case of biotinylated primary antibodies, a second-
ary staining step was necessary and the cells were incubated with fluorescently labeled SA 
for 10 min. on ice before washing and analysis.
Quantitation of TCR Surface Expression on Hybridoma Cell Lines
The levels of TCR expression were measured using the FITC labeled anti-TCR-Cβ mAb, 
H57-597 and flow-cytometrical analysis on a FACSCalibur using CellQuest Pro version 3.0. 
Due to the different T1-TCR expression levels observed on the various 58 and 58CD8αβ hy-
bridomas the ligand binding signals obtained from the binding analysis by autoradiography 
had to be normalized for the different T1-TCR expression levels to be able to compare the 
signal per TCR and hence the binding capacity of the different T1-TCR variants tested. To 
calculate the relative amounts of the three different TCRs expressed on CD8+ and CD8- hy-
bridomas, the expression of the TCR, measured with the anti-TCR-Cβ mAb, H57-597 was 
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normalized to the expression of the wild type TCR measured on CD8+ hybridomas. The fol-
lowing equation was used:
relative TCR expression = MFI of TCR staining expressing variant TCR/MFI of TCR staining 
on CD8+ hybridomas expressing wildtype T1-TCR. 
2.8 Biochemical Techniques 
Photoaffinity Labeling Using 125I-Ag11.3-Kd and 125I-P255A-Kd pMHC Monomers
Soluble H-2Kd molecules loaded with the 125IASA-YIPSAEK(ABA)I peptide or the P255A de-
rivative were generously provided by Immanuel Lüscher. TCR photoaffinity labelings were 
performed by incubation of 107 T hybridoma cells (109 cells/ml in 58 hybridoma medium) ei-
ther at 0°C for 1.5 hrs. or at 37°C for 10 min., with 5 x 106 cpm of H-2Kd-125IASA-YIPSAEK(ABA)I 
or P255A pMHC monomers followed by UV irradiation at 312 ± 40 nm. After UV irradiation, 
cells were washed three times in ice cold PBS before lysis and immunoprecipitation. 
Lysis and Immunoprecipitation
Cells were washed three times in ice cold PBS and incubated in lysis buffer (2 x 107 cells/
ml) containing a protein inhibitor cocktail (1mM PMSF, 10µg/ml leupeptin, 10µg/ml aprotinin 
and 10µg/ml iodoacetamide) for 30 min. at 4°C. Lysed cells were centrifuged at 12000 rpm 
for 15 min. at 4°C and the supernatants were transferred to fresh 1.5ml Eppendorf tubes 
containing saturation amounts of the antibodies used for immunoprecipitation. In the case 
of the T1-TCR transfected 58 and 58CD8αβ hybridoma cells the α-TCR-Cβ mAb (H57-597) 
was used at 20µg/ml final concentration. In the case of the thymocytes from T1;Rag-/-mice 
immunoprecipitation was either performed with the α-TCR-Cβ mAb (H57-597) used at 20µg/
ml or the α-CD3-ε mAb (142-2C11) used at 20µg/ml. Following 2 hrs. of incubation at 4°C, 
the immune complexes were isolated using BSA-blocked protein A sepharose beads. After 
further incubation at 4°C for 30 min., the beads were washed three times in IP wash buffer 
and twice in PBS. 
Polyacrylamide Gel Electrophoresis
The immunoprecipitated material on protein A sepharose beads was boiled immediately 
in 5X SDS sample buffer and analyzed on 10% reducing SDS PAGE gels. In the case of the 
samples obtained from photoaffinity labeling assays on hybridoma cells, the gels were fixed 
(45% MeOH, 10% acetic acid, 45% H2O), dried and exposed to Kodak Biomax films at -80°C. 
In the case of the thymocytes from T1-TCR mice, SDS-PAGE gels were further processed by 
Western Blotting.
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Coomassie Blue Staining of Gels
Gels were incubated for 3 min. in Coomassie blue staining solution and washed 3 times 
30 min. with Coomassie wash at RT. 
Western Blotting
SDS PAGE gels were electroblotted for 1 hour at 0.7A in ice-cold transfer buffer onto 
PVDF membranes. After blotting, the membranes were blocked using blocking solution for 
30 min. at RT followed by incubations with 1:2000 dilutions of primary antibodies for 1 hour 
at RT. After 3 washes in blocking solution 1:8000 diluted secondary HRP-coupled antibodies 
were added for 30 min. at RT. The membranes were washed twice for 5 min. in blocking so-
lution and finally washed once in PBS containing 0.1% Tween-20 before being dried. Proteins 
were detected using the ECL detection kit from Amersham and Kodak Biomax films. In the 
case of reprobing with a different antibody, membranes were boiled in PBS + 0.1% Tween-20 
for 2 min. at 80°C before addition of the reprobing primary antibody and being processed 
the same way as described above. 
Quantification of Radioactive Signals from SDS-PAGE Gels 
Signals obtained on Kodak BioMax films were quantified using a PhosphorImager and 
ImageQuant software. To compare the photoaffinity labeling of the various receptors, the 
values were normalized for TCR expression and compared to the labeling value obtained on 
CD8+ hybridomas expressing the wild type T1 TCR. 
The following equation was used: relative binding = (CPM bound by variant TCR/CPM 
bound by CD8+ hybridoma expressing wildtype TCR)/ relative TCR expression).
2.9 Production of Soluble Monomeric pMHC Complexes 
Production of Inclusion Bodies
BL21(DE3)pLys bacteria transformed either with the pET3α vector containing the cDNA 
encoding human β2m or containing the cDNA encoding H-2Kd-BSP were kindly provided by 
Immanuel Lüscher. Bacteria were grown at 37°C in LB medium containing 50µg/ml carbeni-
cillin. Inclusion body production was induced by addition of 0.5mM IPTG at an OD600 of 0.9 
of the bacterial culture. Cultures were incubated at 30°C and 250 rpm for 5 hrs. before 
isolation and purification of the inclusion bodies.
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Isolation and Purification of Inclusion Bodies 
IPTG induced bacterial cultures were centrifuged and resuspended in ‘Tris freezing buf-
fer’ (50ml/1L of bacterial culture) before shock-freezing in liquid nitrogen. After thawing 
in a 37°C water bath lysozyme (1mg/ml) was added for 10 min. on ice before addition of 
2% Triton X-100 and DNAse I (30µg/ml) to lyse the cells and degrade bacterial DNA and 
RNA. After sonification and centrifugation at 8500xg for 12 min., the pellet containing the 
inclusion bodies was further lysed in ‘DOC detergent buffer’, followed by sonification, cen-
trifugation and resuspending in ‘Detergent buffer’ until a clean white pellet was obtained. 
The inclusion bodies were washed in ‘Inclusion body wash buffer’ to remove the detergent, 
solubilized in ‘Upscaled urea buffer’ and frozen in liquid nitrogen. The purity of the protein 
was assessed by SDS-PAGE and Coomassie blue staining. 
Refolding of pMHC Complexes
pMHC complexes were produced by refolding of H-2Kd heavy chain in the presence of the 
peptide derivative PbCS252-260 SYIPSAEK(ABA)I or variants. 18mg of H-2K
d heavy chain and 
9mg of β2m in upscaled urea buffer were mixed and the volume of the solution was ad-
justed to 5ml with urea buffer. This mixture was added dropwise to 500ml ice cold refolding 
buffer containing 10mg of peptide under continuous stirring in the cold room. After stirring 
for 4 days at 4°C in the dark, insoluble components were removed by filtration over a 0.45 
µm membrane filter and the solution was concentrated 50-fold by ultrafiltration in a stirred 
ultrafiltration cell and polyethersulfone membranes (molecular cut-off: 10kD). 
Purification of Soluble pMHC Complexes
The refolded pMHC complex concentrates were loaded onto a 10ml superloop and run 
over a HiPrep 26/10 desalting column equilibrated with 20mM Tris pH 8.0 using an Äkta 
FPLC. The protein fraction was collected and applied on a 6ml ResorceQ anion exchange 
column. Proteins were eluted using an isocratic gradient of 1M NaCl in 20mM Tris pH 8.0. 
The monomeric pMHC complexes were eluted at a conductivity of 18mSi and concentrated 
to a final concentration of 3mg/ml using 4ml spinning concentrators (cut-off: 10kD) and 
stored at 4°C in the dark.  
Photoaffinity Labeling Using Fluorescently Labeled pMHC Monomers and Tetramers
50µl of CD69 assay medium containing 2.5x105 freshly isolated thymocytes or T-lympho-
cytes from T1 transgenic mice were plated in 96-well flat bottom plates and 50µl of diluted 
Cy5 labeled monomeric or tetrameric pMHC complexes (provided by Immanuel Lüscher) 
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were applied either on ice, at 24°C or at 37°C. After various incubation times depending on 
the temperature (90 min. on ice, 15 min. at 24°C or 2 min. at 37°C) the samples were irradi-
ated for 30 sec. with UV light of 312 ± 40 nm (60 Watt) to induce covalent UV-crosslinking of 
T1-TCR associated ligand. Irradiated cells were transferred to 96-well round bottom plates 
and 3 times washed with 200µl ice-cold T cell medium and once washed with 200µl FACS 
buffer before FACS analysis. 
Two Step TCR Photoaffinity Labeling
The first step of the two step TCR photoaffinity labeling was performed with unlabeled 
peptide-H-2Kd monomers as described for the direct photoaffinity labeling using Cy5-labeled 
pMHC complexes. Instead of the last washing step using FACS buffer, the cells were incu-
bated for 90 min. on ice in 100µl T cell medium containing 5x10-7 molar of fresh 4P-Kd-Cy5 
monomers before the second irradiation with UV light of 312 ± 40 nm (60 Watt) to induce 
covalent UV-crosslinking of the freshly applied fluorescently labeled pMHC monomers. Cells 
were then washed 3 times with 200µl ice-cold T cell medium and once washed with 200µl 
FACS buffer before FACS analysis. 
Ligand Dissociation Kinetic Measurements
105 cells were incubated in 50µl of DMEM containing 5% FCS for a defined period of time 
(90 min. at 0°C, 15 min. at 24°C or 2 min. at 37°C). Samples were 200-fold diluted with me-
dium containing 40µg/ml α-H2-Kd(α1) mAb (20-8-4S) and samples were UV (~312 nm) irradi-
ated at defined intervals. Cells were washed three times with medium and subsequently 
incubated for 90 min. on ice in 50µl cell culture medium containing 5x10-6 M 4P-Kd-Cy5. 
After UV irradiation (~312 nm), cells were washed and analyzed by flow cytometry. 
Determination of Dissociation Constants
Affinities of T1-TCR-ligand interactions were measured by determining the concentration 
of free ligand leading to half-maximal fluorescence signals on single cells (represented by 
the KD values). Values were determined using either Scatchard analysis or non-linear re-
gression using the Prism4 software. KD values shown in Tables III, IV and VIII represent the 
means determined from at least two independent experiments. The differences between 
the determined KD values from multiple repetitions of experiments were less than 2-fold at 
0°C and less than 3-fold at 24°C and 37°C.
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3. Results
3.1 Functional Responses and TCR-Ligand Affinities in T1 Mice 
3.1.1 Production and Characterization of T1-TCR Transgenic Mice
To study TCR-pMHC ligand affinities and functional responses of T cells at different de-
velopmental stages, T1-TCR transgenic mice were produced by co-injection of T1-TCRα and 
T1-TCRβ cDNAs into zygotes of BDF2 mice (see Materials and Methods). To eliminate cells 
which expressed endogenously rearranged TCRs, these mice were backcrossed onto Balb/c; 
Rag2-/- mice, preventing endogenous TCR gene rearrangements. Consequently, these Balb/c 
T1-TCR; Rg-/- mice (referred to as T1 mice) gave only rise to T-cells expressing the H-2Kd 
restricted T1-TCR. As illustrated in Figure 3.1A, flow-cytometrical analysis of T1 thymocytes 
Figure 3.1: Flow cytometric analysis of thymocytes and lymph node cells from T1 mice. Thymocytes and 
lymph node cells from 6 to 8 week old T1; Rag-/- mice were isolated and stained with fluorescently labeled 
α-CD4(RM4-5), α-CD8α(53-6.7), α-CD8β(53-5.8), α-TCRβ(H57-597) mAb. (A) CD4 and CD8α cell surface 
expression measured on thymocytes or lymph node cells. Numbers in the upper left corner of each panel 
indicate total cell number of thymocytes or lymph node cells per animal (SED indicated; n=3). Cells were 
electronically gated and the percentages of double negative (DN), single positive (SP) and double positive 
(DP) determined. (B) Mean fluorescence intensities of TCRβ and CD8β were determined on electronically 
gated DPs, SPs and lymph node cells. MFI of TCR levels on DP thymocytes was determined for TCRintermediate  
cells (bracket). 
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revealed that 68% (50x106 ± 20x106 cells) of all cells co-expressed the CD4 and CD8α/β 
coreceptor molecules representing the double positive (DP) population. Following T1-TCR 
dependent and H-2Kd restricted positive selection, DP cells further developed into CD8+ 
single positive (SP) cells, which represented 30% of all T1 thymocytes (20x106 ± 9x106 cells). 
Only 1% of thymocytes expressed neither CD4 nor CD8 and account for the double negative 
(DN) population. In T1 mice CD8+ T-cells populated the spleen and the lymph nodes. These 
animals showed similar numbers of splenic T cells (6x106 ± 3x106 cells, data not shown) and 
lymph node T cells (6x106 ± 3x106 cells). The histograms in Fig. 3.1B show TCR and CD8β 
coreceptor expression on thymocytes and lymphnode T cells. While TCR expression levels 
were low on DP thymocytes (MFI: 53) the levels increased upon positive selection and were 
higher in SP cells (MFI: 350). Approximately 20% of DP thymocytes expressed no or only very 
low levels of TCR on their surface. TCR on peripheral T cells was comparable to SP thymo-
cytes. CD8α and CD8β expression levels were similar throughout all developmental stages 
(DP, SP and LN; MFIs: 900-1000, see Fig. 3.1A and B). As these mice displayed the expected 
subpopulations of thymocytes and peripheral T cells, they were used to study TCR ligand 
binding and cellular responses at various developmental stages.
3.1.2 Characterization of Photo-reactive T1-TCR Peptide Ligands
Five variants of the photo-reactive, Plasmodium berghei circumsporozoite derived pep-
tide SYIPSAEK(ABA)I, were used to probe cellular responses and TCR binding properties of 
thymocytes and lymphocytes from T1 mice. The five photo-reactive peptide variants are 
shown in Figure 3.2A. All of them carried an azidobenzoic acid (ABA) group linked to the 
lysine at position eight of the peptide. The variants differed in one amino acid at position 
four of the peptide. Position four of the peptide either consisted of a leucine (4L), a proline 
(4P), an alanine (4A), a serine (4S) or an asparagine (4N) residue. To determine the capac-
ity of the variant peptides to bind to H-2Kd molecules presented by antigen presenting cells 
(APCs), their efficiencies in binding to H-2Kd expressed on RMA-S cells were tested (see Ma-
terial and Methods). As indicated in Figure 3.2B, all peptides tested were capable of bind-
ing to H-2Kd molecules and stabilizing cell surface expression of the H-2Kd complexes. The 
strongest H-2Kd binding was observed for the 4P peptide (EC50: 1.5x10
-8 M, relative binding 
capacity: 1.0) followed by the 4N (0.7), the 4A (0.5), the 4S (0.3) and the 4L (0.2). The big-
gest difference in binding to H-2Kd molecules was the 5-fold difference observed between 
the 4P and the 4L peptides.
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3.1.3 T1-TCR Ligands: Analysis of Biological Potency and CD8 Dependency
The potency of the five photo-reactive PbCS peptide variants to stimulate T1-TCR ex-
pressing T cells was analyzed. Thymocytes or peripheral T cells of T1 animals were incu-
bated overnight in the presence of peptide loaded T2-Kd antigen presenting cells and sub-
sequently analyzed by flow-cytometry for the percentage of T1 cells which had upregulated 
the CD69 activation marker. Figure 3.3A shows the percentage of cells undergoing CD69 up-
regulation upon stimulation with peptide loaded APCs as a function of peptide dose. When 
thymocytes were analyzed, DP and SP thymocytes were gated separately. DP cells were 
most sensitive for the 4L peptide and the 4P peptide, followed by the 4A, the 4S and the 
4N peptides. SP cells were similarly sensitive for the 4L, the 4P and the 4A peptide, while 
their sensitivity for the 4S and 4N peptides was reduced as indicated by a shift in the dose 
response curves of these peptides towards higher concentrations compared to DP cells. 
Figure 3.2: Stabilization of H-2Kd cell surface expression by binding of PbCS252-260 SYIPSAEK(ABA)I peptide 
variants. (A) Variants of the photo-reactive PbCS252-260 SYIPSAEK(ABA)I peptide derivative. For PbCS252-260 
SYIPSAEK(ABA)I variants, proline255 at position 4 of the peptide (4P) was replaced either by alanine (4A), 
leucine (4L), asparagine (4N) or serine (4S) residues. Photo-reactivity (~312 nm) was mediated by the azido-
benzoic acid (ABA) moiety linked to lysine259. (B) Peptide induced stabilization of cell surface pMHC class 
I molecules expressed on RMA-S H-2Kd cells determined by fluorescence labeled α-H-2Kd(α3) SF1-1.1 mAb 
staining and measured by flow cytometry. Doses of the peptides shown in (A) required for half-maximal 
H-2Kd stabilization are indicated by the EC50 values. Relative stabilization of H-2K
d was determined by 
comparison of the EC50 values  for each peptide with the EC50 value obtained with 4P (Relative stabilization 
= EC50 (peptide X) / EC50 (4P)). 
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Dose response curves obtained from peripheral T cells on the other hand were comparable 
to response curves obtained on SP thymocytes. In case of DP thymocytes, only 80% of the 
cells upregulated CD69, due to the fact that about 20% of the DP thymocytes of T1 mice did 
not express TCRs (Fig. 3.1B) and were therefore unresponsive to pMHC ligands. 
When these same experiments were performed in the presence of the α-H-2Kd(α3) mAb 
SF1-1.1, which blocks the CD8 binding site on H-2Kd, a substantial increase of the EC50 of both 
DP and SP thymocytes was observed for the 4S and the 4A peptide while the EC50 values 
of 4L and 4P peptides were only slightly increased (Fig. 3.3B). This indicated that the cel-
lular responses to the 4L and 4P peptide were slightly CD8 dependent while the responses 
to the 4A and 4S peptide were highly CD8 dependent. These results were consistent with 
a previous report claiming that the CD8 dependence in functional responses was inversely 
correlated with the strength of the peptides tested, i.e. weak peptides were highly CD8 
Figure 3.3: Peptide dose dependent CD69 upregulation on T1 thymocytes and lymph node T cells. 
Thymocytes and lymph node cells from T1 mice were stimulated for 18 hrs. with various doses of 4L(■), 
4P(●), 4A(▼), 4S(▲) or 4N(◆) peptides presented on T2-Kd cells in the presence or absence of α-H-2Kd(SF1-
1.1) (20µg/ml). Cultures were subsequently stained with fluorescently labeled α-CD4(RM4-5), α-CD8α(53-
6.7), α-CD69 (H1.2F3) mAb. CD69 expression on DP and SP thymocytes was discriminated by electronic 
gating. (A) Percentages of DP thymocytes, SP thymocytes and lymph node T cells expressing surface CD69, 
in the absence of α-H-2Kd(SF1-1.1) mAb. (B) Percentages of DP thymocytes and SP thymocytes expressing 
surface CD69, stimulated in the presence of α-H-2Kd(SF1-1.1) mAb. A representative experiment from a 
total of at least two independent experiments is shown. 
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dependent while strong peptides were only moderately CD8 dependent (Kerry et al., 2003). 
Based on the sensitivity and the CD8 dependence of the cells for the different peptide vari-
ants the 4L and 4P were considered strong peptides, (indicated in red), while the 4S and 
the 4N peptides were considered weak peptides (indicated in blue). The 4A peptide on the 
other hand elicited CD69 upregulation responses which could not be characterized as either 
weak or strong and was therefore considered a peptide of moderate potency (indicated in 
grey). Table I lists the EC50 values representing peptide concentrations leading to CD69 up-
regulation in 50% of the cells analyzed. 
3.1.4 Sensitivity Differences Between DP and SP Thymocytes 
The difference in responsiveness between DP and SP thymocytes depended on the po-
tency of the tested peptides. This is illustrated in Figure 3.4. The CD69 upregulation curves 
from DP and SP thymocytes were normalized for their maximal values and overlaid to allow 
comparison of the CD69 responses obtained with either strong (e.g. 4P), moderate (e.g. 
4A) or weak (e.g. 4S) peptides. In the case of the strong 4P peptide, the two curves were 
very similar and the EC50 values for DP and SP thymocytes specified in Table II were almost 
equivalent (1.4-fold difference). Similarly with the moderate 4A peptide, the EC50 value 
for SP thymocytes was 2.6-fold higher than the EC50 value obtained for DP thymocytes. In 
terms of the weak 4S ligand the EC50 value observed with DP thymocytes was 54.3-times 
Table I: EC50 values [M] determined for T1 thymocytes.
Cell type; mAb 4L 4P 4A 4S 4N
DPs; no mAb
DPs; + SF1-1.1 mAb
∆EC50 (+/- SF1-1.1)
1.0 x10-12
3.0 x10-11
3.1 x10-12
1.0 x10-11
5.2 x10-11
1.7 x10-8*
3.3 x10-10
2.8 x10-8*
1.1 x10-9
5.5 x10-7*
26 x 3 x > 335 x >> 83 x >515 x
SPs; no mAb
SPs; + SF1-1.1 mAb
∆EC50 (+/- SF1-1.1)
1.2 x10-12
4.5 x10-12
4.3 x10-12
1.8 x10-11
1.3 x10-10
2.0 x10-7*
1.8 x10-8
5.3 x10-8*
3.6 x10-8
1.0 x10-5*
4 x 4 x > 1468 x >> 3 x >280 x
Mean values of at least two experiments are shown. (*) less than 50% of all cells responded
LNs; no mAb not done 3.2 x10-12 3.5 x10-10 1.3 x10-7 not done
Peptides
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higher than that observed with DP thymocytes. A similar observation was made for the 4N 
peptide where the EC50 difference between SP and DP thymocytes was 33.6-fold (Table II). 
Therefore, in terms of sensitivity differences between SP and DP thymocytes the moderate 
potency 4A peptide showed characteristics reminiscent of strong peptides. 
Figure 3.4: Sensitivity differences between DP and SP T1 thymocytes. Dose response curves obtained 
from DP or SP T1 thymocytes shown in Figure 3.3 were normalized for the fraction of the cells undergoing 
CD69 upregulation (% responding cells). Overlays of these normalized CD69 response curves of DP and SP 
thymocytes stimulated with either 4P (red curves), 4A (gray curves) or 4S (blue curves) are shown. The fold 
difference between the  EC50 values  determined from DP and SP thymocytes is indicated in the lower right 
of each panel. 
Table II: EC50 values [M] determined for T1 thymocytes and LN T Cells.
Cell type 4L 4P 4A 4S 4N
DPs
SPs
∆EC50 (SP/DP)
1.0 x10-12
1.2 x10-12
3.1 x10-12
4.3 x10-12
5.2 x10-11
1.3 x10-10
3.3 x10-10
1.8 x10-8
1.1 x10-9
3.6 x10-8
1.2 x 1.4 x 2.6 x 54.3 x 33.6 x
Mean values of at least two experiments are shown. (*) less than 50% of all cells responded
LNs not done 3.2 x10-12 3.5 x10-10 1.3 x10-7 not done
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3.1.5 Determination of TCR-Ligand Affinities Using Fluorescent pMHC Monomers 
To study the correlation between the affinity of a specific TCR ligand interaction and the 
cellular response, affinities of T1-TCR for its various peptide-MHC ligands were determined. 
The TCR affinity labeling system developed by Immanuel Lüscher was ideal for this purpose 
(see Introduction 1.3.3). To examine the differences in ligand binding between DP and SP 
thymocytes, flow-cytometry was an optimal detection method allowing single cell analysis. 
By electronic gating for thymocytes which either expressed CD4 and CD8 or CD8 alone, DP 
thymocytes could be distinguished from SP thymocytes. Three requirements had to be ful-
filled to allow affinity measurements on thymocytes and lymphocytes by flow-cytometry. 
First, the TCR bound, monomeric pMHC complexes had to be stably fixed to the cell to al-
low flow-cytometric analysis, as preliminary studies (data not shown) showed that interac-
tions of TCRs with pMHC monomers that were not covalently crosslinked to the cells were 
too unstable to be quantified by flow-cytometry. Stable association of TCR bound pMHC 
monomers was achieved by photochemical crosslinking of the ligands to bound TCR (see 
Introduction 1.3.3.2). Second, the ligand derived fluorescence signal had to be high enough 
to be detected on a single cell and third, the highest concentration of pMHC monomers had 
to be high enough to lead to TCR saturation. 
In a first set of experiments it was tested whether the photo-reactive, Cy5 labeled 4P-Kd 
monomers were suitable to determine the affinities of TCR ligand interactions on thymo-
cytes and lymphocytes. Figure 3.5A shows a schematic representation of a photo-reactive 
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Figure 3.5: TCR ligand binding measurements using fluorescence labeled, photo-reactive 4P-Kd 
monomers. (A) Schematic representation of a Cy5 labeled complex of photo-reactive peptide (4P) bound 
to a soluble, monomeric H-2Kd MHC class I molecule. (B) Overlay of histograms obtained from electronically 
gated DP thymocytes, which were subjected to photoaffinity labeling using the indicated doses of 4P-Kd-
Cy5. (C) Graphical representation of fluorescence signals obtained as described in (B) for DP thymocytes 
(DP), SP thymocytes (SP) or lymph node T cells (LN) from T1 mice. Curves were obtained by curve fitting 
of the measured fluoresence intensities using non-linear regression. The arrow indicates a signal which was 
higher than the fitted TCR saturation curve.
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4P-Kd-Cy5 monomer. When thymocytes were incubated with various concentrations of the 
4P-Kd-Cy5 monomers for 90 minutes on ice, photochemical crosslinking led to concentration 
dependent fluorescent signals on these cells. As illustrated in Figure 3.5B, the fluorescent 
signals obtained from DP thymocytes that were incubated with various concentrations of 
4P-Kd-Cy5 monomers and photo-crosslinked could easily be distinguished. When the fluo-
rescent signals obtained from DP and SP thymocytes and from lymphocytes were plotted 
against the 4P-Kd-Cy5 concentration, TCR-ligand saturation curves were obtained (Fig. 3.5C). 
As discussed above and shown in Figure 3.1B the TCR expression levels were substantially 
higher on SP thymocytes and lymph node cells (LNs) compared to DP thymocytes. Therefore 
the same concentration of ligand resulted in higher fluorescence signals on SP thymocytes 
compared to DP thymocytes. These experiments demonstrated that the signal intensities 
were strong enough to allow single cell flow-cytometric analysis of TCR ligand binding on 
cells from all stages of T cell development. It is noteworthy that at 4P-Kd-Cy5 concentra-
tions higher than 10-6 M an enhanced increase in the Cy5 signal was measured that could 
not be explained by TCR saturation and that was most prominent on DP thymocytes (see 
arrow in Figure 3.5C). Although this was not hampering these measurements, it would have 
been detrimental for studying saturation curves of TCR ligand interactions with affinities 
that were more than 10-fold lower than the one shown in Figure 3.5C because then the TCR 
mediated signal would be distorted by this enhanced signal of unknown origin. This non-
TCR-mediated binding of the 4P-Kd-Cy5 ligand observed at high ligand doses (>10-6M) was 
studied in more detail. 
3.1.6 Non-Cognate, CD8 Mediated Ligand Binding
The enhanced signals obtained with ligand concentrations higher than 10-6 M were stud-
ied in more detail. It was evident that these signals were mainly observed on DP and to a 
lesser extent on SP thymocytes of T1 mice. When TCR-/-, CD4-, CD8α/β-/- double negative 
(DN) thymocytes were analyzed, these signals were not observed (Fig. 3.6A), excluding 
nonspecific monomer binding to thymocytes. When DP thymocytes were pretreated with 
antibodies which either enhanced or reduced the binding of CD8α/β to pMHC monomers, 
more distinct results were obtained (Fig. 3.6B). When the α-CD8α mAb 53.6-7 was applied 
prior to ligand binding TCR specific, pMHC binding was slightly enhanced at saturating con-
centrations of pMHC complexes. Binding of the 53.6-7 mAb also enhanced pMHC labeling at 
10-5 M 4P-Kd-Cy5 (red curve Fig. 3.6B). This has been implicated in several other studies to 
alter cognate as well as non-cognate pMHC interactions on T cells (Bosselut et al., 2000; 
Daniels et al., 2001; Moody et al., 2001). Due to the results obtained with this enhancing 
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α-CD8 antibody the studies were repeated in the presence of the α-CD8β mAb H35 which 
was previously reported to block the CD8 contribution to pMHC ligand binding (Lüscher et 
al., 1995). This was confirmed with the T1-TCR when this antibody was included in ligand 
binding assays using DP T1 thymocytes (gray curve in Figure 3.6B). Cognate binding was 
clearly reduced and importantly the signal obtained with 10-5 M 4P-Kd-Cy5 was also reduced 
when the H35 mAb was included. Thus, CD8 was responsible for the enhanced fluorescence 
signals observed with high ligand concentrations. This was confirmed when thymocytes 
were included in these studies which either expressed a TCR of different specificity, i.e. 
the OT-1 TCR (specific for SIINFEKL-Kb) or which only expressed a pre-TCR and no mature 
Figure 3.6: CD8 mediated non-cognate photo-crosslinking to DP thymocytes at high ligand doses. 
Thymocytes of either T1-TCR; Rag-/- (A and B), (OVA)H2-Kb specific OT-1-TCR; Rag-/-(C) or TCRβ+; Rag-/- (D) 
mice were incubated with indicated doses of 4P-Kd-Cy5 either in the absence (black curves) or in the presence 
(red curve) of α-CD8α(53-6.7) or α-CD8β(H35) mAbs (gray curves). Following UV crosslinking (~312nm), cells 
were stained with α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAb and analyzed by flow cytometry. 
MFIs of Cy5 fluorescence signals obtained from (TCR-negative) DN T1 thymocytes (A), (TCR-positive) DP 
T1 thymocytes (B), (OT-1 TCR-positive) DP thymocytes from OT-1 transgenic (C) or TCRα/β-negative DP 
thymocytes from TCRβ transgenic mice (D) are shown. 
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TCRα/β. The data in Figure 3.6C show that DP thymocytes from C57BL/6 OT-1;Rg-/- mice can 
be labeled with 10-5 M 4P-Kd-Cy5 complexes even though they only express a non-cognate 
TCR (Fig. 3.6C, black curve). This labeling was almost completely blocked in the presence 
of the α-CD8β mAb H35 (gray curve), arguing that the non-cognate labeling observed at 
high pMHC concentrations was mediated by CD8. A similar observation was made when DP 
thymocytes of C57BL/6 β+/β+; Rag-/- mice were analyzed (Fig. 3.6D). Due to their expression 
of a transgenic TCRβ chain in the absence of endogenous TCR gene recombination (Rag-/-) 
these thymocytes proceed to the DP stage expressing only a pre-TCR. Again, the enhanced 
signal (black curve) was strongly reduced in the presence of the α-CD8β mAb H35 (gray 
curve). Taken together, these experiments revealed that at ligand concentrations higher 
than 10-6 M, the photo-reactive pMHC monomers were covalently crosslinked to the cells 
in a CD8 dependent and TCR independent manner. This was possible because the TCR and 
the CD8 (or CD4) coreceptor bind to independent binding sites on MHC molecules (see Fig. 
1.3).
This observation led to two important consequences. First, when used at ligand concen-
trations greater than 10-6 M, ligand binding reflected a combination of cognate (TCR/CD8) 
and non-cognate (CD8 only) components. Second, for low affinity TCR/CD8-pMHC interac-
tions the shape of the binding curves would no longer represent a hyperbolic receptor satu-
ration curve and thus no dissociation constants could be determined. Therefore an alterna-
tive method to determine the affinities of TCR ligand interactions was developed. 
3.1.7 Development of a Two Step TCR Labeling Assay
To avoid non-cognate pMHC binding signals at high ligand concentrations and to be able 
to determine dissociation constants for high, medium and low TCR/CD8-pMHC ligand affini-
ties an assay was developed in which the effect of the non-cognate (CD8-MHC only) inter-
action was excluded. This assay was based on a first round of photoaffinity labeling with 
pMHC monomer ligands of interest followed by the measurement of the free TCR molecules 
remaining. Given a constant number of TCR molecules on the cell surface during the course 
of an experiment, the number of free TCR molecules on a cell reflected the total number 
of TCRs minus the number of TCRs engaging pMHC ligand. At half maximal saturation of all 
TCR molecules the numbers of bound and free TCR molecules are identical. The affinity of 
a receptor-ligand interaction is defined by the dissociation constant (KD), which equals the 
concentration of free ligand that leads to half-maximal receptor saturation on a single cell. 
Therefore the dissociation constants determined by the measurement of either the fraction 
of engaged TCRs or the fraction of free TCR are theoretically identical. Figure 3.7 illustrates 
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Figure 3.7: Principle of the two step labeling assay. (A) Direct photoaffinity labeling was assessed by 
incubation of thymocytes or lymph node T cells with various doses of 4P-Kd-Cy5 monomers followed by UV 
crosslinking (~312nm). Cell were subsequently stained with fluorescently labeled α-CD4(RM4-5), α-CD8α(53-
6.7), α-TCRβ(H57-597) mAb and the Cy5 fluorescence signals obtained from DP thymocytes, SP thymocytes 
or lymph node T cells were analyzed by flow-cytometry. (B) In the two step labeling assay, a first round of 
photoaffinity labeling was performed with unlabeled, photo-reactive pMHC monomers as described in (A). 
TCRs remaining unoccupied in the first round were detected in a second step by incubating the cells with 
fluorescently labeled 4P-Kd-Cy5 (500nM) followed by a second round of UV crosslinking (~312nm). Cells were 
subsequently stained with fluorescently labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAbs and 
the Cy5 fluorescence signals were analyzed by flow-cytometry.
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the principle of the two step TCR labeling assay. As described above, direct photoaffinity 
labeling with the 4P-H-2Kd-Cy5 monomers resulted in fluorescent signals proportional to the 
portion of ligand bound to cells expressing T1-TCR molecules (Fig. 3.7A). In the two step as-
say unlabeled, monomeric pMHC ligands were applied at different concentrations to the T1-
TCR expressing cells. After steady state binding was achieved, TCR-bound pMHC monomers 
were covalently crosslinked to the TCR by photochemical crosslinking and unbound mono-
mers were washed off (Fig. 3.7B). Depending on the concentration and affinity of the cross-
linked pMHC monomers the fraction of covalently crosslinked TCR-pMHC complexes varied 
and hence the fraction of free, unbound TCR varied in the different samples. The fraction 
of free, unbound TCR was then determined in a second step by incubation of these various 
samples with 5x10-7 M Cy5 labeled 4P-Kd at 0°C and subsequent photocrosslinking which la-
beled the remaining, unbound TCRs. Therefore the Cy5 signals observed by flow-cytometry 
(Fig. 3.7B) were proportional to the portion of unbound, free TCRs remaining after the 
first round of photoaffinity labeling with the pMHC ligands of interest. The two step assay 
is not a classical ligand competition assay. Due to the photochemical crosslinking after the 
first step and the removal of unbound ligand by washing, the labeled 4P-Kd-Cy5 monomers 
used in the second step were not competing for TCR binding with the first step ligands. This 
was important to ensure that the 4P-Kd-Cy5 monomers used in the second step exclusively 
labeled unbound TCR. Importantly, the 4P-Kd-Cy5 monomers were applied at a concentra-
tion (5x10-7 M) which only reflected cognate TCR binding; this avoided additional signals 
from non-cognate binding. It should be noted that the pMHC monomers applied in the first 
step were used at concentrations as high as 5x10-5 M. At these concentrations, non-cognate 
interactions between the unlabeled first step monomers and CD8 were also taking place, 
but they did not reduce the number of free TCRs and were therefore excluded from signals 
obtained with the two step TCR labeling assay. A series of experiments was performed to 
ensure the practical accuracy of this assay to determine TCR ligand binding affinities. 
3.1.8 Comparison of Direct and Two Step TCR Photoaffinity Labeling Assays 
Several properties of the two step assay were characterized to ensure that the disso-
ciation constants determined by this assay were accurate. First, the concentration of the 
4P-Kd-Cy5 probe used in the second step (5x10-7 M) was sufficient to saturate only 90 to 
95% of the TCRs on a cell. The fact that this probe was therefore not able to bind every 
free TCR could potentially have influenced the determination of the dissociation constant 
(KD). Therefore the dependence of the KD value on the concentration of the second step 
4P-Kd-Cy5 was tested. As shown in Figure 3.8A, the fluorescence signal was decreased with 
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Figure 3.8: Comparison of KD determinations using direct photoaffinity labeling or two step labeling. 
The accuracy of affinity determinations using the two step labeling assay was tested by comparison to the KD 
values determined by direct photoaffinity labeling. KD values were in both cases measured by determining 
the concentration of ligand leading to half-maximal fluorescence signals using non-linear regression and the 
Prism4® software. (A) Relative independence of the KD determination on concentration of the second step 
reagent (4P-Kd-Cy5). All three concentrations of 4P-Kd-Cy5 tested (10 nM (◆), 100 nM(■) or 1000 nM(●)) led 
to a calculation of very similar KD values. (B) At high primary ligand concentrations, specific fluorescence 
signals were observed with the two step labeling assay (indicated by arrow). (C) Performing three rounds of 
direct photoaffinity labeling (at ~312nm) with 500nM 4P-Kd-Cy5 led to incrementally  increasing fluorescence 
signals, consistent with a UV-crosslinking efficiency of ~70%. (D) Comparison of KD values determined by 
direct photoaffinity labeling  or two step labeling for the binding of 4P-Kd to either T1 thymocytes or lymph 
node T (LN) cells at 0°C or 37°C. KD values, which were determined from direct photoaffinity labeling curves 
that represented a mixture of cognate TCR-pMHC and non-cognate CD8-MHC binding are marked with an 
asterisk (*). 
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decreasing concentration of 4P-Kd-Cy5 monomers. Nevertheless, the determined KD of the 
first step ligand 4P-Kd was 3nM for the two highest concentrations (1x10-6 M, 1x10-7 M) of 
second step probe and 4nM for the lowest concentration (10-8 M) of the second step reagent 
(4P-Kd-Cy5) tested, demonstrating that the determination of KD values in the two step assay 
was very robust over a broad range of second step reagent concentrations. A concentration 
of 5x10-7 M was therefore considered an optimal concentration for the second step reagent. 
At this concentration the fluorescence signals were high enough to allow flow-cytometric 
analysis while being 20-fold lower than the concentration at which the non-cognate cross-
linking was observed. Second, as indicated in Figure 3.8B even at concentrations where the 
first step ligand (4P-Kd) should saturate all TCRs on a cell (5x10-5 M) the signals observed 
in the two step labeling assay (red curve), were not zero (indicated by the arrow). This is 
due to the fact, that the treatment of TCR-bound ligands in the first step did not lead to 
covalent crosslinking of all pMHC molecules bound by TCR. As shown in the right panel of 
Figure 3.8C, when UV crosslinking of the 4P-Kd-Cy5 ligand used at high concentrations was 
performed repeatedly, the signal increased with every round of ligand binding and UV cross-
linking, approaching a maximum. Considering the increase of labeling with each cycle, the 
efficiency of UV-crosslinking was estimated ~70%. Thus, despite using a ligand concentration 
that should lead to TCR saturation, only 70% of the bound pMHC monomers were actually 
covalently crosslinked by the UV crosslinking reaction. pMHC monomers, which were bound 
to TCRs, but failed to be covalently crosslinked were washed off between the first and the 
second step of the two step TCR labeling assay. Therefore even at concentrations of the 
first step pMHC monomers which led to saturation of all TCRs on a cell with non-covalently 
bound ligand, the second step 4P-Kd-Cy5 monomers were crosslinked to some TCRs which 
had failed to be crosslinked to TCR bound pMHC monomers from the first step binding. As 
a result of this inefficiency in establishing a cross-link there was a background fluorescent 
signal even when the unlabeled ligand was used at high concentrations in the first step. 
In Figure 3.8D, KD values of the TCR/CD8-4P-K
d interaction were determined either by 
direct labeling (black curves; 4P-Kd-Cy5 monomer) or the two step labeling protocol (red 
curves). The measurements were carried out for T1-TCRs expressed on DP and SP thymo-
cytes and lymph node T cells (LN) from T1 animals and were performed at 0°C or 37°C. Im-
portantly the indicated temperatures and concentrations, only refer to the 4P-Kd-Cy5 ligand 
from the direct labeling or the unlabeled 4P-Kd ligand of the first step from the two step 
assay. The 2nd step 4P-Kd-Cy5 monomer was applied at 0°C and at a constant concentration 
(5x10-7 M) for all measurements described in this thesis. The curves obtained from these 
comparisons between direct labeling with the 4P-Kd-Cy5 monomers and the two step TCR 
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labeling measuring the level of TCR occupancy mediated by the first step 4P-Kd monomer 
were compared as illustrated in Figure 3.8C. At 0°C the differences between the KD values 
of the two different labeling assays were within 2-fold. At 37°C the differences between 
the two methods were maximally 3-fold. In conclusion, the two step TCR labeling assay was 
considered to be reliable for determining the KDs of the T1-TCR for its various pMHC ligands, 
with a 2-fold deviation of KDs at 0°C and a three fold deviation at 37°C. 
Furthermore the experiments described in Figure 3.8D led to two observations: First, the 
affinity of the interaction between the T1-TCR, CD8 and 4P-Kd appeared to be substantially 
temperature dependent. The T1-TCR affinity for 4P has a KD of 3.4x10
-9 M at 0°C and a KD 
of  2.2x10-7 M at 37°C. Second, no significant differences in the affinities of the T1-TCR/CD8-
pMHC interaction were observed, when DP thymocytes were compared to SP thymocytes 
and lymph node T cells (LN). These observations were studied in further detail by includ-
ing all ligands available, representing pMHC complexes which lead to different cellular re-
sponses. 
3.1.9 CD8 Mediated Temperature Dependence of TCR-Ligand Binding
The affinities of the 4L, 4P, 4A, 4S and 4N pMHC ligands for T1-TCRs expressed on DP 
thymocytes were determined. As described above, the affinities measured were dependent 
on the temperature at which ligand binding was performed. Figure 3.9A shows the curves 
obtained with the two step TCR labeling assay where the first labeling step was either per-
formed at 0°C, 24°C or 37°C. When these ligand binding curves were compared with the 
CD69 response curves in Figure 3.3A it was evident that the biological potency of a given 
peptide was proportional to its affinity for the T1 receptor, i.e. strong ligands showed high 
affinities for the T1-TCR (red curves in Fig. 3.3A and Fig. 3.9A) while weak ligands bound the 
T1-TCR with lower affinities (blue curves in Fig. 3.3A and Fig 3.9A). These measurements 
further showed that the affinity of a given TCR/CD8-pMHC interaction was considerably 
temperature dependent. All binding curves were shifted to the right with increasing tem-
peratures, demonstrating a decrease in TCR/CD8 ligand affinities with increasing tempera-
tures. This is illustrated by the KD values shown in Table III: For all ligands tested the KD 
values of the trimolecular TCR/CD8-pMHC interactions increased from 0°C to 24°C and even 
further from 24°C to 37°C. 
To test, whether this temperature dependent change in affinity was due to changes in 
the bimolecular TCR-pMHC interaction or rather due to a change in the binding contribution 
of the CD8 coreceptor, the affinity measurements were repeated with pMHC ligands that 
allowed TCR binding but were defective in binding to CD8. These peptide- Kd
∆223/227 mono-
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Figure 3.9: Temperature dependence of TCR-ligand binding. T1 thymocytes were incubated with various 
doses of photo-reactive, unlabeled monomers at 0°C, 24°C or 37°C and subsequent photo-crosslinking 
(~312nm); this was followed by incubation with 500nM 4P-Kd-Cy5 and a second round of photo-crosslinking 
(~312nm) according to the two step TCR labeling protocol. Cells were stained with fluorescently labeled 
α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAbs. MFIs of Cy5 fluorescence signals obtained from DP 
thymocytes are plotted as a function of primary ligand dose. (A) Fluorescent signals obtained with the two 
step labeling assay for various doses of 4L-Kd(■), 4P-Kd (●), 4A-Kd (▼), 4S-Kd (▲) or 4N-Kd (◆) at 0°C, 24°C 
and 37°C are shown. (B) Fluorescent signals obtained with the two step labeling assay for various doses 
of 4P-Kd∆223/227 (●) or 4S-Kd∆223/227 (▲) at 0°C, 24°C and 37°C. (C) Comparison of the signals obtained for 4P-
Kd∆223/227 (●) or 4S-Kd∆223/227 (▲) and 4P-Kd (●) or 4S-Kd (▲) at 0°C and 37°C. The differences of the affinities 
determined for TCR binding at 0°C or 37°C are indicated by ∆KD. A representative experiment from a total 
of at least two independent experiments is shown. 
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mers carried two charge inversions (D223K and D227K) which abolished binding of the pMHC 
molecule to the CD8 coreceptor. As previously described, the affinities of the bimolecular 
TCR-pMHC interactions are much lower than the affinities resulting from the trimolecular 
TCR/CD8-pMHC interactions. In the case of the T1-TCR the affinities of the weak peptide 
ligands loaded on the mutant Kd
∆223/227  monomers were too low to be determined (Fig. 3.9B; 
gray curve and Table III), therefore only the affinity of the strong 4P peptide on the Kd
∆223/227  
monomers could be determined (Fig. 3.9B; black curve). In contrast to the binding data ob-
tained with the 4P-Kd monomers that were able to bind CD8 (see Fig. 3.9C) the decrease in 
affinity from 0°C to 37°C was only 2.8-fold in case of the 4P-Kd
∆223/227  monomers representing 
the bimolecular TCR-pMHC interaction. In contrast, when the affinity differences between 
0°C and 37°C were compared for the TCR-ligand binding including CD8, a 10-fold difference 
in the affinity of the 4S-Kd monomer and a 63-fold difference for the 4P-Kd monomers was 
measured. 
Surprisingly, the CD8 impact on pMHC binding was higher at low temperatures than at 
high temperatures, resulting in higher affinity interactions at 0°C than at physiological tem-
peratures. One reason could be that the reduced membrane fluidity at 0°C might stabilize 
the trimeric TCR/CD8-pMHC binding complexes by reducing the lateral mobility of the 
coreceptor in the membrane at 0°C. This hypothesis was supported by the fact that the 
steady state binding equilibrium of the TCR/CD8-4P-Kd complexes was only reached after 90 
minutes at 0°C while it was reached in less than 30 seconds at 37°C (data not shown). This 
may be due to the faster co-recruitment of the TCR and CD8 at 37°C than 0°C. In any event 
the differences in TCR/CD8-ligand affinities at different temperatures were shown to be 
mediated by CD8 and seemed to affect high affinity ligands more than low affinity ligands. 
On the other hand the rank order of the KD values for high affinity, intermediate affinity 
and low affinity ligands was preserved at all three temperatures tested and reflected the 
potency hierarchy determined in CD69 assays. 
Table III: KD values [M] determined for pMHC monomers bound to DP T1 thymocytes at 0oC, 24oC and 37oC.
Temperature 4L-Kd 4P-Kd 4A-Kd 4S-Kd 4N-Kd
0oC
24oC
2.0 x10-9
1.6 x10-8
3.4 x10-9
5.3 x10-8
4.7 x10-7
3.3 x10-6
5.7 x10-7
3.8 x10-6
1.5 x10-6
>1.0 x10-5*
Mean values of at least two experiments are shown. (*) half-maximal TCR saturation was not reached.
Ligands
4L-Kd∆223/227
37oC 6.5 x10-8 2.2 x10-7 4.5 x10-6 5.4 x10-6 >1.0 x10-5*
5.7 x10-7
1.4 x10-6
1.6 x10-6
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3.1.10 Similar TCR-Ligand Binding on Thymocytes and Peripheral T Cells
Several previous studies using multimeric pMHC ligands have shown that the avidities 
of non-cognate CD8-pMHC interactions were increased on DP thymocytes compared to SP 
thymocytes and peripheral T-cells (Bosselut et al., 2000; Daniels et al., 2001; Moody et 
al., 2001). To test whether these differences could be detected with the cognate TCR/CD8 
pMHC monomers, two step labeling studies performed on DP thymocytes (Fig.3.9) were car-
ried out with SP thymocytes and lymph node T cells as well. Thymocytes and lymph node 
T cells of T1 mice were analyzed for their ability to bind monomeric pMHC ligands of vari-
ous potencies. Figure 3.10 shows the fluorescence signals observed with the two step TCR 
labeling assay derived either from DP thymocytes, SP thymocytes or lymphocytes (LN) incu-
bated with the 4L-Kd, 4P-Kd, 4A-Kd, 4S-Kd and 4N-Kd monomers at 0°C. As expected, due to 
the different TCR expression levels, the signal maxima were different when DP thymocytes 
(MFImax: 90) were compared to SP thymocytes (MFImax: 350) and lymphocytes (MFImax: 420). 
Despite these different signal intensities, the hierarchy of the dose dependence on ligand 
binding was not changed when DP, SP and LN cells were compared. Even more importantly 
the curves were not shifted when the three developmental stages were compared, indicat-
ing that the affinities measured on DP thymocytes, SP thymocytes and lymphocytes were 
very similar (see below). 
3.1.11 TCR-Ligand Affinity Does not Change During T Cell Development
To compare TCR saturation at the three different stages of T-cell development, the 
fluorescence signals shown in Figure 3.10 were normalized for the different TCR expres-
sion levels observserved on thymocytes and lymphocytes. The normalized values represent 
the binding ratio (r = occupied TCRs / total TCR) for TCR saturation and in the case of the 
two step TCR labeling assay the ratio of free TCRs (1-r). Direct comparison of fluorescence 
signals obtained with the 4P-Kd, the 4A-Kd and the 4S-Kd monomers bound to DP, SP and LN 
cells at 0°C were made by overlaying binding curves representing the ratio of free TCRs (1-r) 
(Fig. 3.11A). For each ligand tested the affinity labeling curves obtained from DP, SP and LN 
cells of T1-TCR;Rg-/- mice were equivalent. For a given ligand, the affinity of the T1-TCR was 
constant irrespective whether the TCR was expressed on DP thymocytes, SP thymocytes 
or peripheral lymph node T cells. The experiments were also repeated at 37°C (Fig. 3.11B 
and Table V). Again no differences in the affinities of the TCR/CD8-pMHC interaction were 
evident between DP thymocytes and SP thymocytes. The KD values determined from these 
measurements are shown in Table IV. In the case of the 4P-Kd and the 4A-Kd monomers the 
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Figure 3.10: TCR ligand binding on T1 thymocytes and lymph node T cells. T1 thymocytes were incubated 
with various doses of photo-reactive, unlabeled monomers at 0°C and subsequent photo-crosslinking 
(~312nm);  this was followed by incubation with 500nM 4P-Kd-Cy5 and a second round of photo-crosslinking 
(~312nm) according to the two step TCR labeling  protocol. Cells were stained with fluorescently labeled 
α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAbs. MFIs of Cy5 fluorescence signals obtained from DP 
thymoctyes (DP) or SP thymocytes (SP) and lymph node T cells (LN) are plotted as a function of primary 
ligand concentration (4L-Kd(■), 4P-Kd (●), 4A-Kd (▼), 4S-Kd (▲) or 4N-Kd (◆)). 
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two step TCR labeling at 37°C was also performed on lymph node T cells and no differences 
in the KD values compared to the thymocytes were observed. 
To further characterize the binding between the T1-TCR and pMHC monomer ligands, 
‘off-rate’ studies were performed. In these studies the pMHC ligands tested were incubated 
with DP or SP thymocytes at concentrations leading to TCR saturation binding. Instead of UV 
photo-crosslinking the bound ligands the samples were diluted 200-fold in the presence of 
the α-H-2Kd (α1) mAb 20-8-4S which binds to the pMHC monomers and prevents rebinding to 
the TCR. Therefore, once diluted, pMHC ligands that were not bound to TCR were no longer 
able to rebind to T1-TCR molecules. Following dilution of the samples in the presence of the 
20-8-4S antibody UV crosslinking was performed on aliquots of the cells at defined inter-
vals. Subsequently cells were washed and labeled with ligand from the second step of the 
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Figure 3.11: Comparisons of TCR ligand binding between DP thymocytes, SP thymocytes or lymph node 
T cells. Cy5 fluorescence signals obtained from two step labeling of T1 thymocytes and lymph node T cells 
were normalized for TCR expression levels. The curves representing the ratio of free TCRs (1-r) obtained 
from thymocytes and lymph node T cells were overlaid to allow direct comparison of changes in ligand 
binding at different stages of development. Symbols representing results obtained with DP thymocytes, 
SP thymocytes or lymph node T cells are shown in each panel. (A) Ratios of free TCRs observed with DP 
thymocytes (DP), SP thymocytes (SP) or lymph node T cells (LN) at 0°C are shown in three different panels 
representing either binding to 4P-Kd, 4A-Kd or 4S-Kd primary ligand. (B) Similar to (A) but from primary ligand 
bindings performed at 37°C. 
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two step assay as described. This allowed to study the ‘off-rates’ of the T1-TCR/CD8-pMHC 
interactions. Figure 3.12 shows ‘off-rates’ of the 4P-Kd, the 4A-Kd and the 4S-Kd monomers 
when incubated on DP or SP thymocytes at 0°C. Similar to the observations made with the 
dose dependent ligand binding, no differences in the half-lives (t1/2) of the TCR/CD8-pMHC 
interactions were observed between DP and SP thymocytes for all three ligands tested. 
Interestingly, at 0°C the differences in the half-lives (see Table V) between the 4P-Kd (23 
min.) and the 4A-Kd (28 sec.) and 4S-Kd (27 sec.) ligands were between 50- and 60-fold, ap-
proximating the affinity differences between these ligands (see Table IV). This argues that 
the differences in affinity between different TCR ligands was largely due to differences in 
their ‘off-rates’. Unfortunately the half-lives of the TCR/CD8-pMHC interactions could not 
be determined at 37°C due to very high ‘off-rates’ (TCR/CD8-4P-Kd: t1/2< 5 sec.). In conclu-
sion, these affinity comparisons between different stages of T cell development showed 
that the affinity of a given TCR/CD8-pMHC monomer interaction was equivalent on DP and 
SP thymocytes as well as on LN cells. Previous studies using pMHC multimers showed, that 
non-cognate pMHC multimers bound less avidly to SP and LN cells than to DP cells argu-
ing for altered ligand binding when DP thymocytes were compared to SP thymocytes and 
lymphocytes (Daniels et al., 2001; Moody et al., 2001) and a correlation between the cell 
Table IV: KD values [M] determined for pMHC monomers bound to T1 thym. and LN T cells at 0oC and 37oC.
Temperature;
Cell type 4L-Kd 4P-Kd 4A-Kd 4S-Kd 4N-Kd
DP
SP
2.0 x10-9
2.1 x10-9
3.4 x10-9
2.9 x10-9
4.7 x10-7
4.2 x10-7
5.7 x10-7
5.7 x10-7
1.5 x10-6
2.6 x10-6
Ligands
LN 2.2 x10-9 3.5 x10-9 4.2 x10-7 5.7 x10-7 2.4 x10-6
DP
SP
6.5 x10-8
6.5 x10-8
2.2 x10-7
3.7 x10-7
5.4 x10-6
7.6 x10-6
5.5 x10-6
7.8 x10-6
5.9 x10-5
8.1 x10-5
Mean values of at least two experiments are shown.
LN not done 1.6 x10-7 7.5 x10-6 not done not done
0oC
37oC
∆KD (SP/DP) 1.1 x 0.9 x 0.9 x 1.0 x 1.8 x
∆KD (SP/DP) 1.0 x 1.7 x 1.4 x 1.4 x 1.3 x
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surface protein glycosylation status and the binding capacity of pMHC multimer per TCR has 
been described (Casabo et al., 1994). It was proposed, that addition of a sialic acid residue 
to the CD8β coreceptor was responsible for the reduced CD8 mediated binding capacity of 
SP thymocytes compared to DP thymocytes. Removal of the sialic acid residues by enzymat-
ic cleavage with neuraminidase increased the avidity of non-cognate tetramer binding on 
SP thymocytes to levels observed on DP thymocytes. To test the impact of neuraminidase 
on TCR mediated, cognate binding of monomeric pMHC ligands and to compare it to binding 
of pMHC multimers, binding studies with 4P-Kd-Cy5 monomers, 4P-Kd-Cy5 tetramers and 4A-
Kd-Cy5 tetramers were performed using DP and SP thymocytes that were either untreated 
or pre-treated with neuraminidase prior to ligand binding. 
Time (min.)
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r
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DP
SP
DP
SP
DP
SP
Figure 3.12: ‘Off-rates’ determined by two step labeling assays from DP and SP thymocytes. T1 
thymocytes were incubated for 90 min. with either 100nM of 4P-Kd or 1µM of 4A-Kd or 4S-Kd prior to dilution 
in the presence of 20µg/ml α-H-2Kd(α1)(20-8-4S) mAb. Aliquots of the diluted cells were incubated for 
defined intervals and subjected to UV crosslinking (~312nm). The ratios of free TCRs (1-r) were determined 
by the two step assay. Cells were stained with fluorescence labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-
TCRβ(H57-597) mAbs. MFIs of Cy5 fluorescence signals obtained from DP and SP thymocytes are plotted as 
a function of time.
+-
Table V: Half-lifes (t1/2) of pMHC monomers bound to T1 thymocytes at 0oC.
Cell type 4P-Kd 4A-Kd 4S-Kd
DP
SP
23 min. 4 min.
24 min. 5 min.
28 sec. 8 sec.
30 sec. 8 sec.
27 sec. 6 sec.
26 sec. 7 sec.
Mean values of at least two experiments are shown.
Ligands
+-
+-
+-
+-
+-
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3.1.12 Analysis of Cognate TCR-Ligand Binding Using pMHC Tetramers
To compare differences in cognate TCR/CD8 binding of pMHC monomers and tetramers, 
4P-Kd-Cy5 monomers and tetramers were applied to T1 thymocytes. Moreover the differ-
ences in ligand binding between high affinity 4P-Kd and low affinity 4A-Kd tetramers were 
compared. To better compare the monomeric and tetrameric forms of the 4P-Kd ligand, 
these experiments were performed with directly labeled reagents. In a first step, the gly-
cosylation status of the cells under study was examined using fluorescence labeled pea-
nut agglutinin (PNA). PNA has been shown to bind to desialylated O-linked glycosylation 
branches on cell surface proteins of DP thymocytes including the CD8β molecule (Priatel et 
al., 2000). Due to developmental upregulation of sialyltransferases in DP thymocytes, sialic 
acid moieties are added to Galβ-1-3GalNac branches during positive selection; this leads to 
reduced PNA binding on SP thymocytes. To test the impact of differential glycosylation on 
ligand binding these studies were performed on freshly isolated thymocytes or on thymo-
cytes which were pre-treated with neuraminidase. Neuraminidase reverts the effects of 
the sialyltransferases by enzymatic removal of the sialic acids on glycoproteins leading to 
an increase in PNA binding (Figure 3.13A). Untreated SP thymocytes showed the lowest PNA 
staining (MFI: 50) indicating that they express highly sialylated proteins on their surface. 
Neuraminidase treatment increased the PNA binding on DP and SP thymocytes to similarly 
high levels (MFI:~1000) indicating a reduction in sialylation. 
Figure 3.13B shows ligand binding studies performed on DP and SP thymocytes which 
were either untreated (black curves) or neuraminidase treated (green curves). Two major 
observations were made concerning cognate binding of pMHC monomers and pMHC tetra-
mers. First, as described for experiments using the two step labeling assay, no significant 
differences in ligand affinity was observed for 4P-Kd monomers, when bound to untreated 
DP (Panel I, black curve) or SP (Panel IV, black curve) thymocytes. In both cases the KD 
values were ~4nM. 4P-Kd tetramers bound more avidly to DP (Panel II, black curve) and SP 
(Panel V, black curve) thymocytes compared to 4P-Kd monomers indicated by the lower 
concentrations needed to reach half-maximal TCR saturation (apparent KD = 0.4nM). 
Importantly, as in the case of 4P-Kd monomers, no significant difference in the concentra-
tion leading to half-maximal TCR saturation of cognate 4P-Kd tetramer binding was observed 
when SP thymocytes were compared to DP thymocytes. In the case of the 4A-Kd tetramers 
TCR saturation was not reached by the highest concentration of tetramers applied (Pan-
els III and VI) and therefore half-maximal TCR saturation could not be determined. But 
as expected from the low affinities measured for the 4A-Kd monomers (5.7x10-7 M, Table 
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Figure 3.13: Direct photoaffinity labeling on T1 thymocytes using fluorescence labeled pMHC monomers or 
tetramers. (A) Neuraminidase treated or untreated thymocytes were incubated with 0.2µg/ml FITC-labeled 
peanut agglutinin (PNA) in the presence of α-CD4(RM4-5)-PerCP, α-CD8α(53-6.7)-APC and α-TCRβ(H57-597)-
PE and analyzed by flow cytometry. Cells were electronically gated and the mean fluorescence of PNA 
binding to DP or SP thymoyctes was determined. (B) Neuraminidase treated (green curves) or untreated 
(black curves) thymocytes were incubated with varying doses of Cy5 labeled 4P-Kd monomer (panels I and 
IV), 4P-Kd tetramer (panels II and V) or 4A-Kd tetramer (panels III and VI). After UV-crosslinking (~312nm) 
cells  were incubated with fluorescence labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAbs. DP 
(panels I, II and III) and SP thymocytes (panels IV, V and VI) were analyzed by flow-cytometry. 
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IV) the 4A-Kd tetramers bound less avidly to DP and SP thymocytes than 4P-Kd tetramers. 
Second, removal of sialic acid by neuraminidase treatment did not significantly alter the 
binding of 4P-Kd monomers to either DP (Panel I, green curve) or SP (Panel IV, green curve) 
thymocytes. Despite the slightly stronger binding at low concentrations and slightly weaker 
binding at high ligand concentrations the KD values were not significantly affected by neur-
aminidase treatment. A very similar observation was made for the 4P-Kd tetramers, where 
neuraminidase treatment did not alter the apparent KD (Panels II and V, green curves). 
In the case of the low avidity 4A-Kd tetramer, neuraminidase treatment led to increased 
binding on both DP thymocytes (Panel III, green curve) and SP thymocytes (Panel VI, green 
curve) at all ligand concentrations tested. Thus neuraminidase treatment increased ligand 
binding of the lower affinity tetramer.
In conclusion, using direct photoaffinity labeling on T1 thymocytes it was shown, that 
cognate TCR ligand binding to pMHC monomers and tetramers was not significantly different 
between DP thymocytes and SP thymocytes and that the different degrees of sialylation on 
these two populations had no significant influence on the TCR mediated cognate binding of 
monomeric or multimeric ligands.
3.1.13 Defining Positive and Negative Selecting Ligands
To be able to perform fetal thymic organ cultures (FTOC) the T1-TCR mice were bred to 
B10.D2; Rg-/-; β2m-/- mice (see Material and Methods). As shown in Figure 3.14A, thymocytes 
of these T1-TCR; Rg-/-; β2m-/- mice were arrested at the DP stage prior to positive and nega-
tive selection due to the lack of pMHC class I expression in β2m-/- mice. Using ex vivo cul-
tures of fetal thymi in the presence of exogenous β2m and peptide (Hogquist et al., 1994) 
the developmental arrest was abrogated and depending on the potency of the peptide ap-
plied thymocytes were either positively or negatively selected (Fig. 3.14B). Downregulation 
of CD4 was indicative for positive selection (Fig. 3.14B; blue arrow) and downregulation of 
both CD4 and CD8 for negative selection (Fig. 3.14B; red arrow). The 5 peptides (Fig. 3.14C) 
used in the CD69 upregulation assays and the ligand binding studies were tested for their 
ability to induce positive or negative selection of T1-TCR; Rag-/-; b2m-/- thymocytes in FTOC 
assays. 10µM of each peptide were applied to the FTOC cultures and thymocytes were ana-
lyzed for the CD4 and CD8β expression levels by flow-cytometry after 7 days of culture. Fig-
ure 3.14D shows representative dot blots for the 5 peptides tested. The 4L and 4P peptides 
induced negative selection, while the 4S and 4N peptides induced positive selection. The 4A 
peptide gave a mixed picture. Although 32% of the cells were CD8 SP and expressed CD8β 
(consistent with positive selection), most of the remaining cells were DN, expressing neither 
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coreceptor. The presence of the latter population was a product of negative selection. As 
the 4A peptide induces both types of selection, this peptide was referred to as transitional 
or ‘borderline’ selecting peptide. 
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Figure 3.14: Defining positive and negative selecting peptides using fetal thymic organ culture (FTOC). 
(A) CD4 and CD8α expression on thymocytes from T1-TCR; Rag-/-; β2m-/- mice. Thymic development in 
these mice is blocked at the DP stage due to the absence of β2m. (B) Defining positive and negative 
selecting peptides using FTOC: 7 day culture of fetal thymi (E14) in the presence of β2m and peptide did 
not affect CD4 and CD8 expression when ‘null’ peptides were added. Positive selecting ligands only induced 
downregulation of CD4 (blue arrow) while negative selecting peptides induced downregulation of both CD4 
and CD8β (red arrow). (C) Peptides used in FTOCs. (D) Selection properties of various peptides added at 
10µM final concentration to FTOC: 4L and 4P induced negative selection (red arrows). 4S and 4N induced 
positive selection (blue arrows). 4A induced negative selection on the majority of cells. Numbers indicate 
percentages of cells found in a quadrant.  
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3.1.14 Evidence for a Positive-Negative Selection Affinity Threshold 
To further characterize the mixed phenotype that was observed with the 4A peptide, 
FTOCs were repeated including various concentrations of each peptide. Interestingly, the 
selection properties of the 4L, the 4P, the 4S and the 4N peptides were relatively concen-
tration independent. In the case of the 4L and the 4P peptides, all concentrations tested 
led to negative selection, while in the case of the 4S and the 4N peptides all concentrations 
tested led to positive selection. In contrast, high concentrations of 4A led to negative selec-
tion, while low concentrations of 4A led to positive selection. This is illustrated in Figure 
3.15A. These results combined with the finding, that the 4L and 4P peptides were consid-
ered strong peptides and the 4S and 4N peptide were considered weak peptides in CD69 
upregulation assays while the 4A peptide was considered a moderate potency peptide (see 
Results 3.1.3; Fig. 3.3A), favoured the affinity model of thymic selection (see Introduction 
1.4.1 and Reviewed by Starr et al., 2003 ) with the 4A peptide being at the affinity border 
between positive and negative selection. 
Combining FTOC data with TCR-ligand binding data this argues that the affinity of the 
4A-Kd ligand was too high to induce dose-independent positive selection and too low to in-
duce a dose-independent negative selection. Therefore, the affinity of the TCR/CD8-4A-Kd 
interaction reflected the affinity threshold between positive and negative selection in the 
T1-TCR system. To directly compare the affinity and the selection properties, the affinity 
measurements of the 4L-Kd, the 4A-Kd and the 4S-Kd ligands were repeated on DP thymo-
cytes from T1-TCR; Rg-/-; β2m-/- mice at 37°C. These measurements revealed an affinity 
threshold defining positive and negative selection for the T1-TCR, which was 4µM.
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Figure 3.15: Comparison of thymic selection and ligand affinity. (A) Thymocyte positive and negative 
selection after 7 days of FTOC in the presence of various doses of 4P (●), 4A (▼) or 4S (▲) peptide. High 
percentages of CD8β+ cells are indicative of positive selection and low percentages are indicative of negative 
selection. (B) Dose dependence of the ratio of free TCRs with the 4P-Kd (●) the 4A-Kd (▼) or the 4S-Kd (▲) 
monomers assessed on DP thymocytes from T1; Rag-/-; β2m-/- mice using the two step labeling assay at 37°C. 
(C) KD values representing the affinities of TCR ligand interactions determined from (B). 
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3.2 Role of the α-CPM in TCR-Ligand Binding and Function
3.2.1 The Role of the α-CPM in Thymocyte Development
The α-chain connecting peptide domain (α-CPM) is an evolutionary very conserved mo-
tif consisting of eight amino acids (FETDxNLN) located in the constant region of the TCRα 
chain in all vertebrates. Its function has been analyzed by several studies of mutant TCR 
molecules in which the α-CPM was replaced by a short amino acid sequence found in the 
corresponding constant region of TCRδ chains. Using hybridoma cell lines and transgenic 
mice expressing such α-CPM mutant TCRs, a series of defects were reported elucidating the 
importance of the evolutionary conservation of this motif (see Introduction 1.2.2.3). Most 
strikingly, TCR transgenic mice expressing mutant TCRs lacking the α-CPM showed a com-
plete block of thymocyte development at the DP stage of T cell development (Backstrom 
et al., 1998; Werlen et al., 2000). It was shown that this defect was not due to a complete 
abrogation of TCR function, but specifically affected the TCR’s ability to mediate positive 
selection; negative selection was unaffected by the absence of the α-CPM. Analysis of the 
signaling pathways revealed that the specific defect in positive selection was due to the 
absence of Erk MAP kinase signaling and altered CD3ζ and LAT phosphorylation in α-CPM 
deficient thymocytes stimulated with positive selecting ligands (Werlen et al., 2000). Al-
though these studies described major defects in the signaling cascades by the absence of 
the α-CPM they did not address the question whether replacement of the α-CPM changed 
the pMHC ligand binding capacity of such mutant TCR receptors. To address this question, 
α-CPM mutant T1-TCRs were produced which allowed studying the impact of the α-CPM in 
TCR ligand binding by using the photoaffinity labeling technique (see Introduction 1.3.3.1). 
3.2.2  Chimeric TCRs including or lacking the α-CPM
To study the role of the α-CPM in TCR-ligand binding the wildtype T1-TCR and two mu-
tant, chimeric forms of the T1-TCR were generated. Mutant α-CPM deficient TCRs were 
produced by replacing parts of the TCRα chain constant regions by a sequence derived 
from the TCRδ chain constant region (more detailed explanations are found in the Introduc-
tion 1.1.3 and Results 3.2.4: Figure 1). Because it had previously been reported that TCRs 
consisting of such α-CPM deficient chimeric TCRα/δ chains were only expressed on the cell 
surface in conjunction with chimeric TCRβ/γ chains (Backstrom et al., 1996) the α-CPM 
mutant T1-TCRs did not only differ from the wildtype T1-TCRs by the absence of the α-CPM 
but also by the replacement of the transmembrane (TM) and cytosolic regions of the TCRα 
and TCRβ chains with homologous, corresponding sequences of TCRγ/δs. To be able to more 
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specifically test the α-CPM mediated differences observed between the wildtype and the α-
CPM mutant TCRs a third, transmembrane (TM) control T1-TCR was included in the studies. 
This chimeric TCR consisted of the same TCRβ/γ chimeric chain as the α-CPM mutant T1-
TCR, but in contrast to the α-CPM mutant T1-TCR the TCRδ derived sequences were slightly 
shorter than those included in the α-CPM mutant chain. Therefore the TM control receptor 
contains the wildtype α-CPM motif. The three different T1-TCRs used in these studies are 
shown in Figure 3.16A. 
3.2.3 Hybridoma Cell Lines Expressing WT or chimeric T1-TCRs 
As a first step, measurements of T1-TCR-ligand binding and functional responses were 
performed on the thymoma derived ‘58’ hybridoma cell line. This hybridoma cell line does 
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Figure 3.16: T1-TCR variants and hybridomas used to study the role of the α-CPM. (A) Schematic 
representation of wildtype (1), α-CPM mutant (2) and TM control (3) T1-TCRs. TCRα/β derived regions 
are shown in black; TCRγ/δ derived regions are shown in gray. The location of the α-chain connecting 
peptide motif (α-CPM) is shown in red. In the case of the α-CPM mutant (2) and TM control TCR (3) the 
transmembrane and cytosolic regions are derived from TCRγ/δ. In the case of the α-CPM mutant TCR, the α-
CPM is replaced by homologous connecting peptide sequences derived from the TCRδ chain. For the amino-
acid sequences see Results 3.2.4 (Fig. 1 in Naeher et al., 2002). (B) Wildtype T1-TCR (1), α-CPM mutant TCR 
(2) and TM control TCR (3) were independently transfected into 58 and 58CD8α+β+ hybridomas.
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not express endogenous TCRs nor the CD4 or CD8 coreceptor molecules (Letourneur et al., 
1989). To perform TCR-ligand binding studies including the three different T1-TCR variants 
in the presence or absence of the CD8α/β coreceptor the cDNAs of the T1-TCR variants 
were either introduced in the 58 hybridomas or 58CD8α/β hybridomas which had been 
previously transfected with the cDNAs of the CD8α/β coreceptor (Stotz et al., 1999). Figure 
3.16B shows the TCRs and coreceptors expressed in six different hybridoma lines produced. 
Binding to T1-TCRs was assessed by UV induced crosslinking of TCR-bound H-2Kd monomers 
loaded with radioactive (125I) variants of the PbCS253-260(IASA)YIPSAEK(ABA)I peptides illus-
trated in Figure 3.17A (see Introduction 1.4.3.3). Therefore quantification of bound ligand 
could be assessed by immunoprecipitation of the T1-TCR, SDS-PAGE analysis and autoradi-
ography. The results from the photoaffinity labeling experiments were compared to func-
tional responses elicited by the peptides shown in Figure 3.17B when presented by the T2 
hybridoma line (Cerundolo et al., 1990) expressing H-2Kd.
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Figure 3.17: Ligands used in the studies performed with hybridomas. (A) Monomeric pMHC ligands used. 
The bifunctional, PbCS253-260 derived, radioactively labeled 
125I-Ag11.3 peptide or the  125I-P255A peptide 
variant were covalently crosslinked (UV irradiation at 350nm) to the H-2Kd heavy chain complexed with 
β2m. (B) Bifunctional IASA-YIPSAEK(ABA)I peptides were used for IL-2 assays. Arrows indicate the amino 
acid residues by which the peptide variants differ. 
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3.2.4 ‘A Role for the α-CPM in Mediating TCR/CD8 Cooperativity’
The results of these experiments were published in the Journal of Immunology (2002), 
169:2964. 
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A Role for the �-Chain Connecting Peptide Motif in Mediating
TCR-CD8 Cooperation
Dieter Naeher,* Immanuel F. Luescher,† and Ed Palmer1*
To generate peripheral T cells that are both self-MHC restricted and self-MHC tolerant, thymocytes are subjected to positive and
negative selection. How the TCR discriminates between positive and negative selection ligands is not well understood, although
there is substantial evidence that the CD4 and CD8 coreceptors play an important role in this cell fate decision. We have previously
identified an evolutionarily conserved motif in the TCR, the �-chain connecting peptide motif (�-CPM), which allows the TCR to
deliver positive selection signals. Thymocytes expressing �-CPM-deficient receptors do not undergo positive selection, whereas
their negative selection is not impaired. In this work we studied the ligand binding and receptor function of �-CPM-deficient TCRs
by generating T cell hybridomas expressing wild-type or �-CPM-deficient forms of the T1 TCR. This Kd-restricted TCR is specific
for a photoreactive derivative of the Plasmodium berghei circumsporozoite peptide252–260 IASA-YIPSAEK(ABA)I and is therefore
amenable to TCR photoaffinity labeling. The experiments presented in this work show that �-CPM-deficient TCRs fail to coop-
erate with CD8 to enhance ligand binding and functional responses. The Journal of Immunology, 2002, 169: 2964–2970.
During T cell development thymocytes are subjected topositive and negative selection, establishing a pool ofmature T cells that is self-MHC restricted and self-MHC
tolerant. TCR-mediated ligand recognition is essential for positive
and negative selection of thymocytes. Although how the TCR gen-
erates distinct positive and negative selection signals is not com-
pletely understood, thymocytes are sensitive to ligand affinity in
that low-affinity ligands induce positive selection and high-affinity
ligands induce negative selection (1–3). The CD4 and CD8 core-
ceptors play an important role during thymic selection by enhanc-
ing ligand binding to the TCR (4–8). In addition, these coreceptors
play a key role in lineage commitment. Several lines of evidence
suggest that the strength of the signal delivered by the coreceptor
determines whether a thymocyte will develop into a helper or a
cytotoxic T cell (9–12). Although the precise role of coreceptor
involvement on positive and negative selection is still unresolved,
their importance in modulating TCR ligand binding and recruit-
ment of the membrane proximal tyrosine kinase p56lck to the TCR-
CD3 complex has been demonstrated (13–18). p56lck-mediated
phosphorylation of immunotyrosine-based activation motifs
present in the cytoplasmic tails of the CD3 chains is necessary for
the appropriate induction of the signaling cascades involved in
both types of thymic selection (12, 19–22).
The TCR constant regions couple the �� heterodimer to the
CD3 complex. TCR�� constant regions are composed of the cy-
tosolic (Cyto),2 the transmembrane (TM), the connecting peptide
(CP), and the Ig-like domains. In terms of positive selection, a
particularly important role is played by a motif located in the mem-
brane proximal CP domain of the TCR� chain (23, 24). This
�-chain connecting peptide motif (�-CPM) consists of seven
highly conserved amino acids (FETDxNLN), is only found in
TCR��, and is absent from TCR��. Thymocytes from mice ex-
pressing �-CPM mutant TCRs fail to undergo positive selection,
while negative selection is not impaired. Characterization of thy-
mocytes or hybridomas expressing �-CPM mutant TCRs revealed
an impaired CD3� phosphorylation (23, 25), a defective activation
of the p56Fyn protein kinase (26), and an impaired CD3� associ-
ation (24). CD3� is also important for thymic selection signals
because thymocytes from CD3� knockout mice fail to undergo
positive selection as well (27, 28). The defect observed with
�-CPM mutant receptors is selective for low-affinity (positive-se-
lecting) ligands. Low-affinity ligands fail to recruit tyrosine-phos-
phorylated isoforms of the signaling components lck, CD3-�, ZAP-
70, and linker for activation of T cells into detergent-insoluble,
membrane rafts in �-CPM mutant thymocytes (25). Why these
defects are specific for positive-selecting ligands is still unclear.
To investigate whether the defects observed with �-CPM-defi-
cient TCRs are mediated by altered ligand binding, we studied the
T1 TCR, a receptor that was developed to investigate TCR-ligand
interactions by photoaffinity labeling (29). In the T1 TCR system,
photoaffinity labeling is used to cross-link soluble, monomeric,
pMHC ligands to surface TCRs on living cells. This system is
based on the Plasmodium berghei circumsporozoite (PbCS) pep-
tide derivative, IASA-YIPSAEK(ABA)I, with two photoreactive
groups, IASA and ABA, which can be selectively activated by UV
light of different wavelengths. This bireactive peptide derivative
can be covalently cross-linked to the Kd molecule by selective
photoactivation of the IASA group, leaving the ABA group intact.
After specific binding of these pMHC complexes to T1 TCRs,
photoactivation of the ABA group allows covalent cross-linking of
the pMHC ligand to the TCR.
In this study we generated the wild-type and two chimeric forms
of the T1 TCR, in which the �-CPM was either present or absent.
All receptors were expressed in CD8� and CD8� hybridomas. We
were able to show that replacement of the �-CPM does not alter
the binding of the T1 TCR to its pMHC ligand per se. However,
these studies demonstrate that the �-CPM is required for mediating
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TCR-CD8 cooperation to increase ligand binding. Furthermore,
we show that the functional defects observed in hybridomas ex-
pressing �-CPM-deficient TCRs are CD8 mediated and most
prominent with low-affinity ligands.
Materials and Methods
DNA constructs
The T1 TCR is derived from the Kd-restricted, PbCS derivative peptide253–260
(IASA)-YIPSAEK(ABA)I (Ag11.3)-specific CTL clone, T1 (30). The
cDNA encoding the TCR� chain was cloned into the G418-resistant ret-
roviral vector, LXSN (31–33). Similarly, the T1 TCR� chain was cloned
into the puromycin-resistant retroviral vector, LXSP (23). The cDNAs en-
coding the T1 TCR �� chimeras were constructed using the previously
described �II and �IV chimeric cDNAs (23) specific for the 3BBM74 TCR
(34) by replacing the VJC-containing EcoRI-SpeI fragment by T1 TCR VJC
�-chain sequences. Similarly, the T1 TCR �� chimera �III was constructed by
replacing the VDJC-containing EcoRI-XbaI fragment of the 3BBM74 chi-
meric �-chains by T1 TCR VDJC �-chain-containing sequences.
Cells
The TCR�CD8� T hybridoma, 58, and its TCR�CD8� derivative,
58CD8��, have been described previously (35, 36). Retroviral infection
was used to introduce the wild-type or chimeric T1 TCR� chains and the
wild-type or chimeric T1 TCR� chains into the 58 (TCR�CD8�) and the
58CD8�� (TCR�CD8�) hybridomas. Transduced hybridomas were sub-
sequently FACS-sorted for high TCR expression. All cells were grown in
IMDM supplemented with 2% FCS, 2 mM L-glutamine, 100 U/ml peni-
cillin, 100 �g/ml streptomycin, and 50 �M 2-ME. The T2-Kd cell line
(generously provided by T. Potter, National Jewish Medical and Research
Center, Denver, CO) used for peptide presentation was grown in IMDM
with 10% FCS. The indicator cell line HT-2 (37) was grown in IMDM
containing 10% FCS and 250 U/ml rIL-2. The ectotropic packaging cell
line BOSC23 was purchased from American Type Culture Collection (Ma-
nassas, VA) and grown in IMDM containing 10% FCS.
Transduction of cDNAs
The BOSC23 packaging cell line was transfected as previously described
(38). The supernatant containing retroviral particles was used to infect the
TCR�CD8� cell line, 58, and its CD8� derivative, 58CD8��. In short,
5 � 105 58 or 58CD8�� hybridomas were resuspended in 500 �l IMDM
containing 4 �g/ml polybrene (Sigma-Aldrich, St. Louis, MO). After 24 h,
5 ml of fresh IMDM and the appropriate selective drugs were added (1
mg/ml G418 (Life Technologies, Rockville, MD), 3 �g/ml puromycin
(Sigma-Aldrich), 2 mM histidinol (Sigma-Aldrich), or 0.5 mg/ml hygro-
mycin B (Calbiochem, La Jolla, CA)). Surviving cells were analyzed after
4 days and sorted for high TCR surface expression by FACS. Transfected
cells were continuously maintained in medium containing selective drugs.
Antibodies
The anti-TCR C� mAb H57-597 (39), the anti-CD3� mAb 145-2C11 (40),
and the anti-CD8� mAb H35-17 (41) were purified from culture superna-
tants using protein G (Amersham Pharmacia Biotech, Piscataway, NJ). The
anti-CD8� mAb 53-6.7 and the anti-CD8� mAb 53-5.8 were purchased
from BD PharMingen (San Diego, CA).
Quantitation of TCR surface expression
To calculate the relative amounts of the three different TCRs expressed on
CD8� and CD8� hybridomas, the expression of the TCR, measured with
the anti-TCR C� mAb H57-597, was normalized to the expression of the
wild-type TCR measured on CD8� hybridomas. The following equation
was used: relative TCR expression � MCF of TCR staining expressing
variant TCR/MCF of TCR staining on CD8� hybridomas expressing the
wild-type TCR.
Kd and TCR photoaffinity labeling
Soluble Kd molecules were produced and loaded with the 125IASA-YIP-
SAEK(ABA)I peptide or the P255A derivative as previously described
(29). TCR photoaffinity labeling was also performed as previously de-
scribed (5). Briefly, 5 � 106 cpm of Kd-125IASA-YIPSAEK(ABA)I were
incubated with 107 T hybridoma cells either at 0°C for 2 h or at 37°C for
10 min, followed by UV irradiation at 312 � 40 nm. After UV irradiation,
cells (107 cells/ml) were washed twice and lysed in 1 ml lysis buffer con-
taining 1% Triton X-100, 1% Nonidet P-40, 150 mM NaCl, 0.2 mM
EDTA, 50 mM HEPES, 1 mM PMSF, 10 �g/ml leupeptin, 10 �g/ml apro-
tinin, and 10 �g/ml iodoacetamide for 2 h at 4°C. Postnuclear supernatants
were subjected to immunoprecipitation with anti-TCR C� mAb H57-597.
The immunoprecipitates were analyzed by reducing SDS-PAGE and quan-
tified using a PhosphorImager and ImageQuant software (Molecular Dy-
namics, Sunnyvale, CA). To compare the photoaffinity labeling of the var-
ious receptors, the values were normalized for TCR expression and
compared with the labeling value obtained on CD8� hybridomas express-
ing the wild-type T1 TCR. The following equation was used: relative bind-
ing � (CPM bound by variant TCR/CPM bound by CD8� hybridoma
expressing wild-type TCR)/relative TCR expression.
IL-2 assays
A total of 80 �l IMDM containing 6 � 104 T2-Kd cells was plated in
flat-bottom 96-well plates and incubated with the indicated amounts of
peptide (see Fig. 4) for 2 h at 37°C. T hybridoma cells (6 � 104 in 100 �l
IMDM) were subsequently added. After a further 24 h of incubation at
37°C, the supernatant was harvested and assayed for IL-2 using the indi-
cator line HT-2 as previously described (23).
Calculation of relative receptor sensitivities
Relative receptor sensitivities were defined by determining the peptide con-
centration required for half-maximal IL-2 production from each hybridoma
and peptide tested. These values were normalized to the concentration of
P255S peptide required for half-maximal IL-2 production from the CD8�
hybridomas expressing the wild-type T1 TCR. The following equation was
used: relative receptor sensitivity � [P255S] required for 1/2 max IL-2
production of CD8� hybridomas expressing wild-type TCR/[pep] required
for 1/2 max IL-2 production of hybridomas expressing a variant TCR
Results
Wild-type and chimeric T1 TCRs
To test whether altered ligand binding was responsible for the
functional defects previously observed with mutant TCRs lacking
the �-CPM domain (23–26), we analyzed the ligand binding prop-
erties of several chimeric T1 receptors. The T1 receptors are spe-
cific for photoreactive derivatives of a PbCS peptide253–260
(IASA)YIPSAEK(ABA)I (29), which can be photo-cross-linked to
Kd and the TCR. The CP, TM, and Cyto domains of the wild type
and the two chimeric TCRs used in this study are schematically
shown in Fig. 1A. Because a simple deletion or replacement of the
�-CPM prevented TCR expression (data not shown), we generated
chimeric TCRs in which the CP, TM, and Cyto domains were
replaced with the corresponding domains from a TCR��. In Fig.
1A, TCR� sequences, which replaced �-sequences, are shown in
black and TCR-� sequences, which replaced the TCR� sequences,
are shown in gray. The �-CPM mutant receptor is comprised of
�IV and �III chains. The �IV chain encodes V, D, J, and parts of
the C region sequences from the T1 TCR� chain followed by C�
sequences; this chain lacks the �-CPM (Fig. 1B). In the �III chain,
the TM and the Cyto domains of the �-chain were replaced by
homologous C� sequences (Fig. 1B, boxed sequences); the �III
chain is required for expression of the �IV chain, which lacks the
�-CPM. The control for the �-CPM mutant receptor is the TM
control receptor, which expresses the �III chain and the �II chain.
The �II chain is identical to the �IV chain, except that it includes
the �-CPM (Fig. 1B). Thus, the only difference between the
�-CPM mutant and the TM control receptors is the absence of the
�-CPM domain from the �-CPM mutant receptor.
Cell surface expression of wild-type and variant T1 TCRs
The expression of chimeric TCRs was examined on 58 (CD8�)
and 58CD8�� (CD8�) T cell hybridomas (Fig. 2 and data not
shown). The wild-type and �-CPM mutant receptors were ex-
pressed at comparable, low levels while the TM control (�-CPM
intact) receptor was expressed at higher levels. TCR expression
was similar on CD8� and CD8� hybridomas (data not shown) and
expression of a particular TCR did not significantly affect CD8
2965The Journal of Immunology
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expression (Fig. 2). Finally, CD8�� expression was similar in all
CD8� cell lines used in this study (Fig. 2).
Ligand binding on wild-type and chimeric T1 TCRs
To test whether replacement of the �-CPM affects ligand binding,
we performed photoaffinity labeling of wild-type and chimeric T1
TCRs using photoreactive ligands. To this end, hybridomas ex-
pressing the different T1 TCRs were incubated with monomeric
Kd-peptide complexes. Two different ligands were used: the high-
affinity Ag11.3 and the variant, P255A, which has a lower relative
affinity for the T1 TCR (42). After incubating hybridomas express-
ing the different T1 TCRs with equal amounts of Kd-peptide com-
plexes, TCR-bound Kd-peptide complexes were cross-linked by
UV irradiation. TCRs were immunoprecipitated and analyzed by
SDS-PAGE and phosphor imaging. Fig. 3A shows a representative
experiment in which TCR photoaffinity labeling was performed on
CD8� and CD8� hybridomas expressing the various T1 TCRs.
The labeled material at 90 kDa represents the trimolecular com-
plex consisting of the TCR, the peptide, and Kd. The material at 45
kDa represents a minor fraction of peptide-Kd complexes that were
not cross-linked to but were coprecipitated with the T1 TCR.
When TCR� and CD8� hybridomas were incubated with pep-
tide-Kd complexes under the same conditions, no signal could be
detected, demonstrating that the binding of the peptide-Kd com-
plexes was specific for the T1 TCR (Fig. 3A).
Fig. 3, B–D, shows a quantification of the signal intensities mea-
sured by phosphor imaging after correction for the different TCR
expression levels and normalization to the signal observed on hy-
bridomas expressing the wild-type T1 TCR on CD8� hybridomas
at 0°C (see Materials and Methods for calculations).
Fig. 3B shows relative ligand binding observed for the different
T1 TCRs upon incubation with 125IASA-YIPSAEK(ABA)I-Kd
(Ag11.3) complexes at 37°C. Importantly, ligand binding at 37°C
was equivalent on all TCRs in the absence of CD8 (Fig. 3B, open
bars), demonstrating that the �-CPM-deficient TCR binds ligand
as well as the wild-type and TM control TCRs. In contrast, a sig-
nificant increase in ligand binding was observed only on CD8�
hybridomas (Fig. 3B, filled bars) expressing the wild-type or the
TM control receptor, which contain an intact �-CPM. No increase
in ligand binding was observed for CD8� hybridomas expressing
the �-CPM mutant receptor, which lacks the �-CPM. Therefore, at
37°C only hybridomas expressing receptors with an intact �-CPM
showed a CD8-mediated increase in ligand binding. We also per-
formed affinity labeling of T1 TCRs using the weak 125IASA-
YIASAEK(ABA)I-Kd (P255A) ligand. Because the signals ob-
tained with the weak ligand at 37°C were too weak to be accurately
quantified, we repeated the experiments with the strong (Ag11.3) and
the weak (P255A) ligands at 0°C where the signal intensities were
higher, which is in accordance with previous observations (5).
FIGURE 1. Sequences of the T1 TCRs used in this study. A, Schematic
representation of the constant regions of the wild-type and chimeric TCRs
used in this study. Only the CP, TM, and Cyto domains are shown. The
complete �- and �-chain cDNAs have been described previously (29).
Open bars, C� and C� sequences; vetical filled bars, C� sequences; shaded
bars, C� sequences. The interchain disulfide bond is represented by a filled
horizontal bar. The location of the �-CPM domain is indicated by an as-
terisk. The �-CPM mutant receptor (�IV/�III) is similar to the TM control
(�II/�III) receptor, except that the �-CPM has been removed and replaced
by C� sequences in the �IV chain. B, Amino acid sequences of chimeric
TCR� chains and TCR� chains. Only the CP, TM, and Cyto domains of
the TCR constant regions are shown. The sequences of the wild-type TCR�
(�wt) and TCR� (�wt) chains, two chimeric TCR�� chains (�II and �IV),
and one chimeric TCR�� chain (�III) are shown using the single letter
amino acid code. The �-CPM is underlined. The boxes indicate C�-derived
sequences in the case of the �II and �IV chains and a C�-derived sequence
in the case of the �III chain. The interchain Cys224 of the T1 TCR� chain
and the interchain Cys257 of the T1 TCR� chain are indicated by bold
letters. The vertical dotted lines indicate the approximate boundary of the
TM domain, defined using the Lasergene Navigator Protean Software pro-
gram (DNAstar, Madison, WI).
FIGURE 2. TCR and CD8 cell surface expression. CD8� (58CD8��) T
cell hybridomas expressing wild-type or chimeric TCRs were stained with
the anti-TCR C� mAb H57-597 or with the anti-CD8� mAb 53-5.8 and
analyzed by flow cytometry. The open histograms represent the staining of
untransfected 58 (TCR�CD8�) control hybridomas stained with the same
Abs. Filled histograms represent the TCR or CD8� expression profiles for
each CD8� hybridoma used in this study. The number in each panel in-
dicates the mean fluorescence intensity observed with hybridomas express-
ing the indicated T1 TCRs or the CD8 coreceptor. TCR expression levels
were similar in CD8� (58) hybridomas (data not shown). In all CD8�
hybridomas, the mean fluorescence intensity for CD8� expression was
250, irrespective of the TCR expressed (data not shown).
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As shown in Fig. 3, C and D, binding on CD8� hybridomas
(open bars) was similar for all TCRs tested, irrespective of whether
the strong (Ag11.3) ligand (Fig. 3C) or the weak (P255A) ligand
(Fig. 3D) was used. In the presence of CD8, a significant increase
in ligand binding was observed only on hybridomas expressing the
wild-type and TM control receptors, while the �-CPM mutant
TCR exhibited only a small increase in ligand binding mediated by
CD8 (Fig. 3, C and D). Therefore, the impact of CD8 on ligand
binding was more pronounced with receptors containing the
�-CPM (wild type and TM control) compared with the receptor
lacking this motif (�-CPM mutant) (Fig. 3). The importance of the
�-CPM is illustrated when comparing the CD8-mediated ligand
binding increase observed on the �-CPM mutant and the TM con-
trol TCRs. These two receptors differ only by the absence or pres-
ence of the �-CPM (Fig. 1A).
The ligand binding experiments were repeated on CD8� hybrid-
omas expressing the chimeric T1 TCRs in the presence of a CD8�
blocking mAb, H35-17. Ligand binding observed in the presence
of this Ab was similar to the results obtained on CD8� hybridomas
(data not shown). Because a mAb directed against the CD8� chain
completely blocks the increase in ligand binding this enhancement
can be attributed to CD8�� heterodimers rather than CD8��
homodimers.
The fact that the absence of the �-CPM precludes proper CD8
participation in the binding of pMHC ligands suggests that the
�-CPM is an important structural feature orchestrating TCR/CD8
cooperation.
IL-2 production of hybridomas expressing wild-type or chimeric
T1 TCRs
We examined the ability of �-CPM mutant receptors to transduce
a signal by measuring the IL-2 produced in response to peptide
ligands. To determine whether the functional deficit observed with
hybridomas expressing �-CPM-deficient TCRs was dependent on
the potency of the peptide tested, we performed IL-2 assays using
three ligands with varying potencies for the T1 TCR. Fig. 4A
shows the IL-2 responses of CD8� and CD8� hybridomas ex-
pressing the various receptors when stimulated with ligands of
high (Ag11.3; Fig. 4A, a–c), medium (P255S; Fig. 4A, d–f) or low
(P255A; Fig. 4A, g–i) affinities. Stimulation of CD8� hybridomas
(Fig. 4A, open symbols) generally resulted in lower IL-2 produc-
tion than the stimulation of CD8� hybridomas (Fig. 4A, filled sym-
bols). When comparing IL-2 production of the various hybridomas
stimulated by the high-affinity Ag11.3 ligand, CD8 significantly
increased the IL-2 responses of hybridomas expressing the wild-
type, �-CPM mutant, or TM control receptor (Fig. 4A, a–c). A
similar CD8-mediated increase in IL-2 production was observed
when the various hybridomas were stimulated with the medium-
affinity P255S peptide variant (Fig. 4A, d–f). Interestingly, a clear
difference in the CD8 participation was observed when comparing
ious T1 TCRs after incubation with the 125I-Ag11.3-Kd ligand at 37°C. The
numbers represent the fold increase in ligand binding mediated by CD8.
The values representing the 90-kDa bands were corrected for the different
mean values of TCR expression shown in Fig. 2. The corrected TCR ligand
binding values were then normalized to the Ag11.3 binding observed at
0°C to CD8� hybridomas expressing the wild-type TCR ligand, which was
defined as 1.0. Normalized binding of the 125I-Ag11.3-Kd complexes is
shown for wild-type and chimeric T1 TCRs either in the absence or pres-
ence of the CD8 coreceptor. C, Normalized, relative ligand binding ob-
served with the 125I-Ag11.3-Kd ligand at 0°C. See B for experimental de-
tails. D, Normalized, relative ligand binding with the 125I-P255A-Kd ligand
at 0°C. See B for experimental details.
FIGURE 3. TCR photoaffinity labeling studies on CD8� or CD8� hy-
bridomas using soluble, monomeric peptide-Kd complexes. A, Photoaffin-
ity labeling of the untransfected 58 (TCR�CD8�) control hybridoma or the
T cell hybridomas expressing the indicated T1 TCR variants in the absence
(�) or presence (�) of CD8 coreceptors. Cells were incubated with equal
amounts of radiolabeled soluble covalent complexes of monomeric Kd and
the peptide derivative 125IASA-YIPSAEK(ABA)I (Ag11.3) at 37°C. After
UV irradiation at 312 nm, TCR-ligand complexes were immunoprecipi-
tated and analyzed by SDS-PAGE as described in Materials and Methods.
The 90-kDa bands representing the trimolecular, TCR-peptide-Kd com-
plexes were quantified by a PhosphorImager. The 45-kDa band is the sol-
uble pMHC ligand, which was immunoprecipitated with the TCR but was
not covalently cross-linked. B, Normalized, relative ligand binding of
CD8� (open bars) and CD8� hybridomas (filled bars) expressing the var-
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the responses to the low-affinity P255A ligand. Hybridomas ex-
pressing the wild-type T1 TCR (Fig. 4Ag) or the TM control TCR
(Fig. 4Ai) showed a significant CD8-mediated increase in IL-2
production when stimulated with the weak P255A peptide. In con-
trast, �-CPM mutant hybridomas failed to produce any detectable
IL-2, even when CD8 was present (Fig. 4Ah).
To quantify the CD8-mediated differences between the wild-
type, �-CPM mutant, and TM control receptors, we reanalyzed the
IL-2 data obtained with CD8� hybridomas to determine the sen-
sitivity of each receptor for each Ag. We calculated the relative
sensitivity of each TCR by determining the peptide concentration
required for half-maximal IL-2 production for each hybridoma line
and comparing it to the P255S concentration required for half-
maximal IL-2 production from the CD8� hybridoma expressing
wild-type receptor; this was defined as 1.0 (see Materials and
Methods for calculation).
The results are shown in Fig. 4B, where the three ligands have
been ordered according to their potency. Although the wild-type,
�-CPM mutant, and TM control receptors showed the highest sen-
sitivity for the high-affinity Ag11.3 peptide, the �-CPM mutant
TCR displayed a 30-fold reduced sensitivity for this ligand. Sim-
ilar observations were made with the intermediate-affinity P255S
peptide. Again, the �-CPM mutant receptor was 10- to 30-fold less
sensitive than the wild-type or TM control receptors. However, in
response to the low-affinity P255A peptide, the �-CPM mutant
receptor was strikingly unresponsive. Compared with the wild-
type receptor, the �-CPM mutant TCR was at least 10,000-fold
less responsive to this low-affinity ligand. Therefore, we conclude
that the �-CPM is of particular importance in mediating TCR/CD8
cooperation in functional responses to weak ligands.
Discussion
To generate a functional T cell repertoire, �� thymocytes express-
ing self-MHC-restricted TCRs survive and differentiate (positive
selection), while thymocytes, whose receptors are self-MHC reac-
tive, undergo apoptosis (negative selection) (43–47). Although
thymocytes can discriminate between different antigenic ligands,
which induce positive or negative selection, the mechanisms by
which the TCR couples ligand binding to distinct cellular re-
sponses are still unclear.
We have previously identified a highly conserved motif in the
constant region of the TCR� chain, �-CPM, which is required for
the positive selection of thymocytes (24). Thymocytes expressing
�-CPM mutant TCRs have specific signaling defects in responses
to positive-selecting ligands, while their responses to negative-se-
lecting ligands are unaffected (25). While it seems that the �-CPM
TCR. Shown in c, f, and i are the IL-2 responses of hybridomas that express
the TM control T1 TCR in the absence (�) or presence (�) of the CD8
coreceptor molecules. B, Receptor sensitivities of CD8� hybridomas to
peptide ligands of varying potency. Relative receptor sensitivities of CD8�
hybridomas expressing the various T1 TCRs were calculated from the pep-
tide concentration required for half-maximal IL-2 synthesis in each hy-
bridoma line and normalized to the receptor sensitivity calculated from
CD8� hybridomas expressing the wild-type receptor responding to P255S
(see Materials and Methods for calculation of receptor sensitivity). The
numbers indicate the different T1 TCRs tested: 1, wild type; 2, �-CPM
mutant; 3, TM control. Three different peptides were tested: Ag11.3,
P255S, and P255A. The asterisk indicates that the �-CPM mutant receptor
was at least 10,000-fold less sensitive to the low-affinity ligand, P255A,
than the wild-type TCR. Data are expressed as the mean of triplicates from
a representative experiment. IL-2 assays were independently conducted
three times in the case of the Ag11.3 and the P255A peptides and twice
with P255S peptide.
FIGURE 4. IL-2 responses of T1 TCR expressing CD8� and CD8�
hybridomas to peptide ligands of varying potency. A, CD8� and CD8�
hybridomas expressing different T1 TCRs were stimulated with the strong
Ag11.3 peptide (a–c) or the lower-affinity derivatives P255S (d–f) or
P255A (g–i) and their IL-2 production was measured. Results obtained
from CD8� (�) and CD8� (f) hybridomas expressing the wild-type T1
TCR are shown in a, d, and g. Shown in b, e, and h are IL-2 responses of
CD8� (E) and CD8� (F) hybridomas expressing the �-CPM mutant T1
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plays an important role in generating positive selection signals,
how the �-CPM functions is still unclear.
To further characterize the defects observed with �-CPM mu-
tant receptors, we used a hybridoma cell line that expressed a
wild-type or �-CPM mutant form of the T1 TCR, in either the
presence or the absence of the CD8 coreceptor. Because the
�-CPM mutant and wild-type TCRs differ in their TM and cyto-
plasmic domains as well, we included the TM control TCR, which
provides a direct control for the role of the �-CPM (Fig. 1).
To test whether �-CPM-deficient TCRs bind ligand defectively,
we performed photoaffinity labeling studies (29) with the different
TCR mutants expressed on hybridoma cell lines. Relative affinities
were determined for the strong Ag11.3 ligand at 0°C and at 37°C,
and for the weak P255A ligand at 0°C. Two major observations
were made. First, there was no obvious (TCR-intrinsic) ligand
binding defect observed with �-CPM mutant receptors when as-
sessed on CD8� hybridomas (Fig. 3, B–D, open bars). Therefore,
the �-CPM mutation does not decrease ligand binding per se.
However, a significant difference in ligand binding was observed
with CD8� hybridomas when comparing wild-type, TM, and
�-CPM mutant TCRs (Fig. 3, B–D, filled bars). Our results clearly
show that the �-CPM mutant TCR has a significant defect in en-
gaging CD8 for ligand binding. Photoaffinity labeling performed
with the weak P255A ligand variant showed a similar picture. The
inability of CD8 to participate in ligand binding was due to the
absence of the �-CPM, because ligand binding to the TM control
TCR was comparable to that observed on the wild-type TCR (Fig.
3, B and D, filled bars). Taken together, these results imply that the
�-CPM plays an important role in orchestrating the cooperation
between the TCR and CD8, which is required to enhance the bind-
ing of both high- and low-affinity ligands.
The functional consequences of defective TCR/CD8 coopera-
tion were also studied using IL-2 assays. Interestingly, CD8 en-
hanced IL-2 production from �-CPM mutant hybridomas when
stimulated with ligands of high (Ag11.3) or medium (P255S) po-
tency. However, no IL-2 production could be detected when hy-
bridomas expressing the �-CPM mutant receptor were stimulated
with the weak P255A ligand, not even in the presence of CD8 (Fig.
4Ah). Because CD8� hybridomas expressing the wild-type and
TM control receptors showed a substantial IL-2 response to P255A
peptide, loading limitations on the APC do not account for the
failure of the �-CPM mutant hybridomas to respond.
When the IL-2 responses of CD8� hybridomas were analyzed
for their peptide dose dependency, i.e., receptor sensitivity, similar
observations were made. As shown in Fig. 4B, �-CPM mutant
receptors were 10- to 30-fold less sensitive than wild-type and TM
control receptors in response to peptides of high (Ag11.3) or me-
dium (P255S) potencies. Strikingly, the differences mediated by
the �-CPM were much more pronounced in the case of the weak
P255A peptide. Comparing CD8� hybridomas, the �-CPM mutant
receptor is 3,000- to 10,000-fold less sensitive in the response to
P255A than the wild-type and TM control receptors. Furthermore,
the wild-type receptor is only 10-fold less sensitive to the low-
affinity ligand P255A compared with the medium-affinity ligand
P255S. In contrast, the �-CPM mutant receptor is 10,000-fold less
sensitive to the low-affinity P255A ligand compared with the me-
dium-affinity P255S ligand. This underscores the particular impor-
tance of the �-CPM-mediated TCR/CD8 cooperation in response
to weak ligands.
The fact that the functional defect of the �-CPM mutation is so
pronounced with low-affinity ligands is surprising, because the
binding of both strong (Ag11.3) and weak (P255A) ligands is sim-
ilarly affected by the absence of the �-CPM (Fig. 3). Previous
studies measuring the kinetics of the Ag11.3, the P255S, and the
P255A binding to the wild-type T1 TCR showed a clear correla-
tion between their off-rates and their functional potencies (42).
Therefore, the high affinity (and slow off-rate) of the Ag11.3 ligand
for the T1 TCR might compensate for the poor TCR/CD8 coop-
eration observed with the �-CPM mutant receptor. In this context,
high-affinity pMHC ligands tend to be more CD8 independent. In
contrast, the reduced TCR/CD8 cooperativity observed with the
�-CPM mutant receptors has a catastrophic effect on weak ligands,
which are more dependent on CD8 assistance to initiate intracel-
lular signaling cascades. These observations are reminiscent of the
phenotype displayed by thymocytes expressing �-CPM mutant
TCRs. These mutant thymocytes cannot undergo positive selection
and are specifically unresponsive to low-affinity ligands (25).
Although the precise mechanism responsible for mediating
TCR/CD8 cooperation is not known, we propose a model in which
the CD8�� molecules are recruited to the TCR complex by the
�-CPM. Support for such a model comes from crystallographic
studies of many murine and human TCR-pMHC complexes, which
show a conserved orientation of the pMHC over the TCR, placing
the MHC coreceptor binding site over the �-chain side of the TCR
(34, 48–53). Furthermore, certain V� domains show a preference
for selection into the CD4 or CD8 subset of mature T cells (54).
This could be explained by a preference of certain V� domains to
physically interact with CD4 or CD8. Such an arrangement would
likely recruit the membrane proximal domain of the coreceptor to the
�-chain constant region, an event that requires an intact �-CPM.
Thymocytes from CD8� knockout mice were specifically
blocked in undergoing positive selection (9, 15, 18, 55), which
emphasizes the critical role played by the coreceptor in responding
to weak ligands. While studies by Bosselut et al. (21) have clearly
shown that the extracellular, TM, and cytoplasmic domains of
CD8� contribute to its ability to support positive selection, little is
known about the structural elements of the TCR, which mediate
the engagement between the receptor and the coreceptor. The stud-
ies presented in this work suggest that the �-CPM is an important
structural element mediating TCR/CD8 cooperation.
Whether the association of the CD8 coreceptor to the TCR is
mediated by a direct interaction of CD8 with the �-CPM has not
yet been ruled out. Because proper association of CD3� to the
TCR� chain also requires the �-CPM (24, 25), CD3� may asso-
ciate with the coreceptor as well. Consistent with this idea is the
observation that thymocytes from CD3�-deficient mice cannot un-
dergo positive selection (27, 28).
These studies provide evidence that the �-CPM plays an important
role in mediating TCR/CD8 cooperativity. Although not considered in
these studies, a similar role might be played by the �-CPM in case of
cooperation with the CD4 coreceptor, because the �-CPM mutation
blocks the positive selection of a class II MHC-restricted TCR as well
(24). The precise mechanism by which the cooperation between the
TCR and its coreceptor allows a “reading” of ligand affinity and to
what extent this controls the decisions taken during positive and neg-
ative selection require additional work.
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3.2.5 Summary of the Published Results 
Three major findings were described in this paper. First, the bimolecular TCR-pMHC bind-
ing was not altered by replacement of the α-CPM. Second, replacement of the α-CPM led to 
reduced CD8 cooperativity in TCR/CD8-pMHC binding. Third, the decreased CD8 cooperativ-
ity observed with α-CPM mutant TCRs was similar for the strong I-Ag11.3-Kd and the weak 
I-P255A-Kd monomers. On the other hand, the functional deficiencies observed with α-CPM 
mutant TCRs were much more pronounced with weak ligands than with strong ligands. 
Therefore the functional defects observed in the Il-2 assays performed with hybridomas 
expressing α-CPM mutant T1-TCRs could not be completely explained by a simple decrease 
in the binding of weak ligands. Due to limitations in the production of radioactively labeled 
ligands, the maximal ligand concentration used was 5x10-10 M. As described for the T1 mice, 
these concentrations were far too low for TCR saturation and hence determinations of the 
dissociation constants (KDs) could not be achieved. Moreover, despite the similarities in the 
functional defects observed with the hybridomas expressing α-CPM mutant T1-TCRs and 
previously published observations of transgenic mice expressing α-CPM mutant TCRs, it 
could not be predicted to what degree the observations made on hybridomas reflected the 
features of developing thymoyctes. To circumvent these limitations, transgenic mice were 
produced which expressed the three different T1-TCR variants.
3.2.6  WT, α-CPM Mutant or TM control T1-TCR Transgenic Mice
Transgenic mice expressing the three different T1-TCRs were produced as described 
above (see Results 3.1.1). Figure 3.18A shows the flow-cytometric analysis of the thymo-
cytes from wildtype, α-CPM mutant and transmembrane (TM) control T1; Rag-/- mice. As 
previously described for transgenic mice expressing α-CPM mutant TCRs with various speci-
ficities (Backstrom et al., 1998; Werlen et al., 2000) only very few SP thymocytes were 
observed in α-CPM mutant T1; Rag-/- mice. On the other hand, TM control mice did not show 
any reduction in their number of SP thymocytes compared to wildtype mice, attesting that 
the lack of SP thymocytes observed in α-CPM mutant mice was due to the absence of the 
α-CPM rather than the replacement of the transmembrane and cytosolic portions of the 
TCRα/β constant regions. Moreover the number of lymph node T cells (6x106 ± 3x106) was 
similar for wildtype and TM control mice, while very few peripheral T cells were detected 
in the α-CPM mutant mice (data not shown). TCR and CD8α/β expression levels on DP thy-
mocytes were similar in all three mouse lines studied as shown in Figure 3.18B. In the case 
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of the wildtype and the TM  control T1; Rag-/- mice, where SP thymocytes and lymph node 
T cells could be analyzed, no significant differences in the TCR nor the CD8α/β expression 
levels were observed.
Figure 3.18: Flow cytometric analysis of thymocytes and lymph node cells from mice expressing either 
wildtype, α-CPM mutant or TM control T1-TCR. Thymocytes and lymph node cells from 6 to 8 weak old 
Balb/c;Rag-/- mice, which were either transgenic for the wildtype, the α-CPM mutant or the TM control T1-
TCR were isolated and stained with fluorescence labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-CD8β(53-5.8), 
α-TCRβ(H57-597). (A) CD4 and CD8α cell surface expression measured on thymocytes of mice expressing the 
T1 variants. Numbers in the upper left corner of each panel indicate total cell number of thymocytes per 
animal (SED indicated; n=3). Thymocytes were electronically gated and the percentages of double negative 
(DN), single positive (SP) and double positive (DP) determined. (B) Mean fluorescence intensities of TCRβ 
and CD8β were determined on DPs, SPs and lymph node T cells (LN) from each strain. MFI of TCR levels on 
DP thymocytes from wildtype T1 mice was determined for TCRintermediate cells (upper left panel indicated by 
bracket). 
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3.2.7 Reduced Responsiveness of α-CPM Mutant Thymocytes 
To analyze the functional differences between wildtype, α-CPM mutant and TM control 
thymocytes, CD69 upregulation assays were performed. As described in Section 3.1.3  these 
experiments were evaluated by plotting the percentage of cells undergoing CD69 upregula-
tion as a function of peptide concentration. In the case of the DP thymocytes derived from 
wildtype mice, only 80% of all cells expressed T1-TCRs on the cell surface and therefore the 
maximal percentage of DP cells undergoing peptide specific CD69 upregulation was 80% in 
the case of the wildtype mice, while it was 100% in the case of the α-CPM mutant or the 
TM control mice. Figure 3.19 shows the dose response curves representing the cell surface 
expression of CD69 observed on thymocytes of the three different mouse lines tested. The 
responses to the 4L, 4P, 4A, 4S and 4N peptides characterized in Results 3.1.2 were ana-
lyzed. As indicated in Panels I, III, IV and V, very similar dose dependent CD69 upregulation 
was observed on DP thymocytes of wildtype and TM control mice. In contrast, the DP thy-
mocytes of α-CPM mutant mice (Panel II) appeared to be dramatically less responsive to the 
weak 4A, 4S and 4N ligands, while the strong 4P and 4L ligands gave comparable levels of 
CD69 upregulation as observed for wildtype and TM control DP thymocytes. Indeed for the 
4S and the 4N ligands, only a fraction of the α-CPM mutant thymocytes upregulated CD69, 
even at high peptide doses. Therefore the dose response curves of these peptides appeared 
to plateau at much lower percentages of CD69+ cells (~40%) than in the case of the strong 4L 
and 4P peptides (100%). Therefore DP thymocytes of α-CPM mutant T1; Rag-/- mice showed 
defective CD69 upregulation compared to wildtype and TM mutant mice which was most 
prominent with weak ligands. This observation made with the α-CPM mutant T1; Rg-/- mice 
was in accordance with previous studies which similarly reported a specific defect in the re-
sponse to weak ligands when cells expressing an α-CPM mutant TCR were analyzed (Werlen 
et al. 2000; Naeher et al., 2002). In contrast, the percentage of DP thymocytes upregulating 
CD69 was very similar for wildtype and TM control mice in response to all peptides tested.
In the case of the wildtype and TM control mice CD69 upregulation was also studied on 
SP thymocytes. Very similar dose response curves were observed for the 4L, 4P, 4A and 
4S peptides underlining functional similarity of the wildtype and the TM control receptors. 
However, when the percentage of SP thymocytes upregulating CD69 in response to the 4N 
peptide was analyzed a slightly reduced maximum in the percentage of responding cells 
was observed in TM control mice (70%) compared to wildtype mice (90%). Panels VI, VII 
and VIII illustrate the results obtained from CD69 upregulation assays in the presence of 
the α-H-2Kd(α3) mAb SF1-1.1. This antibody blocks the CD8 binding site on H-2Kd molecules 
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and hence allows one to study the impact of the CD8-pMHC interaction on the functional 
responses. Blocking the binding site for CD8 on the pMHC molecules of the APCs led to 
distinct results concerning the CD69 upregulation in response to weak or strong peptides. 
The responses to weak peptides (blue curves) were much more affected by the presence 
of the blocking antibody than responses to strong peptides (red curves). Considering the 
wildtype and TM control DP thymocytes, the responses to the weak ligands (4A, 4S and 
4N) were dramatically inhibited by blocking CD8. On the other hand, the responses to the 
strong ligands, 4L and 4P were only modestly reduced by this blocking mAb. This pattern 
was even more pronounced with DP thymocytes expressing the α-CPM mutant receptor. 
The response to strong ligands was modestly inhibited, while the response to weak ligands 
was eliminated (Panel VII). It is interesting that the peptide responses of wildtype and 
TM control thymocytes in the presence of the CD8 blocking mAb were very similar to the 
peptide responses of α-CPM mutant thymocytes in the absence of this mAb (Panels VI and 
VIII compared to Panel II in Fig. 3.19). This implied that α-CPM mutant thymocytes might 
suffer from a disturbed TCR-CD8 cooperativity in ligand binding. To compare these differ-
ences in a more quantitative way, the EC50 values representing the sensitivity of cells for a 
given ligand were determined. Table VI summarizes the EC50 values determined for the five 
different peptides tested on thymocytes of wildtype, α-CPM mutant and TM control mice. 
The EC50 values represent the peptide concentrations at which 50% of the responding cells 
upregulated CD69. In those cases where the maximal percentage of cells responding was 
reduced the EC50 value potentially overestimated the sensitivity of the cells; these values 
are therefore marked with an asterisk. As described above (see Results 3.1.4 and Table II), 
the EC50 values were higher for SP thymocytes than for DP thymocytes reflecting the sensi-
tivity drop generally observed between these two stages of thymocyte development. This 
sensitivity drop was more pronounced with weak 4S and 4N peptides and correlated with 
the CD8 dependence of the thymocyte sensitivity for the various peptides, as shown by the 
increased EC50 values determined in the presence of the SF1-1.1 antibody. Importantly, the 
EC50 values observed on DP and SP thymocytes of TM control mice were equivalent to those 
determined on wildtype DP and SP thymocytes. In contrast, the sensitivities of α-CPM DP 
thymocytes were lower for all peptides tested compared to wildtype and TM control mice 
and the biggest differences were observed for the intermediate (4A) and the weak (4S and 
4N) peptides tested. 
Table VII shows a direct comparison of EC50 values obtained from TM control and α-CPM 
mutant thymocytes. While the EC50 values of the α-CPM mutant DP thymocytes were 8-fold 
higher for the 4L peptide and 17-fold higher for the 4P peptide compared to wildtype or 
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TM control thymocytes, the EC50 values of the α-CPM mutant thymocytes for the 4A pep-
tide were more than 17000-fold higher compared to wildtype and TM control thymocytes. 
For the even weaker 4S and 4N peptides this differences in sensitivity could not accurately 
be quantified due to the fact that only very few thymocytes from α-CPM mutant mice up-
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Figure 3.19: Peptide dose dependent CD69 upregulation on thymocytes from wildtype, α-CPM mutant or 
TM control T1 thymocytes. Thymocytes from wildtype, α-CPM mutant or TM control mice were stimulated 
for 18 hrs. with various doses of 4L(■), 4P(●), 4A(▼), 4S(▲) or 4N(◆) peptides presented on T2-Kd cells in 
the presence or absence of α-H-2Kd(SF1-1.1) (20µg/ml) and subsequently stained with fluorescence labeled 
α-CD4(RM4-5), α-CD8α(53-6.7), α-CD69(H1.2F3) mAbs. Percentage of DP and SP thymocytes of the three 
mouse strains were analyzed. (A) Percentages of DP thymocytes and SP thymocytes expressing surface CD69, 
in the absence of α-H-2Kd(α3)(SF1-1.1) mAb. (B) Percentages of DP thymocytes and SP thymocytes expressing 
surface CD69, stimulated in the presence of α-H-2Kd(α3)(SF1-1.1) mAb. A representative experiment from 
a total of at least two independent experiments is shown. 
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regulated CD69 at all and therefore the EC50 values for these peptides were substantially 
overestimating the responsiveness of the cells. The developmental consequences of these 
differences were tested using FTOCs. 
Table VI: EC50 values [M] determined for wildtype, α-CPM mutant or TM control T1 thymocytes.
Strain:
Cell type; mAb 4L 4P 4A 4S 4N
DP
SP
1.2 x10-12
1.0 x10-12
3.1 x10-12
4.3 x10-12
5.2 x10-11
1.3 x10-10
3.3 x10-10
1.8 x10-8*
1.1 x10-9
3.6 x10-8*
Peptides
DP + SF1-1.1 mAb 3.0 x10-11 1.8 x10-11 2.8 x10-8* 1.7 x10-8* 5.4 x10-7*
A. Wildtype
DP
SP
9.0 x10-12
not done
7.4 x10-11
not done
>9.0 x10-7
not done
5.0 x10-7*
not done
2.3 x10-7*
not done
DP + SF1-1.1 mAb 4.3 x10-11 4.4 x10-10 >1.0 x10-4* >1.0 x10-4* >1.0 x10-4*
B. α-CPM mutant
DP
SP
1.2 x10-12
1.0 x10-12
4.3 x10-12
2.1 x10-12
5.2 x10-11
1.3 x10-10
3.3 x10-10
1.8 x10-8
1.1 x10-9
3.6 x10-8*
DP + SF1-1.1 mAb 3.0 x10-11 1.8 x10-11 2.8 x10-8* 1.7 x10-8* >5.0 x10-7
C. TM control
Mean values of at least two experiments are shown. (*) less than 50% of all cells responded.
Table VII: α-CPM mediated differences in EC50 values [M] of DP T1 thymocytes.
Strain;
Cell type 4L 4P 4A 4S 4N
TM control; DP
α-CPM mutant; DP
∆EC50 ( α-CPM)
1.2 x10-12
9.0 x10-12
4.3 x10-12
7.4 x10-11
5.2 x10-11
8.9 x10-7
3.3 x10-10
5.0 x10-7*
1.1 x10-9
2.3 x10-7*
8 x 17 x >17000 x >>1400 x >200 x
Mean values of at least two experiments are shown. (*) less than 50% of all cells responded
Peptides
+-
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3.2.8 Wildtype, α-CPM Mutant and TM Control T1; Rag-/-; β2m-/- Mice
The three different T1; Rag-/- mouse lines were backcrossed onto β2m deficient B10D2; 
Rag-/-; β2m-/- mice. As previously described, absence of the β2m protein abolished the class 
I MHC expression in these mice and led to an arrest of thymocyte development at the DP 
stage (prior to positive and negative selection). Figure 3.20 shows the CD4, CD8 and TCR 
expression profiles of thymocytes from wildtype, α-CPM mutant and TM control T1; Rag-/-; 
β2m-/- mice measured by flow-cytometry. The dot plots show that a majority of thymocytes 
were DP due to the developmental block resulting from the lack of MHC class I expression. 
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Figure 3.20: Flow cytometric analysis of thymocytes from B10.D2; Rag-/-; β2m-/- mice expressing either 
wildtype, α-CPM mutant or TM control T1-TCR. Thymocytes and lymph node cells from 6 to 8 week old 
B10.D2; Rag-/- ; β2m-/- mice which were either transgenic for the wildtype, the α-CPM mutant or the TM 
control T1 TCR were isolated and stained with fluorescence labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-
CD8β(53-5.8), α-TCR(H57-597) mAbs. (A) CD4 and CD8α cell surface expression measured on thymocytes 
of the mice expressing the T1 variants. Numbers in the upper left corner of each panel indicate total cell 
number of thymocytes per animal (SED indicated; n=3). The percentages of double negative (DN), single 
positive (SP) and double positive (DP) thymocytes were determined. (B) Expression levels of TCRβ and 
CD8β on DP thymocytes. MFI of TCR levels on DP thymocytes from wildtype T1-TCR; Rag-/-; β2m-/- mice was 
determined for TCRintermediate cells (left panel, bracket). 
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The number of SP thymocytes in wildtype and TM control mice was dramatically reduced 
due to the absence of positive selection in these β2m-/- mice (Fig. 3.20A). Interestingly, 
thymocytes of TM control T1; Rag-/-; β2m-/- mice had increased levels of DN cells compared 
to wildtype and α-CPM mutant mice. Dependent on the age of the mice, the percentage 
of DN cells varied considerably, being higher in young mice (2-5 week old) and decreasing 
with time. In 6 weak old TM control T1; Rag-/-; β2m-/- mice ~20% of all thymocytes were DN 
(Figure 3.20A, right panel).
The T1-TCR expression levels (Fig. 3.20B) were similar to the TCR expression levels ob-
served with T1; Rag-/- mice (Fig. 3.18B). Similar to T1;Rag-/- mice, not all DP thymocytes from 
wildtype T1; Rag-/-; β2m-/- mice expressed the TCR. Nevertheless ~60% of all T1; Rag-/-; β2m-
/- DP thymocytes expressed the T1-TCR at levels comparable to the α-CPM mutant and the 
TM control mice (Fig. 3.20B). CD8α and CD8β levels were comparable on all DP thymocytes 
of the three T1; Rag-/-; β2m-/- mouse lines. To study the thymic selection properties of the 
three different T1-TCR mouse lines wildtype, α-CPM mutant and TM control T1; Rag-/-; β2m-
/- mice were used to perform FTOCs. 
3.2.9 Positive Selection Defect in α−CPM Mutant Mice   
Fetal thymic organ cultures (FTOCs) were used to study the role of the α-CPM motif as 
well as the α/β transmembrane (TM) and cytosolic regions. As described in Section 3.1.13 
and shown in Figure 3.21, culturing of fetal thymi from wildtype T1; Rag-/-; β2m-/- mice in the 
presence of exogenous β2m and peptide led to different levels of CD4 and CD8β downregu-
lation indicative for positive or negative selection of the DP thymocytes. FTOCs from mice 
expressing the wildtype T1 receptor gave different results depending on the peptide used 
in the culture. The strong peptides, 4L and 4P induced negative selection as evidenced by 
the predominance of DN thymocytes and the absence of DP and SP thymocytes in FTOCs 
(Figure 3.21A). The weak peptides, 4S and 4N induced positive selection given the presence 
of many CD8α/β SP thymocytes and relatively few DN thymocytes. The 4A peptide gives a 
mixed picture of positive and negative selection.  FTOCs incubated with this peptide gener-
ated some CD8α/β SP thymocytes but many DN thymocytes as well. For this reason, 4A was 
considered a transitional selector (see Results 3.1.14). The results for the TM control FTOCs 
are similar (Figure 3.21C) indicating that the substitution of TM and cytoplasmic domains 
does not change the relationship of pMHC affinity and the outcome of thymic selection. 
FTOCs from thymi expressing the α-CPM mutant T1 TCR provided interesting results (Fig-
ure 3.21B). The 4P and 4L peptides induced negative selection, similar to wildtype and TM 
control FTOCs. The weak ligands, 4S and 4N failed to induce positive selection, which was 
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expected from an α-CPM mutant receptor. Interestingly, the 4A peptide induced positive 
selection in α-CPM FTOCs indicating that positive selection can be achieved through an α-
CPM mutant receptor, but that a higher affinity ligand is required. 
3.2.10 Binding of Strong Ligands to Wildtype and Chimeric T1-TCRs
To directly compare TCR/CD8-pMHC interactions on DP thymocytes of wildtype, α-CPM 
mutant or TM control T1; Rg-/-; b2m-/- mice two step TCR labeling assays (see Section 3.1.7) 
were performed at 0°C, 24°C and 37°C. The studies included the 4L-Kd, 4P-Kd, 4A-Kd, 4S-
Kd and 4N-Kd pMHC monomers which allowed CD8 binding to the α3 domain of the Kd 
molecules. In addition the 4P-Kd
∆223/227 pMHC monomers were used for which the charge 
mutations at position 223 and 227 led to abrogated CD8-Kd binding. Figures 3.22 and 3.23 
show the two step labeling experiments for each pMHC ligand performed on thymocytes of 
either wildtype, αCPM mutant or TM control mice. As the TCR ligand binding interactions 
were shown to be substantially temperature dependent (see Figure 3.9), the ligand binding 
assays were performed at 0°C, 24°C and 37°C. In the case of the 4P peptide, the experi-
Figure 3.21: α-CPM mutant thymocytes are defective in undergoing positive selection. FTOC were 
performed with fetal thymi derived from wildtype (A), α-CPM mutant (B) or TM control (C) T1-TCR; Rag-/-
;β2m-/- mice. The percentage of cells in each quadrant are indicated. The 4L (not done for TM control mice) 
and 4P peptides induced negative selection indicated by the downregulation of CD4 and CD8β (red arrows) 
after 7 days of FTOC. Positive selection monitored by CD4 downregulation (blue arrow) was observed with 
wildtype and TM control thymocytes in response to 4A, 4S and 4N, while it was only observed with the 
‘borderline’ 4A peptide when thymocytes from α-CPM mutant mice were tested. α-CPM mutant thymocytes 
were not positively selected when the 4S and the 4N peptides were used. 
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ments were also performed with the 4P-Kd
∆223/227 pMHC monomers which are defective in 
CD8 binding. This mutant ligand allowed the study of the bimolecular TCR-pMHC interac-
tion in the absence of coreceptor binding. Figure 3.22 summarizes the results obtained 
from titration studies including pMHC monomers loaded with the strong, negative selecting 
4P and 4L peptides. For all temperatures tested the 4L-Kd and the 4P-Kd monomers bound 
with slightly lower affinity to α-CPM mutant thymocytes than to wildtype and TM control 
thymocytes. In contrast, no significant differences between wildtype, α-CPM mutant and 
TM control thymocytes were observed when the binding to the 4P-Kd
∆223/227  monomers was 
Figure 3.22: Binding of strong ligands to thymocytes from wild type, α-CPM mutant or TM control 
T1-TCR; Rag-/-; β2m-/- mice. The ratios of free TCRs (1-r) obtained from two step labeling experiments 
performed either on wildtype (■ or ■), α-CPM mutant (▲ or ▲) or TM control mice (◆ or ◆) were overlaid 
to allow direct comparisons of binding differences mediated by the replacement of the α-CPM. Experiments 
representing dose dependent binding of the 4L-Kd, the 4P-Kd or the 4P-Kd∆223/227 primary ligands at 0°C, 
24°C or 37°C are shown in individual panels. A representative experiment from a total of at least two 
independent experiments is shown.
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studied. This implied that the α-CPM mutation per se does not alter binding of the pMHC 
to the TCR. Rather the effect of the α-CPM mutation on ligand binding involves CD8. This 
was in accordance with the observation made on hybridoma cells, where a CD8 mediated 
defect in ligand binding was evident when hybridomas expressing the α-CPM mutant T1-TCR 
were analyzed. The binding defects observed with α-CPM mutant thymocytes were not very 
pronounced at 0°C but clearly increased with rising temperatures. At 37°C binding of the 
4L-Kd and 4P-Kd monomers was clearly reduced on thymocytes expressing α-CPM mutant 
TCRs compared to thymocytes expressing wildtype TCRs. In contrast to the data observed 
on hybridomas, the TM control thymocytes showed also slightly reduced binding to the 4L-Kd 
and the 4P-Kd monomers compared to wildtype thymocytes, especially at 37°C. Therefore 
the binding defect mediated by the replacement of the α-CPM was relatively small. On the 
other hand, the functional defects observed with α-CPM mutant thymocytes for the strong 
4L and 4P peptides were also small (see Fig. 3.19) and negative selection in response to 4L 
and 4P peptides was unaffected as shown by the FTOC experiments (Fig. 3.21). Thus the 
very small functional defects observed in responses of α-CPM mutant thymocytes to strong 
ligands were also reflected in a slightly decreased capacity of the α-CPM mutant TCR to 
bind strong ligands (Fig. 3.22). 
3.2.11 Binding of Weak Ligands to Wildtype and Chimeric T1-TCRs
The binding of the weak 4A-Kd, 4S-Kd and 4N-Kd ligands to TCRs expressed on DP thymo-
cytes was also examined (Fig. 3.23). The data show that at 0°C and 24°C α-CPM mutant 
thymocytes bound weak pMHC ligands almost as well as wildtype and TM control thymo-
cytes. However at 37°C the binding of weak ligands to the α-CPM mutant receptor is notably 
weaker than their binding decrease in the wildtype and the TM control TCRs. This ligand 
binding may partially explain the functional defects in CD69 upregulation and positive se-
lection with α-CPM mutant thymocytes.  
3.2.12 TCR-Ligand Affinity Determinations
Table VIII summarizes the dissociation constants (KD) determined from the two step TCR 
labeling curves shown in Figures 3.22 and 3.23. Values marked with asterisks indicate ex-
trapolated values from curves which did not reach half-maximal TCR saturation even at 
the highest concentrations tested. While the affinities of the 4P-Kd
∆223/227 reflecting 4P-MHC 
monomers which cannot bind to CD8 were very similar for all mouse strains and tempera-
tures tested, pMHC ligands which can interact with CD8 showed very strong temperature 
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dependence. The KD for each ligand is approximately 30- to 50-fold higher at 37°C compared 
to 0°C. The KD values of the α-CPM mutant receptors were 2- to 5-fold higher than the KD 
values for wildtype and TM control receptors. Interestingly, the relative affinity differences 
between α-CPM mutant and wildtype/TM control receptors were similar for both high and 
low affinity ligands. 
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Figure 3.23: Binding of weak ligands to thymocytes from wildtype, α-CPM mutant or TM control T1-TCR; 
Rag-/-; β2m-/- mice. The ratios of free TCRs (1-r) obtained from two step labeling experiments performed either 
on wildtype (■), α-CPM mutant (▲) or TM control mice (◆) were overlaid to allow for direct comparisons 
of ligand binding differences mediated by the replacement of the α-CPM. Experiments representing dose 
dependent binding of the 4A-Kd, the 4S-Kd or the 4A-Kd∆223/227 primary ligands at 0°C, 24°C or 37°C are shown 
in individual panels. A representative experiment from a total of at least two independent experiments is 
shown.
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3.2.13 TCR-Ligand ‘Off-rate’ Determinations
To test whether the α-CPM replacement affected ligand dissociation from TCR, ‘off-rates’ 
were determined and compared. The results of these experiments are shown in Figure 
3.24. At 0°C the ‘off-rates’ were ~2-fold faster for α-CPM mutant thymocytes compared to 
wildtype and TM control thymocytes irrespective of the ligand tested. In the case of the 
4P-Kd monomers, the half-life of the TCR/CD8-pMHC interactions was ~12 minutes for α-CPM 
mutant thymocytes while it was ~20 minutes for the wildtype and the TM thymocytes (see 
Table IX). A similar observation was made for the low affinity 4S-Kd monomers, for which 
the half-lives of the α-CPM mutant thymocytes were faster (~14 sec.) compared to wildtype 
and TM control thymocytes (~21 sec.). Determining the ‘off-rates’ at higher temperatures 
was hampered by the extremely short half-lives of the TCR/CD8-pMHC interactions. How-
ever, ‘off-rate’ of the high affinity 4P-Kd monomers could be assessed at 24°C. Similar to the 
values obtained at 0°C, the half-life of 4P-Kd was 2-fold shorter on α-CPM mutant thymo-
cytes (~10 sec.) than on wildtype or TM control thymocytes (~25 sec.). 
Table VIII: KD values [M] determined for pMHC monomers bound to wildtype, α-CPm mutant or TM control
DP T1 thymocytes and α-CPM mediated affinity differences (∆KD).
Temperature;
Strain 4L-Kd 4P-Kd 4A-Kd 4S-Kd 4N-Kd
Wildtype
α-CPM mutant
6.9 x10-10
1.9 x10-9
1.1 x10-9
4.0 x10-9
1.2 x10-7
4.6 x10-7
1.9 x10-7
7.1 x10-7
7.1 x10-7
2.7 x10-6
Mean values of at least two experiments are shown. (*) half-maximal TCR saturation was not reached.
Ligands
4L-Kd∆223/227
TM control 6.2 x10-10 2.2 x10-9 2.9 x10-7 3.5 x10-7 1.6 x10-6
5.9 x10-7
5.7 x10-7
7.9 x10-7
0oC
∆KD ( α-CPM)+- 3.0 x 1.8 x 1.6 x 2.0 x 1.7 x 0.7 x
Wildtype
α-CPM mutant
9.9 x10-9
3.5 x10-8
3.9 x10-8
8.8 x10-8
1.4 x10-6
3.3 x10-6
2.0 x10-6
4.2 x10-6
9.1 x10-6*
1.9 x10-5*
TM control 1.0 x10-8 5.6 x10-8 1.9 x10-6 1.4 x10-6 1.0 x10-5*
1.0 x10-6
1.2 x10-6
1.1 x10-6
24oC
∆KD ( α-CPM)+- 3.5 x 1.6 x 1.7 x 3.0 x 1.9 x 1.1 x
Wildtype
α-CPM mutant
2.4 x10-8
1.1 x10-7
4.4 x10-8
3.9 x10-7
3.6 x10-6
3.3 x10-5*
6.3 x10-6*
1.7 x10-5*
2.2 x10-5*
1.7 x10-5*
TM control 4.1 x10-8 1.5 x10-7 6.1 x10-6 1.2 x10-5* 4.7 x10-5*
1.9 x10-6
1.9 x10-6
2.1 x10-6
37oC
∆KD ( α-CPM)+- 2.6 x 2.7 x 5.4 x 1.4 x 0.4 x 0.9 x
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3.3.14 CD8 Impact on Ligand Binding 
The relative affinity differences measured between α-CPM mutant and wildtype or TM 
control T1-TCRs were between 2- and 10-fold, depending on the ligand tested and the tem-
perature at which the experiments were performed. These affinity differences were also 
reflected in similar differences in the half-lives of a given TCR/CD8-pMHC interaction. The 
affinity measured with the 4P-Kd
∆223/227 monomers was similar for all T1-TCR variants tested 
(Table VIII); this implied that the bimolecular TCR-pMHC was not altered by the replace-
ment of the α-CPM. To test the impact of CD8 on ligand binding the binding curves obtained 
from 4P-Kd
∆223/227 and 4P-K
d monomers were compared. As shown in Figure 3.25, at 37°C, 
CD8 participation increased the affinity of the wildtype T1-TCR for the 4P-pMHC monomers 
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4P-Kd
Figure 3.24: ‘Off-rates’ determined by two step labeling assays from DP and SP thymocytes from 
wildtype, α-CPM mutant or TM control T1-TCR; Rag-/-; β2m-/- mice. T1 thymocytes were incubated for 90 
min. with either 100nM of 4P-Kd or 1µM of 4A-Kd or 4S-Kd prior to dilution in the presence of 20µg/ml α-H-
2Kd(α1)(20-8-4S) mAb. Aliquots of the diluted cells were incubated for defined intervals and subjected to UV 
crosslinking (~312nm). The ratios of free TCRs were determined by the two step assay. Cells were stained 
with fluorescence labeled α-CD4(RM4-5), α-CD8α(53-6.7), α-TCRβ(H57-597) mAbs. MFIs of Cy5 fluorescence 
signals obtained from DP and SP thymocytes are plotted as a function of time.
12 min. 7 min.
24 min. 8 min.
Table IX: Half-lives (t1/2) of pMHC monomers bound to wildtype, α-CPM mutant or TM control DP
T1 thymocytes at 0oC or 24oC.
Strain 4P-Kd 4S-Kd 4P-Kd
Wildtype
α-CPM mutant
19 min. 4 min. 21 sec. 9 sec.
14 sec. 11 sec.
27 sec. 15 sec.
10 sec. 6 sec.
Mean values of at least two experiments are shown.
TM control 22 sec. 8 sec. 24 sec. 8 sec.
Ligand; 0oC Ligand; 24oC
+−
+−
+−
+−
+−
+−
+−
+−
+−
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by 50-fold. This difference was 25-fold in the case of the TM control TCR indicating that 
the replacement of the TCRα/β transmembrane regions by TCRγ/δ transmembrane regions 
further reduced the CD8 impact in ligand binding by a factor of 2. The impact of CD8 on 
pMHC binding to α-CPM mutant thymocytes was only 10-fold, which represents a 5-fold 
reduction to wildtype and a 2.5-fold reduction compared to TM control thymocytes. These 
data clearly show that the α-CPM mutation has a significant impact on the CD8 contribution 
to ligand binding.
∆ ∆
log[4P-Kd-monomers] or
log[4P-Kd∆223/227-monomers]
log[4P-Kd-monomers] or
log[4P-Kd∆223/227-monomers]
log[4P-Kd-monomers] or
log[4P-Kd∆223/227-monomers]
Wildtype T1
Rg-/-;β2m-/-
α-CPM mutant T1
Rg-/-;β2m-/-
TM control T1
Rg-/-;β2m-/-
∆
∆KD = 50x ∆KD = 10x ∆KD = 25x
1-
r
Figure 3.25: CD8 mediated binding increase on thymocytes of wildtype, α-CPM mutant or TM control 
T1; Rag-/-; β2m-/- mice at 37°C. Results obtained from two step labeling with the 4P-Kd or the 4P-Kd∆223/227 
primary ligands at 37°C were compared for each different mouse strain. Labeling curves with 4P-Kd (■) wt, 
(▲) α-CPM Mutant, (◆) TM control) or with 4P-Kd∆223/227  (■) wt, (▲) α-CPM mutant, (◆) TM control) are 
shown. The CD8 mediated fold differences in the affinities at 37°C are indicated in the lower left of each 
panel. 
In conclusion, these results are consistent with the ligand labeling studies of hybrid-
omas expressing wildtype, TM control or α-CPM mutant receptors. The relatively mild bind-
ing defect observed with α-CPM mutant TCRs due to reduced TCR-CD8 cooperativity was 
paralleled by dramatic functional deficits leading to the abrogation of positive selection. 
Whether the α-CPM phenotype can be completely explained by these differences in ligand 
binding remains an open question.
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4. Discussion
In this thesis, hybridomas and transgenic mice expressing the T1-TCR were used to study 
the role of TCR-ligand affinity in the development of pMHC class I restricted T cells. Photoaf-
finity labeling experiments using soluble, monomeric pMHC complexes were performed on 
thymocytes and lymph node T cells from T1-TCR transgenic mice to study TCR ligand bind-
ing at various developmental stages. TCR affinities were compared to biological responses 
elicited by the various peptide derivatives. These studies revealed a direct correlation be-
tween TCR ligand affinities and the thymic selection properties of the various ligands. The 
role of TCR ligand binding in thymic selection was studied in further detail using a mutant 
form of the T1-TCR, i.e. α-CPM mutant T1-TCR, which was unable to induce positive selec-
tion of thymocytes. The results of these studies are discussed here in the context of previ-
ous studies on TCR ligand binding and thymic selection performed by others. 
4.1 TCR Ligand Binding Measurements: Technical Considerations
TCR ligand binding measurements have been broadly used to study the role of TCR in 
T cell development and activation (Reviewed in Davis et al., 1998; Gascoigne et al., 2001; 
van der Merwe et al., 2003). Despite the development of invaluable techniques to study 
these interactions, it has not yet been possible to perform real-time analysis of TCR ligand 
interactions on live T cells or thymocytes interacting with pMHC expressing APCs. Instead, 
several techniques were developed which allowed to study TCR ligand interactions with 
solubilized forms of at least one of the binding partners. Most of the TCR ligand bind-
ing data available today were obtained from either using the surface-plasmon resonance 
(SPR; BIACore®: reviewed in Rudolph et al., 2002b) or soluble pMHC multimers (Altman et 
al., 1996; Ogg et al., 1998; Daniels et al., 2000). Many TCR-pMHC interactions and several 
CD4-MHC or CD8-MHC interactions have been studied using the SPR technique. These stud-
ies led to the determination of the affinities between specific TCR-pMHC interactions and 
coreceptor-pMHC interactions (Reviewed by van der Merwe et al., 2003). While the SPR 
technique allowed for detailed studies of TCR-ligand binding kinetics including ‘on-rates’, 
‘off-rates’ and steady state binding affinities between bimolecular TCR-pMHC or corecep-
tor-pMHC interactions, it did not allow to study the impact of coreceptors in the trimeric 
TCR/coreceptor-pMHC interactions due to its plate based, cell free configuration. Neither 
was it possible to study developmental differences of these interactions as all the binding 
partners were derived from recombinantly produced molecules in either bacteria or non T 
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cell related fibroblast cell lines. 
The development of fluorscence labeled, soluble pMHC ligands has been very useful 
to study the binding of soluble pMHC complexes to intact T cells and thymocytes. Unfor-
tunately, measurements of pMHC monomers were hampered by the very fast ‘off-rates’ 
generally observed with TCR-pMHC interactions. On the other hand, the usage of pMHC 
multimers allowed binding measurements on live T cells and thymocytes and could be used 
to study both, either cognate TCR-pMHC or non-cognate coreceptor-pMHC interactions. Due 
to the multiple TCR binding sites on pMHC multimers these measurements determined the 
avidities of such interactions, representing a mixture of TCR-ligand affinity and the TCR 
crosslinking efficiency of the multiple pMHCs in a multimer complex. 
Therefore, while the SPR technique allowed bimolecular TCR ligand affinity measure-
ments using cell-free assays, pMHC multimers applied on live cells were used to measure 
ligand avidity. Despite the invaluable measurements performed by these two assays, they 
were unsuitable for TCR-pMHC affinity measurements on live cells. This limitation was over-
come by the development of the photoaffinity labeling technique developed by Immanuel 
Lüscher. Using TCRs specific for photo-reactive, monomeric pMHC ligands, UV-crosslinking 
of TCR bound pMHC molecules led to covalent fixation of the TCR ligand interaction and 
therefore allowed for flow-cytometrical or biochemical analysis of bivalent TCR-pMHC in-
teractions (see Introduction 1.3.3.2). This technique has been intensively used to study the 
role of TCR and CD8 coreceptors in ligand binding and signaling of activated T cells and T 
cell hybridomas (Lüscher et al., 1991; Lüscher et al., 1992; Lüscher et al., 1994; Lüscher et 
al., 1995a; Lüscher et al., 1995b; Anjuere et al., 1997; Kessler et al., 1997a; Kessler et al., 
1997b; Hudrisier et al., 1998; Doucey et al. 2001; Gillaume et al., 2003;).
4.2 Photoaffinity Labeling on T Cells of T1-TCR Transgenic Mice 
To study ligand affinities of TCRs expressed on T cells of different developmental stages 
T1-TCR transgenic mice were produced. Co-expressing transgenic T1-TCRα and TCRβ chains 
in Rag2 deficient mice allowed photoaffinity labeling ligand binding studies and functional 
analysis of DP thymocytes, SP thymocytes and lymph node T cells (Fig. 3.1), which uniquely 
expressed T1-TCRs in the absence of endogenously rearranged TCR molecules.
4.3 TCR-Cognate and Non-Cognate Binding on T1 Thymocytes
The use of Cy5 labeled photo-reactive pMHC monomers and analysis of TCR ligand bind-
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ing by flow-cytometry was considered optimal to study TCR ligand affinities on thymocytes 
and lymph node T cells. By the means of electronic gating, DP and SP thymocytes were 
easily distinguished based on their CD4 and CD8 expression patterns. Titrations of 4P-Kd-
Cy5 monomers (Fig. 3.5A) and photoaffinity labeling led to fluorescence signals which were 
dependent on the concentration of the ligand and the TCR expression levels of the cells 
analyzed (Fig. 3.5B and C). As indicated by the arrow in Figure 3.5C and the black curve 
in Figure 3.6B, using >10-6M 4P-Kd-Cy5 led to fluorescence signals which were unexpect-
edly high, in particular on DP thymocytes. More detailed analysis of this phenomenon (Fig. 
3.6) revealed that CD8 mediated non-cognate binding of the pMHC monomers to these 
cells. Despite the low affinity of CD8 coreceptor for MHC class I molecules (CD8α/β-H-2Kb: 
KD=135µM at 25°C, Leishman et al. 2001) it is likely that the expression of high levels of un-
sialylated CD8 on DP thymocytes (Casabo et al., 1994) enhances non-cognate interactions 
on DP thymocytes and leads to the crosslinking of 4P-Kd-Cy5 to thymocytes. Non-cognate 
binding to CD8 was reported for MHC class I tetramers (Daniels et al., 2001; Moody et al., 
2001). Therefore at concentrations higher than 10-6M the fluorescence signals represented 
a mixture of cognate TCR-pMHC interactions and non-cognate CD8 MHC interactions. It is 
unclear whether the target of this non-cognate binding was CD8 itself or another surface 
protein. However, this non-cognate binding makes it difficult to determine the KD of low af-
finity ligands since high ligand concentrations are required to saturate the TCR.
4.4 Affinity Measurements Using the Two Step Labeling Assay
To avoid non-cognate fluorescence signals, an assay was developed which used 4P-Kd-Cy5 
at concentrations that were too low to be influenced by non-cognate CD8-MHC interactions. 
As described above (see Results 3.1.7) and illustrated in Figure 3.7 a first round of ligand 
titrations and photoaffinity labelings was performed with unlabeled pMHC monomers of 
varying affinity and at different temperatures, followed by washing and a second round 
of incubation performed on ice with a constant concentration (5x10-7M) of the Cy5 labeled 
4P-Kd-Cy5 ligand and subsequent photoaffinity labeling. As a result of this two step label-
ing assay, the fraction of the TCR on a cell, which remained free after the first round of 
photoaffinity labeling was measured. Direct comparison of direct photo-affinity labeling and 
two step labeling performed on DP thymocytes, SP thymocytes and lymph node T cells at 
0°C and 37°C confirmed the accuracy of the KD values determined by the two step labeling 
assay. 
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4.5 Temperature Dependent CD8 Participation in TCR Ligand Binding 
These studies revealed a substantial temperature dependence of the KD values, i.e. affin-
ities (Fig. 3.9 and Table III). TCR ligand affinity dramatically increased at low temperatures 
in that the KD of a ligand for the T1-TCR was 11- to 63-fold higher at 37°C than at 0°C (Fig. 
3.9C). This change in affinity was much less pronounced, when mutant pMHC complexes 
were used that were unable to bind CD8α/β due to charge inversions in the α3 domain 
(D223K and D227K) of H-2Kd. Therefore the increased ligand affinity at low temperatures 
was due to an enhanced CD8 participation at 0°C. These findings are in accordance with a 
previous study, which showed only a small temperature mediated difference in ligand bind-
ing in the absence of CD8 but substantial temperature dependence in ligand binding when 
CD8α/β was present (Lüscher et al., 1995). Therefore it can be speculated that the tem-
perature dependence is due to stability of CD8 recruited to the TCR. The reduced lateral 
mobility of these molecules in the plasma membrane at low temperatures would stabilize 
the trimeric (TCR/CD8-pMHC) complex and decrease the ligand ‘off-rate’ thereby increas-
ing the affinity of the interaction. Reduced lateral mobility due to decreased membrane 
fluidity at low temperature would also lead to slower recruitment of CD8 to the TCR by 
pMHC ligands. Indeed, steady state binding of pMHC ligands was reached after only 90 min-
utes at 0°C while it took only 15 minutes at 24°C and less than 2 minutes at 37°C (data not 
shown). Upon simultaneous binding of TCR and CD8 to pMHC, reduced membrane fluidity 
at low temperatures would lead to slower lateral ‘escape’ of the CD8 coreceptor from the 
TCR-pMHC complex, assuming that the ‘off-rates’ measured for the CD8 MHC interaction 
is much faster than the ‘off-rate’ of most pMHC interactions. This is indeed the case, the 
dissociation kinetic constant koff has been determined for several CD8 MHC interactions and 
was >20 s-1 while the ‘off-rates’ of bivalent cognate TCR-pMHC interaction were much slower 
(0.01-0.2 s-1) (Reviewed in van der Merwe et al., 2003). Such a temperature dependent cor-
relation of the ‘off-rates’ was observed (~20 min. at 0°C, ~30 sec. at 24°C (see Fig. 3.24) and 
< 20 sec. at 37°C (data not shown). Reducing the lateral mobility of TCR and CD8 leading to 
a ‘concentration’ of CD8 around TCR-pMHC complexes would reduce the rate-limiting CD8 
recruitment step and lead to a bigger impact on the stability (e.g. lowering the ‘off-rate’) 
of the TCR-pMHC interaction. Therefore reduced lateral mobility of the molecules on the 
surface of a cell could explain the enhanced increase in TCR/CD8-pMHC binding observed 
for high affinity ligands (63-fold for 4P-Kd between 0°C and 37°C) compared to low affinity 
ligands (11-fold for 4S-Kd between 0°C and 37°C). 
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4.6 TCR-Ligand Affinity Does Not Change During Development
Thymocytes and peripheral T cells elicit very different responses to TCR ligands. While 
strong TCR stimuli lead to activation of T cells in the periphery, the same stimuli lead to 
negative selection and apoptosis in the thymus. Along the same line, weak TCR stimuli lead 
to positive selection and differentiation into the CD4 or the CD8 lineage, but they do not in-
duce any measurable biological response in peripheral T cells (Hogquist et al., 1995; Davey 
et al., 1998; Lucas et al., 1999). It was not clear whether these developmentally regulated 
changes in the responses of T cells were in some measure mediated by changes in the af-
finity of the TCR for its ligands. 
The use of photoaffinity labeling together with the production of T1-TCR transgenic mice 
allowed for the first time to study TCR ligand affinities at various stages of T cell develop-
ment. Using the two step labeling assay, the affinities of the cognate TCR/CD8-pMHC inter-
actions were studied at all three stages of T cell development. Labeling studies involving 
5 different pMHC ligands of distinct affinity revealed no developmentally regulated change 
in TCR affinity (see Fig. 3.10 and 3.11). Similarly, when the dissociation kinetics of trimeric 
TCR/CD8-pMHC complexes were analyzed, equal ‘off-rates’ were measured on DP and SP 
thymocytes (see Fig. 3.12). These results clearly showed, that TCR ligand affinity does not 
change during T cell development. 
This finding is particularly interesting in the light of studies using pMHC multimers, which 
showed differences in the non-cognate CD8-MHC avidity when DP thymocytes were com-
pared to SP thymocytes and peripheral T cells (Daniels et al., 2001; Moody et al., 2001). In 
these studies it was shown that high concentrations of pMHC tetramers (~1x10-7M) lead to 
TCR independent, CD8 mediated binding to DP thymocytes, while this type of binding was 
much weaker on SP thymocytes. These differences were explained by developmentally con-
trolled addition of sialic acid residues to O-linked glycans on CD8β which occurs during the 
transition from DP to SP thymocytes (Casabo et al., 1994). It was proposed that addition of 
sialic acid causes conformational changes in the structure of the CD8α/β heterodimer re-
ducing its ability to bind class I MHC. Whether this leads to changes in the CD8 dependent, 
TCR mediated cognate binding of pMHC ligands was not resolved. 
The affinity measurements using pMHC monomers presented in this thesis argue against 
an influence of altered CD8 glycosylation on cognate TCR ligand binding. Nevertheless, as 
shown by direct photoaffinity labeling with monomeric 4P-Kd-Cy5 pMHCs (see Figure 3.6), 
TCR independent, CD8 mediated non-cognate binding was also observed with monomeric 
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pMHC ligands, when applied at very high concentrations (>10-6M). Although it was shown, 
that DP thymocytes of T1 mice had less sialic acid present on their surface compared to 
SP thymocytes (Figure 3.13A) the affinities of the cognate TCR mediated binding of 4P-Kd 
monomers measured on these two cell populations were not significantly different (Fig. 
3.13, Panels I and IV). Furthermore, using tetramers of 4P-Kd it was shown that the same 
was true for multimers of high affinity ligands (Fig. 3.13, Panels II and V). Binding data ob-
tained using tetramers of the low affinity ligand 4A-Kd were hard to interpret because even 
at 10-7M, TCR saturation was not observed (Fig. 3.13, Panels III and VI, black curves). The 
increase in binding between DP (Panel III) and SP (Panel VI) thymocytes was most likely 
due to increased TCR expression rather than a change in the sialic acid status between DP 
and SP thymocytes. However neuraminidase treatment led to a marked increase in 4A-Kd 
tetramer binding (Fig. 3.13, Panels III and VI, green curves). Thus, it is unclear whether dif-
ferences in the sialylation status between these developmental stages could influence the 
avidity of low affinity ligands.
In conclusion, the data presented in this thesis (see Results 3.1.11 and 3.1.12) argue 
clearly against a developmentally controlled change in TCR affinity despite the changes 
observed for non-cognate CD8-MHC interactions. Furthermore the decrease in sensitiv-
ity of SP thymocytes to weak (4S and 4N) ligands can not be explained by changes in the 
TCR-ligand affinity. The changes in sialylation that occur with thymocyte maturation may 
decrease responsivness to low affinity ligands without affecting ligand binding per se. The 
fact that sialylation of thymocytes in the transition from DPs to SPs does not change the 
cognate TCR ligand affinity does not exclude an important role of glycosylation changes in 
T cell development. Studies using mice deficient in the sialyltransferase ST3Gal-I showed 
relatively normal thymic development but a 90% reduction of the peripheral CD8 T cell 
pool; CD4 T cell numbers were only slightly affected (Priatel et al., 2000). This emphasizes 
the importance of proper sialylation for thymic emigration and peripheral survival. In terms 
of thymocyte and T cell trafficking, reduction of the CD8 avidity on SP thymocytes could 
indeed be very important, as it was shown, that DP thymocytes could be strongly adsorbed 
to surface bound MHC class I, while SP thymocytes and mature T cells were not (Daniels et 
al., 2001). Interestingly, studies using pMHC dimers showed altered cognate TCR-pMHC bind-
ing upon activation of peripheral CD8 T cells (Fahmy et al., 2001). Unfortunately differential 
glycosylation was not studied in this work, but interestingly, desialylation of CD8β was de-
scribed to happen upon activation of peripheral CD8 T cells (Casabo et al., 1994). Therefore 
it is possible that the activation of mature T cells by multimeric pMHC ligands is influenced 
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by these changes in the glycosylation status of CD8. On the other hand, disruption of CD8β 
sialylation did not significantly change the numbers of positively selected thymocytes, argu-
ing against a pivotal role in the thymocyte selection per se (Priatel et al., 2000).  
4.7 Evidence for an Affinity Threshold in Thymic Selection
The fact that T1-TCR ligand affinities did not change during T cell development has im-
portant consequences for the interpretation of how thymocytes and T cells recognize their 
ligands. For DP thymocytes undergoing positive or negative selection it was proposed that 
strong antigenic signals lead to negative selection, while weak antigenic signals lead to posi-
tive selection. Despite the broad acceptance of such a model of T cell selection, there is an 
intensive debate regarding the mechanisms leading to ‘weak’ or ‘strong’ antigenic signals.
Two different models were proposed of how TCR-ligand interaction intensities are inter-
preted by thymocytes undergoing thymic selection processes. In the avidity model, high 
numbers of ligand engaged TCRs (‘strong signal’) lead to negative selection, while low num-
bers of engaged TCRs (‘weak signal’) lead to positive selection. In this model the affinity of 
a given TCR-ligand interaction is not a direct measure of the selection outcome, because 
high affinity ligands applied at low concentrations would only occupy low numbers of TCRs 
and therefore lead to positive selection, while low affinity ligands applied at high concen-
trations would occupy many TCRs and thus lead to negative selection. Therefore in the 
avidity model, the affinity of a given pMHC complex in conjunction with its concentration 
is critical for the selection outcome. Some studies propose that the dose of pMHC ligand is 
critical for the thymic selection outcome (Sebzda et al., 1994; Ashton-Rickard et al., 1994; 
Liu et al., 1998; Smith et al., 1998). In contrast, the affinity model of thymic selection pro-
poses that the affinity of the TCR-ligand interaction per se decides whether thymocytes 
get positively or negatively selected. In this model, the decision whether a thymocyte 
gets positively or negatively selected is ligand concentration independent. In the affinity 
model, it is predicted that high affinity pMHC ligands induce negative selection, even at low 
concentrations, while low affinity ligands lead to positive selection, even when presented 
at high ligand concentrations. Several previous reports were favoring the affinity model of 
thymic selection (Hogquist et al., 1994; Hogquist et al., 1995; McKeithan et al. 1995., Alam 
et al., 1996).
To study the thymic selection properties of the variant ligands tested in this thesis, FTOC 
assays were performed with fetal thymi from T1-TCR; Rag-/-; β2m-/- mice. Fig. 3.14 shows 
that the high affinity 4L and 4P ligands induced negative selection, while the low affinity 
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ligands 4A, 4S and 4N induced positive selection. Importantly, positive and negative selec-
tion were relatively concentration independent (see Fig. 3.15A) which support the affinity 
model of thymic selection. Nevertheless, the 4A peptide is an interesting exception. Unlike 
the other peptides high doses of 4A led to negative selection, while low peptide doses led 
to positive selection (see Fig. 3.15B). These results are consistant with the affinity model of 
thymic selection, assuming that the 4A ligand has an affinity for the T1-TCR which defines 
the border between positive and negative selection.
Analysis of the CD69 data and the TCR ligand affinity data supported this assumption. As 
illustrated in Figure 3.3A, the 4L peptide showed the strongest potency to upregulate CD69 
in DP thymocytes, followed by the 4P, the 4A, the 4S and the 4N peptides. This hierarchy 
in ligand potencies was preserved on SP thymocytes and lymph node T cells. The peptides 
could be grouped into two distinct classes based on their ability to stimulate DP and SP 
thymocytes. In the first group consisting of the strong peptides 4L and 4P, both DP and SP 
thymocytes were similarly sensitive to these ligands. Furthermore DP and SP thymocytes 
were able to upregulate CD69 even in the presence of a mAb which blocked CD8 binding to 
Kd (see Fig. 3.3B). The second group of ligands consisted of the 4S and 4N peptides. Com-
pared to DP cells SP thymocytes were substantially less sensitive to these positive selecting 
ligands (see Fig. 3.3A) and CD69 upregulation was severely reduced in the absence of CD8 
participation in this group (see Fig. 3.3B). The 4A peptide seemed to share properties with 
the strong and weak potency groups. SP thymocytes were only slightly less sensitive to 4A 
compared to DP cells, which is a characteristic of strong ligands. On the other hand, the 
response to 4A was significantly CD8 dependent (see Fig. 3.3B), which is a characteristic of 
low potency ligands. Based on these criteria, the 4A peptide was considered a moderate 
potency ligand. Therefore, it may not be surprising that the 4A peptide can mediate posi-
tive and negative selection depending on the dose. The hierarchy of these peptides in func-
tional assays is reflected in their affinity hierarchy (4L ~ 4P >> 4A > 4S > 4N). Therefore, as 
in the case of the CD69 assay and the FTOC assay, the 4A ligand affinity was lower than the 
affinity of strong, negative selecting ligands (4L-Kd and 4P-Kd) and slightly higher than weak, 
positive selecting ligands (4S-Kd and 4N-Kd). Based on these correlations of ligand potency, 
affinity and selection property, it can be reasoned that the outcome of thymic selection is 
determined by pMHC affinity for the TCR, with the 4A-Kd ligand (KD = 4μM at 37°C) defining 
the affinity threshold between positive and negative selection for the T1 thymocytes.
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4.8 A Role for the α-CPM in Mediating TCR-CD8 Cooperativity
Development of a general hypothesis describing the mechanism of TCR function in T cell 
activation and thymocyte selection has proven to be very difficult, given the enormous 
numbers of clonotypically different TCR molecules in each individual. The classical ap-
proaches used to unravel the mechanisms of TCR binding and function employed the study 
of many different TCRs of various specificities (Reviewed by Davis et al., 1998; Gascoigne 
et al., 2001; van der Merwe et al., 2003). 
Another approach was taken by analysis of the TCR constant regions which are uniform 
in all individuals of a given species. Comparison of TCR constant regions from various spe-
cies led to the identification of the α-CPM, an eight amino acid residue (FETDxNLN) motif, 
which has been evolutionarily conserved for the last 500 million years (Backstrom et al., 
1996). Its biological importance has been shown by the finding that replacement of the α-
CPM with non-homologous residues from the TCRδ connecting peptide, led to a complete 
block of thymocyte development in mice expressing such α-CPM mutant TCRs (Backstrom et 
al., 1998; Werlen et al., 2000). Analysis of the defects observed with α-CPM mutant mice, 
revealed specific defects in the signaling cascades involved in positive selection of thymo-
cytes (Werlen et al., 2000). To investigate the role of the α-CPM in TCR ligand binding, stud-
ies on α-CPM mutant T1-TCR expressed in hybridomas and transgenic mice were performed 
using the photoaffinity labeling system. Using radioactively labeled, monomeric pMHCs (see 
Fig. 3.17A), ligand binding was compared between wildtype, α-CPM mutant or TM control 
T1-TCRs (Fig. 3.16A). To test the role of CD8 co-engagement in TCR ligand binding, these 
TCRs were either expressed in CD8 deficient ‘58’ hybridomas or in 58CD8α/β hybridomas, 
which co-expressed CD8α/β (see Fig. 3.16B). TCR and TCR/CD8 mediated binding between 
the three different T1-TCRs variants were compared. Three observations were made con-
cerning the effect of the replacement of the α-CPM in TCR ligand binding (Naeher et al., 
2002; herein Results 3.2.4). 
First, bimolecular TCR-pMHC binding in the absence of CD8 was similar for all three 
T1-TCR variants tested. This demonstrated that the α-CPM mutation per se does not de-
crease TCR affinity. Second, the α-CPM mutant TCRs were defective in mediating TCR-CD8 
cooperativity in ligand binding. CD8 increased ligand binding 6.7-fold in the case of the 
wildtype and the TM control TCRs but only 2.4-fold in the case of the α-CPM mutant TCR. 
At 37°C, the CD8 mediated increase in ligand binding was 2-fold in the case of wildtype 
and TM control TCRs while no increase at all was observed for the α-CPM mutant TCR. It is 
important to note, that the TCR binding studies performed on hybridomas were using very 
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low concentrations (~5x10-10M) of the radioactive ligands and therefore it was not possible 
to test, whether this absence of CD8 help in binding was due to a complete defect in TCR-
CD8 cooperation at physiological temperatures or if it was due to a reduction in the TCR/
CD8-pMHC affinity. To further investigate the role of the α-CPM in TCR ligand binding and 
function different transgenic mice were produced which expressed the T1-TCR variants. As 
illustrated in Figure 3.18 the replacement of the α-CPM led to a severe block of thymocyte 
development indicated by the absence of SP thymocytes in these mice. The fact that the 
percentage and numbers of SP thymocytes in TM control T1 mice was comparable to wild-
type T1 mice, formally proved that the developmental block observed with α-CPM mutant 
mice was due to the replacement of the α-CPM rather than due to the replacement of the 
transmembrane and cytosolic regions of TCRα/β (by TCRγ/δ derived sequences). This was 
also obvious when the CD69 responses of thymocytes in response to various ligands were 
tested (see Fig. 3.19). While the peptide dose curves between wildtype and the TM control 
T1 thymocytes were very similar, thymoctes from α-CPM mutant mice showed severely re-
duced responses to weak ligands (see Fig. 3.19, panel II). Replacement of the α-CPM led to 
an 8- (4P) to 17-fold (4L) increase in the EC50 values for strong ligands, while the EC50 values 
of 4A were 17’000-fold increased (Table VII). For the weak 4S and 4N peptides the EC50 val-
ues for the α-CPM mutant thymocytes increased >>1400 fold and >>200 fold respectively. 
Interestingly, the responses of wildtype and TM control thymocytes were similarly re-
duced when the binding of CD8 to H-2Kd was blocked with the SF1-1.1 mAb (see Fig. 3.19, 
panels VI and VIII). Therefore, abolished CD8 participation in ligand binding of the wildtype 
and TM control TCRs led to similar CD69 upregulation profiles as observed with α-CPM mu-
tant thymocytes (see Fig. 3.19 panels II, VI and VIII). This functional defect involving im-
paired CD8 participation was reminiscent of the ligand binding defect observed on hybrid-
omas expressing α-CPM mutant TCRs. To measure TCR ligand affinities and thymic selection 
capacities of wildtype, α-CPM mutant and TM control thymocytes, the different T1-TCR 
transgenes were bred to Rag2 and β2m double deficient mice. As expected, given the ab-
sence of class I MHC expression, thymocyte development of all three strains was arrested at 
the DP stage (see Fig. 3.20A). Fetal thymic organ cultures revealed that the replacement of 
the α-CPM did not affect negative selection (see Fig. 3.21, red arrows), while proper posi-
tive selection was only observed with wildtype and TM control thymocytes (see Fig. 3.21, 
blue arrows).  This was in agreement with the positive selection defects observed with two 
other α-CPM mutant TCRs of distinct specificities (Backstrom et al., 1998; Werlen et al., 
2000) and underlining the requirement of the α-CPM for positive selection of thymocytes 
expressing TCRα/β. 
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To characterize the ligand binding properties of α-CPM mutant TCRs defects, two step la-
beling assays were performed on the pre-selection thymocytes from T1; Rag-/-; β2m-/- mice. 
When monomers were used which were unable to bind CD8 (see Fig. 3.22) no significant 
affinity differences were observed between wildtype, α-CPM mutant and TM control TCRs. 
This confirmed the results obtained with the CD8 negative ‘58’ hybridomas and showed 
that the bivalent TCR-pMHC binding was not affected by replacement of the α-CPM. On 
the other hand, the trimolecular TCR/CD8-pMHC binding was reduced on α-CPM mutant 
thymocytes for all ligands and temperatures tested as indicated by the two step assay bind-
ing curves in Figure 3.22 and 3.23. But clearly, in all cases there was a small shift to higher 
ligand concentrations (i.e. an increase in the KD) when the ligand binding curves obtained 
from α-CPM mutant thymocytes were compared to TM control thymocytes. As indicated in 
Table VIII the affinity differences were small but reproducible, indicated by the 2- to 5-fold 
differences in the KD values between α-CPM mutant and TM control TCRs. Along the same 
line, the dissociation kinetics of the 4P-Kd (at 0°C and 24°C) and the 4S-Kd complexes (at 
0°C) were maximally 2-fold faster with the α-CPM mutant TCRs compared to the wildtype 
and the TM control TCRs (see Fig. 3.24). Considering the dramatic functional defects ob-
served with α-CPM mutant thymocytes concerning CD69 upregulation in response to weak 
ligands and abrogated positive selection, these relatively small defects in ligand binding 
which affect strong and weak ligands similarly (2- to 5-fold) do not reflect the dramatic 
differences in the EC50 values (> 17’000-fold in the case of 4A) observed from CD69 assays. 
How can this discrepancy by explained? 
Thymocyte positive selection is critically dependent on proper CD8 co-engagement in 
ligand binding. In mice expressing CD8β chimeric molecules, where the extracellular region 
of CD8β was replaced by the extracellular region of CD8α, the number of SP thymocytes 
dropped by 50%. Exchange of the transmembrane and cytosolic part of CDβ by CD8α re-
gions led to the same phenotype (Bosselut et al., 2000) and knocking out CD8β (leading to 
CD8α/α homodimer expression) was detrimental for thymocyte positive selection as well 
(Fung-Leung et al., 1993; Itano et al,. 1994; Nakayama et al., 1994; Crooks et al., 1994; 
Bosselut et al., 2000). This indicated that the presence of CD8β is absolutely required for 
positive selection of class I MHC restricted T cells and that CD8 fulfilled a dual function 
in terms of ligand binding and signaling. While the extracellular region of CD8β is very im-
portant in contributing to the ligand binding, the cytosolic regions were shown to be im-
portant to coordinate the recruitment of CD8α associated p56lck to the TCR/CD3 complex 
to initiate TCR signaling (Arcaro et al., 2000). Regarding the CD69 assays shown in Figure 
3.19, replacement of the α-CPM or blocking of the interaction between CD8 and MHC on 
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wildtype T1 thymocytes led to equal functional defects. Given the membrane proximal lo-
cation of the α-CPM, it seems unlikely that replacement of the α-CPM directly affected the 
interaction between CD8 and MHC. That α-CPM mutant TCRs bind ligands almost as well as 
wildtype and TM control receptors supports this idea. Nevertheless, in the absence of the 
α-CPM, thymocytes responded to weak ligands in the same way as if the CD8 MHC interac-
tion would not have taken place, i.e. similar to the response of wildtype and TM control 
thymocytes in the presence of an the SF1-1.1 mAb that blocks CD8 engagement of class I 
MHC. The data support the idea that mutation of the α-CPM rather has a minimal impact 
on ligand binding but a profound effect on initializing TCR mediated signals, particularly 
from low affinity ligands. Interestingly, this was not the case for strong ligands. Neither the 
replacement of the α-CPM nor the disruption of the CD8 MHC interaction by mAbs led to a 
dramatic decrease in CD69 upregulation. This argues for a model in which the response to 
strong ligands is relatively independent of CD8 binding to MHC. There are many reports sup-
porting this idea. As described above disruption of CD8β affected positive selection much 
more than negative selection (Fung-Leung et al., 1993; Itano et al,. 1994; Nakayama et 
al., 1994; Crooks et al., 1994) and that CD8 was only pivotal for responses to weak ligands, 
while the cells were not dependent on CD8 to respond to strong ligands (Kerry et al., 2003). 
Interestingly, while α-CPM mutant thymocytes were unable to induce any measurable Erk 
induction in response to weak, positive selecting ligands, the same ligands were able to 
induce p38 and Jnk, indicative of a second signaling pathway which was independent of the 
α-CPM (Werlen et al., 2000). 
Taken together these studies suggest, that only weak TCR ligand interactions required 
the simultaneous binding of CD8 to the same pMHC molecule. Transmission of the informa-
tion, that CD8 and the TCR are simultaneously bound to the same pMHC requires an intact 
α-CPM. It is conceivable that engagement of CD8 and the TCR near the plasma membrane 
is mediated by the α-CPM and the membrane proximal stalk of CD8β. This co-engagement 
would make it possible for low affinity ligands to initiate positive selection signals. The fact 
that mutation of the α-CPM has a small impact on the ability of CD8 to stabilize pMHC bind-
ing makes it unlikely that the α-CPM is just a ‘docking’ site for CD8. If ‘docking’ of CD8 to 
the TCR was needed to stabilize the trimeric, weak affinity TCR/CD8-pMHC interactions, 
replacement of the α-CPM should have led to a severe decrease in affinity or ‘off-rate’. This 
was not observed. Subsequent to ligand binding there might be a very transient interac-
tion between the CD8 and the α-CPM which allows the TCR to ‘sense’ the presence of CD8, 
without substantially altering the ‘off-rate’. How this is achieved is not yet clear. A study 
using the ‘58CD8α/β’ hybridomas described above, assigned a role to CD3δ in building a 
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functional link between the TCR and CD8 which was dependent on the presence of the 
α-CPM (Doucey et al., 2002). Interestingly mice lacking CD3δ or expressing mutant CD3δ 
chains lacking the extracellular region were also unable to undergo positive selection while 
negative selection was not affected (Dave et al., 1997; Delgado et al., 2000), similarly to 
CD8β deficient mice. Furthermore crystallographic studies showed a conserved orientation 
of the pMHC over the TCR, placing the MHC coreceptor binding site over the α-chain side 
of the TCR (Sun et al., 1995; Garcia et al., 1996; Garboczi et al., 1996; Teng et al., 1998; 
Speir et al., 1998). Evolution seems to have selected a pMHC orientation that places the 
coreceptor on the ‘α-side’ of the TCR, a side of the α/β heterodimer that also contains the 
α-CPM. In conclusion, the observations made with α-CPM mutant T1-TCRs combined with 
the data gained from CD8β and CD3δ mutant mice argue for a pivotal role of the α-CPM in 
‘sensing’ TCR-CD8 cooperativity. This cooperativity allows thymocytes responding to weak 
TCR ligands to initiate signals leading to positive selection. Clearly more studies need to be 
performed to understand how the α-CPM ‘reads’ TCR/CD8-pMHC interactions and how it 
‘tells’ it to the signaling machinery of the cell.  
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